Processing 00000000.tx.1: Increased tau Phosphorylation in Apolipoprotein E4 Transgenic Mice Is Associated with Activation of Extracellular Signal-regulated Kinase MODULATION BY ZINC* Faith M. 

Phrase: "Increased tau Phosphorylation in Apolipoprotein E4 Transgenic Mice"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0031715:Phosphorylation [Molecular Function]
   744   C1158886:Phosphorylation [Molecular Function]

Phrase: "Is"

Phrase: "Associated with Activation of Extracellular Signal-regulated Kinase MODULATION"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
   797   C0600388:Extracellular Signal Regulated Kinases [Amino Acid, Peptide, or Protein,Enzyme]
   797   C0752312:Extracellular Signal-Regulated Kinases [Amino Acid, Peptide, or Protein,Enzyme]
   764   C0332281:Associated with [Qualitative Concept]
           Associated
   742   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   742   C0443264:Modulation [Spatial Concept]
   742   C0521119:Extracellular [Cell Component]
   742   C0851285:Regulated [Governmental or Regulatory Activity]
   742   C1710082:Signal [Phenomenon or Process]
   742   C1879547:Activation [Activity]
   708 E C0750490:Associate [Idea or Concept]
   708 E C1706221:Associate [Professional or Occupational Group]

Phrase: "BY ZINC"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0043481:Zinc [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C2348288:Zinc [Element, Ion, or Isotope]

Phrase: "* Faith M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.2: Harris, Walter J. 

Phrase: "Harris,"

Phrase: "Walter J."
Processing 00000000.tx.3: Brecht, Qin Xu, Robert W. 

Phrase: "Brecht,"

Phrase: "Qin Xu,"

Phrase: "Robert W."
Processing 00000000.tx.4: Mahley||, and Yadong Huang** From the Gladstone Institutes of Neurological Disease and Cardiovascular Disease and the Departments of Pathology and ||Medicine, University of California, San Francisco, California 94141-9100 Received for publication, July 19, 2004 , and in revised form, August 18, 2004.  

Phrase: "Mahley||,"

Phrase: "and"

Phrase: "Yadong Huang"

Phrase: "*"

Phrase: "*"

Phrase: "From the Gladstone Institutes"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0021622:Institutes [Organization]
   827 E C1272753:Institute [Idea or Concept]

Phrase: "of Neurological Disease"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0027765:neurological disease [Disease or Syndrome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "and"

Phrase: "Cardiovascular Disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0007222:Cardiovascular disease [Disease or Syndrome]
   861   C0007226:Cardiovascular [Body System]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "and"

Phrase: "the Departments of Pathology"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   802   C0587487:Pathology department [Health Care Related Organization]
   737   C1704729:Department [Organization]

Phrase: "and ||"

Phrase: "Medicine,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0013227:Medicine, NOS [Pharmacologic Substance]
  1000   C0025118:Medicine [Biomedical Occupation or Discipline]

Phrase: "University of California,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0006754:California [Geographic Area]
   827   C0041740:University [Manufactured Object,Organization]
   827   C3146274:California [Plant]

Phrase: "San Francisco,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0036152:San Francisco [Geographic Area]
   861   C1826357:San [Gene or Genome]

Phrase: "California 94141-9100"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0006754:California [Geographic Area]
   827   C3146274:California [Plant]

Phrase: "Received for publication,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0034036:Publication [Intellectual Product,Manufactured Object]
   790   C0034037:Publication [Occupational Activity]
   790   C1514756:Received [Qualitative Concept]
   790   C1704324:Publication [Intellectual Product]

Phrase: "July 19,"

Phrase: "2004 ,"

Phrase: "and in revised form,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0348078:Form [Qualitative Concept]
   770   C0376315:Form [Manufactured Object]
   770   C1515981:And [Idea or Concept]
   770   C1522492:Form [Functional Concept]
   770   C1527075:Revised [Therapeutic or Preventive Procedure]

Phrase: "August 18,"

Phrase: "2004."
Processing 00000000.tx.5: ABSTRACT TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES  Although apolipoprotein (apo) E4 is present in amyloid plaques and neurofibrillary tangles, its pathogenic role in Alzheimer's disease (AD) is unclear. 

Phrase: "ABSTRACT TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   758   C1514811:Reference [Idea or Concept]
   758   C1706462:Reference [Conceptual Entity]

Phrase: "Although"

Phrase: "apolipoprotein (apo) E4"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0052201:Apolipoprotein E-4 [Amino Acid, Peptide, or Protein]
   861   C0003591:Apolipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "is"

Phrase: "present in amyloid plaques"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0150312:Present [Quantitative Concept]
   770   C0449450:Present [Idea or Concept]

Phrase: "and"

Phrase: "neurofibrillary tangles,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0085400:Neurofibrillary Tangles [Acquired Abnormality]
   966 E C3543859:neurofibrillary tangle [Cell Component]

Phrase: "its pathogenic role in Alzheimer's disease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0035820:Role [Social Behavior]
   753   C1705810:Role [Conceptual Entity]

Phrase: "(AD)"

Phrase: "is"

Phrase: "unclear."
Processing 00000000.tx.6: Neuronal expression of apoE4 or apoE4 fragments in transgenic mice increases tau phosphorylation. 

Phrase: "Neuronal expression of apoE4"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "or"

Phrase: "apoE4"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0052201:ApoE4 [Amino Acid, Peptide, or Protein]
  1000   C2984964:APOE4 [Laboratory Procedure]

Phrase: "fragments in transgenic mice"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   833   C0025936:Mice, Transgenic [Mammal]
   770   C0003069:Transgenic [Animal]
   770   C0025914:Mice [Mammal]
   770   C0025929:mice [Mammal]
   770   C0026809:Mice [Mammal]
   770   C0332255:fragment [Functional Concept]
   770   C0486805:Fragments [Body Substance]
   770   C1708096:Fragment [Qualitative Concept]

Phrase: "increases"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "tau phosphorylation."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0031715:Phosphorylation [Molecular Function]
   861   C1158886:Phosphorylation [Molecular Function]
Processing 00000000.tx.7: To identify the kinase responsible for the increase, we studied transgenic mice expressing human apoE3 or apoE4 in neurons under the control of the neuron-specific enolase promoter. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "identify"

Phrase: "the kinase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "responsible for the increase,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1273518:Responsible [Finding]

Phrase: "we"

Phrase: "studied"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0557651:Study [Manufactured Object]
   966   C2603343:Study [Research Activity]

Phrase: "transgenic mice"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0025936:Mice, Transgenic [Mammal]
   861   C0003069:Transgenic [Animal]
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]

Phrase: "expressing"

Phrase: "human apoE3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0052199:Apo E3 [Amino Acid, Peptide, or Protein]

Phrase: "or"

Phrase: "apoE4 in neurons"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0052201:ApoE4 [Amino Acid, Peptide, or Protein]
   790   C2984964:APOE4 [Laboratory Procedure]

Phrase: "under the control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "of the neuron-specific enolase promoter."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   756   C1414404:ENOLASE, NEURON-SPECIFIC [Gene or Genome]
   756   C1880904:Neuron-Specific Enolase [Amino Acid, Peptide, or Protein,Enzyme,Neuroreactive Substance or Biogenic Amine]
Processing 00000000.tx.8: Brain levels of phosphorylated tau (p-tau) and phosphorylated (active) extracellular signal-regulated kinase (p-Erk) increased with age in both groups but were considerably higher in the apoE4 mice. 

Phrase: "Brain levels of phosphorylated tau (p-tau)"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   760   C0006104:Brain [Body Part, Organ, or Organ Component]
   760   C0441889:Levels [Qualitative Concept]
   760   C1269537:Brain [Body Part, Organ, or Organ Component]
   726 E C0456079:Level [Classification]
   726 E C1547707:Level [Geographic Area]
   726 E C2946261:Level [Pharmacologic Substance]

Phrase: "and"

Phrase: "phosphorylated"

Phrase: "(active"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205177:Active [Functional Concept]

Phrase: ")"

Phrase: "extracellular signal-regulated kinase"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   979   C0600388:Extracellular Signal Regulated Kinases [Amino Acid, Peptide, or Protein,Enzyme]
   979   C0752312:Extracellular Signal-Regulated Kinases [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0521119:Extracellular [Cell Component]
   812   C0851285:Regulated [Governmental or Regulatory Activity]
   812   C1710082:Signal [Phenomenon or Process]

Phrase: "(p-Erk)"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C2603361:P' [Clinical Attribute]

Phrase: "increased with age"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0001779:Age [Organism Attribute]
   790   C0205217:Increased [Quantitative Concept]
   790   C0442805:Increased [Functional Concept]
   718 E C1517378:Gain [Quantitative Concept]

Phrase: "in both groups"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0441833:Group [Idea or Concept]
  1000   C0687744:group [Population Group]
  1000   C1257890:Group [Population Group]
  1000   C1552516:Group [Health Care Related Organization]
  1000   C1552839:groups [Idea or Concept]
  1000   C1705428:Group [Conceptual Entity]
  1000   C1705429:Group [Population Group]

Phrase: "but"

Phrase: "were"

Phrase: "considerably higher in the apoE4 mice."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   719   C0205250:High [Qualitative Concept]
   719   C1299351:High [Qualitative Concept]
   719   C2700149:HIGH [Intellectual Product]
Processing 00000000.tx.9: Other candidate kinases, including glycogen synthase kinase 3 and cyclin-dependent kinase-5 and its activators p25 and p35, were not significantly altered. 

Phrase: "Other candidate kinases,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0031727:Kinases [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "glycogen synthase kinase 3"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   923   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   812   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "cyclin-dependent kinase-5"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
  1000   C0249586:Cyclin-Dependent Kinase 5 [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1332735:CYCLIN-DEPENDENT KINASE 5 [Gene or Genome]
   923   C0243045:Cyclin-Dependent Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0072108:Cyclin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0079183:Cyclin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0851827:Dependent [Qualitative Concept]
   812   C1150565:cyclin [Molecular Function]
   812   C1701901:Dependent [Qualitative Concept]
   812   C3244310:dependent [Functional Concept]

Phrase: "and"

Phrase: "its activators p25"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3539715:p25 [Gene or Genome]

Phrase: "and"

Phrase: "p35,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3539715:p35 [Gene or Genome]

Phrase: "were"

Phrase: "not significantly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518422:Not [Functional Concept]

Phrase: "altered."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392747:Altered [Functional Concept]
Processing 00000000.tx.10: The increases in p-Erk and p-tau were highest in the hippocampus, intermediate in the cortex, and lowest in the cerebellum. 

Phrase: "The increases in p-Erk"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0442805:increases [Functional Concept]

Phrase: "and"

Phrase: "p-tau"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1720655:Tau [Intellectual Product]
   861   C1947974:Tau [Research Activity]

Phrase: "were"

Phrase: "highest in the hippocampus,"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   770   C1522410:Highest [Qualitative Concept]
   737 E C0205250:High [Qualitative Concept]
   737 E C1299351:High [Qualitative Concept]
   737 E C2700149:HIGH [Intellectual Product]

Phrase: "intermediate in the cortex,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0205103:Intermediate [Spatial Concept]
   770   C1550465:intermediate [Idea or Concept]
   770   C2827755:INTERMEDIATE [Laboratory or Test Result]

Phrase: "and"

Phrase: "lowest in the cerebellum."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   770   C1708760:Lowest [Qualitative Concept]
   737 E C0205251:low [Qualitative Concept]
   737 E C1299352:Low [Qualitative Concept]
   737 E C1550472:low [Idea or Concept]
Processing 00000000.tx.11: In the hippocampus, p-Erk and p-tau accumulated in the hilus and CA3 region of the dentate gyrus, where high levels of zinc are found along mossy fibers. 

Phrase: "In the hippocampus,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0019564:Hippocampus [Body Part, Organ, or Organ Component]
  1000   C0949582:Hippocampus [Fish]
  1000   C1029104:Hippocampus [Fish]
  1000   C1284077:Hippocampus [Body Part, Organ, or Organ Component]

Phrase: "p-Erk"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C2603361:P' [Clinical Attribute]

Phrase: "and"

Phrase: "p-tau"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1720655:Tau [Intellectual Product]
   861   C1947974:Tau [Research Activity]

Phrase: "accumulated in the hilus"

Phrase: "and"

Phrase: "CA3 region of the dentate gyrus,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0017446:Region [Geographic Area]
   753   C0205147:Region [Spatial Concept]

Phrase: "where high levels of zinc"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
   797   C0729826:levels zinc [Laboratory or Test Result]
   781 E C0373748:Zinc level [Laboratory Procedure]
   760   C0441889:Levels [Qualitative Concept]
   726 E C0456079:Level [Classification]
   726 E C1547707:Level [Geographic Area]
   726 E C2946261:Level [Pharmacologic Substance]

Phrase: "are"

Phrase: "found along mossy fibers."
Meta Candidates (Total=8; Excluded=5; Pruned=0; Remaining=3)
   799   C0596975:mossy fiber [Cell Component]
   770   C0150312:Found [Quantitative Concept]
   770   C1304649:Fibers [Tissue]
   737 E C0012173:Fiber [Food]
   737 E C0225326:Fiber [Pharmacologic Substance]
   737 E C0243095:Find [Finding]
   737 E C0304068:Fiber [Plant]
   737 E C1260603:Fiber [Plant]
Processing 00000000.tx.12: In Neuro-2a cells stably expressing apoE3 or apoE4, treatment with ZnCl2 generated 2-fold more p-Erk and 3-fold more p-tau in the apoE4-expressing cells. 

Phrase: "In Neuro-2a cells stably"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "expressing"

Phrase: "apoE3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0052199:Apo E3 [Amino Acid, Peptide, or Protein]

Phrase: "or"

Phrase: "apoE4,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0052201:ApoE4 [Amino Acid, Peptide, or Protein]
  1000   C2984964:APOE4 [Laboratory Procedure]

Phrase: "treatment with ZnCl2"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0039798:treatment [Functional Concept]
   790   C0087111:Treatment [Therapeutic or Preventive Procedure]
   790   C1522326:Treatment [Functional Concept]
   790   C1533734:Treatment [Therapeutic or Preventive Procedure]
   790   C1705169:Treatment [Conceptual Entity]
   790   C3538994:TREATMENT [Research Activity]

Phrase: "generated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3146294:Generated [Activity]

Phrase: "2-fold more p-Erk"

Phrase: "and"

Phrase: "3-fold more p-tau in the apoE4-expressing cells."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   757   C2362079:TAU 3 [Immunologic Factor]
   739   C1720655:Tau [Intellectual Product]
   739   C1947974:Tau [Research Activity]
Processing 00000000.tx.13: Phosphorylation of Erk and tau was reduced by preincubation with the Erk pathway inhibitor U0126. 

Phrase: "Phosphorylation of Erk"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0031715:Phosphorylation [Molecular Function]
   790   C1158886:Phosphorylation [Molecular Function]

Phrase: "and"

Phrase: "tau"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1720655:Tau [Intellectual Product]
  1000   C1947974:Tau [Research Activity]

Phrase: "was"

Phrase: "reduced by preincubation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0392756:Reduced [Qualitative Concept]

Phrase: "with the Erk pathway inhibitor U0126."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0755562:U0126 [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.14: Thus, increased tau phosphorylation in apoE4 transgenic mice was associated with Erk activation and could be modified by zinc, suggesting that apoE4 and zinc act in concert to contribute to the pathogenesis of AD.  

Phrase: "Thus,"

Phrase: "increased tau phosphorylation in apoE4 transgenic mice"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0031715:Phosphorylation [Molecular Function]
   748   C1158886:Phosphorylation [Molecular Function]

Phrase: "was"

Phrase: "associated with Erk activation"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   770   C1879547:Activation [Activity]
   737 E C0750490:Associate [Idea or Concept]
   737 E C1706221:Associate [Professional or Occupational Group]

Phrase: "and"

Phrase: "could"

Phrase: "be"

Phrase: "modified by zinc,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   882   C0205349:Modified By [Qualitative Concept]
   790   C0043481:Zinc [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   790   C0392747:Modified [Functional Concept]
   790   C2348288:Zinc [Element, Ion, or Isotope]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that apoE4"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0052201:ApoE4 [Amino Acid, Peptide, or Protein]
  1000   C2984964:APOE4 [Laboratory Procedure]

Phrase: "and"

Phrase: "zinc"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0043481:Zinc [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C2348288:Zinc [Element, Ion, or Isotope]

Phrase: "act in concert to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0079613:ACT [Therapeutic or Preventive Procedure]

Phrase: "contribute to the pathogenesis of AD."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0543483:pathogenesis [Functional Concept]
   753   C0699748:Pathogenesis [Pathologic Function]
   753   C1880177:Contribute [Activity]
Processing 00000000.tx.15: INTRODUCTION TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES  Human apolipoprotein (apo)1 E4 has been identified as a major risk factor for Alzheimer's disease (AD) (1, 2). 

Phrase: "INTRODUCTION TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0557061:Discussion [Therapeutic or Preventive Procedure]
   793   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Human apolipoprotein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0003591:Apolipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(apo"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003591:Apolipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ")"

Phrase: "1 E4"

Phrase: "has"

Phrase: "been"

Phrase: "identified as a major risk factor"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   790   C0035648:Risk factor [Quantitative Concept]
   783   C0960756:factor A [Organic Chemical]
   753   C0035647:Risk [Qualitative Concept]
   753   C0205164:Major [Qualitative Concept]
   753   C0205396:Identified [Qualitative Concept]
   753   C1521761:Factor [Functional Concept]
   753   C1550043:Identified [Finding]
   753   C1551388:Identified [Functional Concept]
   753   C2827422:Factor [Conceptual Entity]

Phrase: "for Alzheimer's disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "(AD) (1,"

Phrase: "2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ")."
Processing 00000000.tx.16: It increases the occurrence and lowers the age of onset of AD and is associated with 4065% of cases of sporadic and familial AD (1, 2). 

Phrase: "It"

Phrase: "increases"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "the occurrence"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0243132:occurrence [Functional Concept]
  1000   C1554210:occurrence [Idea or Concept]
  1000   C2745955:Occurrence [Temporal Concept]

Phrase: "and"

Phrase: "lowers"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0441994:Lower [Spatial Concept]
  1000   C1548802:Lower [Body Location or Region]
  1000   C2003888:Lower [Activity]

Phrase: "the age of onset of AD"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0206132:Age of Onset [Quantitative Concept]
           Onset Age
   753   C0001779:Age [Organism Attribute]

Phrase: "and"

Phrase: "is"

Phrase: "associated with 4065% of cases of sporadic"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   778   C0332281:Associated with [Qualitative Concept]
           Associated
   748   C0205422:Sporadic [Temporal Concept]
   748   C0868928:Cases [Functional Concept]
   748   C1533148:Cases [Quantitative Concept]
   714 E C0750490:Associate [Idea or Concept]
   714 E C1706221:Associate [Professional or Occupational Group]
   714 E C1706255:CASE [Medical Device]
   714 E C1706256:Case [Conceptual Entity]

Phrase: "and"

Phrase: "familial AD (1,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0015576:familial [Family Group]
   827   C0241888:Familial [Functional Concept]
   755 E C1704727:Family [Conceptual Entity]

Phrase: "2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ")."
Processing 00000000.tx.17: The neuropathological hallmarks of AD are neuritic amyloid plaques and neurofibrillary tangles (NFTs) in the brain (35). 

Phrase: "The neuropathological hallmarks of AD"

Phrase: "are"

Phrase: "neuritic amyloid plaques"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   913   C0333463:Neuritic Plaques [Acquired Abnormality]
           amyloid plaques
           plaques
   901   C2936349:Plaques, Amyloid [Acquired Abnormality]
   793 E C0011389:Plaque [Disease or Syndrome]
   793 E C0332461:Plaque [Finding]

Phrase: "and"

Phrase: "neurofibrillary tangles (NFTs) in the brain"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   806   C0085400:Neurofibrillary Tangles [Acquired Abnormality]
   773 E C3543859:neurofibrillary tangle [Cell Component]

Phrase: "(35"

Phrase: ")."
Processing 00000000.tx.18: The plaques are extracellular deposits consisting primarily of amyloid-beta (A) peptides (35), the proteolytic products of the amyloid protein precursor. 

Phrase: "The plaques"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0333463:plaques [Acquired Abnormality]
   966 E C0011389:Plaque [Disease or Syndrome]
   966 E C0332461:Plaque [Finding]

Phrase: "are"

Phrase: "extracellular deposits"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0333562:Deposits [Functional Concept]

Phrase: "consisting"

Phrase: "primarily of amyloid-beta"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   833   C3484390:Amyloid beta [Amino Acid, Peptide, or Protein]
   819 E C2825879:Amyloid, Beta [Laboratory Procedure]
   770   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0011560:Amyloid [Pathologic Function]
   770   C0330390:Beta [Plant]
   770   C0439096:Beta [Intellectual Product]
   770   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C2004068:Beta [Qualitative Concept]

Phrase: "(A) peptides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030956:Peptides [Amino Acid, Peptide, or Protein]

Phrase: "(35"

Phrase: ")"

Phrase: ","

Phrase: "the proteolytic products of the amyloid protein precursor."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   744   C1514468:Products [Entity]
   711 E C1704444:Product [Quantitative Concept]
Processing 00000000.tx.19: NFTs are primarily intracellular deposits composed largely of highly phosphorylated tau (p-tau), a microtubule-associated protein (4), as well as phosphorylated neurofilaments of high molecular weight (6, 7). 

Phrase: "NFTs"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0085400:Neurofibrillary Tangles [Acquired Abnormality]
   966 E C3543859:neurofibrillary tangle [Cell Component]

Phrase: "are"

Phrase: "primarily intracellular deposits"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0333562:Deposits [Functional Concept]

Phrase: "composed"

Phrase: "largely of highly phosphorylated tau"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0205250:Highly [Qualitative Concept]
   760   C1720655:Tau [Intellectual Product]
   760   C1947974:Tau [Research Activity]

Phrase: "(p-tau"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1720655:Tau [Intellectual Product]
   861   C1947974:Tau [Research Activity]

Phrase: ")"

Phrase: ","

Phrase: "a microtubule-associated protein (4"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C0127014:microtubule associated protein 4 [Amino Acid, Peptide, or Protein]
  1000   C1417017:MICROTUBULE-ASSOCIATED PROTEIN 4 [Gene or Genome]
   923   C0026045:Microtubule-associated protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0026046:Micro-tubule [Cell Component]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0332281:Associated [Qualitative Concept]
   779 E C0750490:Associate [Idea or Concept]
   779 E C1706221:Associate [Professional or Occupational Group]

Phrase: ")"

Phrase: ","

Phrase: "as well as"

Phrase: "phosphorylated neurofilaments of high molecular weight"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0027834:neurofilaments [Cell Component]

Phrase: "(6,"

Phrase: "7"

Phrase: ")."
Processing 00000000.tx.20: Both plaques and NFTs contain apoE (810), but the role of apoE in the pathogenesis of these lesions is unclear. 

Phrase: "Both plaques"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0333463:plaques [Acquired Abnormality]
   966 E C0011389:Plaque [Disease or Syndrome]
   966 E C0332461:Plaque [Finding]

Phrase: "and"

Phrase: "NFTs"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0085400:Neurofibrillary Tangles [Acquired Abnormality]
   966 E C3543859:neurofibrillary tangle [Cell Component]

Phrase: "contain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "apoE"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0523511:APOE [Laboratory Procedure]
  1000   C1412481:APOE [Gene or Genome]

Phrase: "(810"

Phrase: ")"

Phrase: ","

Phrase: "but"

Phrase: "the role of apoE"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0035820:Role [Social Behavior]
   770   C1705810:Role [Conceptual Entity]

Phrase: "in the pathogenesis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0543483:pathogenesis [Functional Concept]
  1000   C0699748:Pathogenesis [Pathologic Function]

Phrase: "of these lesions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0221198:lesions [Finding]
   966 E C1546698:Lesion [Intellectual Product]

Phrase: "is"

Phrase: "unclear."
Processing 00000000.tx.21: Several hypotheses have been proposed to explain the association of apoE4 with AD (1014). 

Phrase: "Several hypotheses"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1512571:Hypothesis [Idea or Concept]

Phrase: "have"

Phrase: "been"

Phrase: "proposed"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1441414:PROPOSED [Idea or Concept]
  1000   C1553874:Proposed [Qualitative Concept]
  1000   C1578820:Proposed [Idea or Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "explain"

Phrase: "the association of apoE4"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0004083:Association [Mental Process]
   770   C0439849:Association [Qualitative Concept]
   770   C0596306:Association [Phenomenon or Process]
   770   C0699792:association [Social Behavior]

Phrase: "with AD (1014"

Phrase: ")."
Processing 00000000.tx.22: They include modulation of the deposition and clearance of A peptides and the formation of plaques (1521), impairment of the antioxidative defense system (22), dysregulation of neuronal signaling pathways (23), altered phosphorylation of tau and NFT formation (2429), depletion of cytosolic androgen receptor levels in the brain (30, 31), potentiation of A-induced lysosomal leakage and apoptosis in neuronal cells (32), and promotion of endosomal abnormalities linked to A overproduction (3335). 

Phrase: "They"

Phrase: "include"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332257:include [Functional Concept]
  1000   C1552866:include [Idea or Concept]
  1000   C2700399:Include [Activity]

Phrase: "modulation of the deposition"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0443264:Modulation [Spatial Concept]

Phrase: "and"

Phrase: "clearance of A peptides"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0449297:Clearance [Qualitative Concept]
   770   C1382187:Clearance [Clinical Attribute]
   770   C2825073:Clearance [Natural Phenomenon or Process]

Phrase: "and"

Phrase: "the formation of plaques"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0220781:formation [Biologic Function]
   770   C0439634:formation [Spatial Concept]
   770   C1522492:Formation [Functional Concept]

Phrase: "(1521"

Phrase: ")"

Phrase: ","

Phrase: "impairment of the antioxidative defense system"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0684336:Impairment [Pathologic Function]

Phrase: "(22"

Phrase: ")"

Phrase: ","

Phrase: "dysregulation of neuronal signaling pathways"

Phrase: "(23"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "altered phosphorylation of tau"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0031715:Phosphorylation [Molecular Function]
   770   C1158886:Phosphorylation [Molecular Function]

Phrase: "and"

Phrase: "NFT formation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0220781:formation [Biologic Function]
   861   C0439634:formation [Spatial Concept]
   861   C1522492:Formation [Functional Concept]

Phrase: "(2429"

Phrase: ")"

Phrase: ","

Phrase: "depletion of cytosolic androgen receptor levels"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0333668:Depletion [Functional Concept]

Phrase: "in the brain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006104:Brain [Body Part, Organ, or Organ Component]
  1000   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "(30,"

Phrase: "31"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "potentiation of A-induced lysosomal leakage"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0279023:Potentiation [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "apoptosis in neuronal cells"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   870   C1660771:neuronal cell apoptosis [Cell Function]
           neuron apoptosis
   770   C0162638:Apoptosis [Cell Function]
   748 E C1836846:Apoptotic neurons [Finding]

Phrase: "(32"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "promotion of endosomal abnormalities"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0033414:Promotion [Activity]

Phrase: "linked to A overproduction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   737   C1517892:Link [Intellectual Product]
   737   C1704666:Link [Intellectual Product]

Phrase: "(3335"

Phrase: ")."
Processing 00000000.tx.23: However, the mechanisms of these apoE4-mediated detrimental effects are largely unknown, and it is not known which are the primary effects and which are subsequent or downstream effects. 

Phrase: "However,"

Phrase: "the mechanisms of these apoE4-mediated detrimental effects"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   744   C0441712:Mechanisms [Functional Concept]
   711 E C1706376:Mechanism [Manufactured Object]

Phrase: "are"

Phrase: "largely unknown,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439673:Unknown [Qualitative Concept]

Phrase: "and"

Phrase: "it"

Phrase: "is"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "known"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205309:Known [Qualitative Concept]

Phrase: "which"

Phrase: "are"

Phrase: "the primary effects"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1280500:effects [Qualitative Concept]
   827 E C2348382:Effect [Qualitative Concept]

Phrase: "and"

Phrase: "which"

Phrase: "are"

Phrase: "subsequent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332282:Subsequent [Temporal Concept]

Phrase: "or"

Phrase: "downstream effects."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1280500:effects [Qualitative Concept]
   827 E C2348382:Effect [Qualitative Concept]
Processing 00000000.tx.24: ApoE3 and apoE4 have different effects on the structure and function of the cytoskeleton (3638). 

Phrase: "ApoE3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0052199:Apo E3 [Amino Acid, Peptide, or Protein]

Phrase: "and"

Phrase: "apoE4"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0052201:ApoE4 [Amino Acid, Peptide, or Protein]
  1000   C2984964:APOE4 [Laboratory Procedure]

Phrase: "have"

Phrase: "different effects on the structure"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C1280500:effects [Qualitative Concept]
   726 E C2348382:Effect [Qualitative Concept]

Phrase: "and"

Phrase: "function of the cytoskeleton"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0031843:function [Physiologic Function]
   770   C0542341:Function [Functional Concept]
   770   C0700205:FUNCTION [Classification]
   770   C1705273:Function [Intellectual Product]

Phrase: "(3638"

Phrase: ")."
Processing 00000000.tx.25: Levels of p-tau were higher in transgenic mice expressing apoE4 in neurons than in mice expressing apoE4 in astrocytes (25, 39), suggesting a neuron-specific effect of apoE4 on tau phosphorylation. 

Phrase: "Levels of p-tau"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   770   C0441889:Levels [Qualitative Concept]
   737 E C0456079:Level [Classification]
   737 E C1547707:Level [Geographic Area]
   737 E C2946261:Level [Pharmacologic Substance]

Phrase: "were"

Phrase: "higher in transgenic mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   737   C0205250:High [Qualitative Concept]
   737   C1299351:High [Qualitative Concept]
   737   C2700149:HIGH [Intellectual Product]

Phrase: "expressing"

Phrase: "apoE4 in neurons"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0052201:ApoE4 [Amino Acid, Peptide, or Protein]
   790   C2984964:APOE4 [Laboratory Procedure]

Phrase: "than"

Phrase: "in mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mice [Mammal]
  1000   C0025929:mice [Mammal]
  1000   C0026809:Mice [Mammal]

Phrase: "expressing"

Phrase: "apoE4 in astrocytes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0052201:ApoE4 [Amino Acid, Peptide, or Protein]
   790   C2984964:APOE4 [Laboratory Procedure]

Phrase: "(25,"

Phrase: "39"

Phrase: ")"

Phrase: ","

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "a neuron-specific effect of apoE4"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1280500:Effect [Qualitative Concept]
   753   C2348382:Effect [Qualitative Concept]

Phrase: "on tau phosphorylation."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0031715:Phosphorylation [Molecular Function]
   861   C1158886:Phosphorylation [Molecular Function]
Processing 00000000.tx.26: We have shown that apoE4 or apoE4 fragments are much more effective than apoE3 in stimulating abnormal phosphorylation of tau in transgenic mice (28, 29, 40). 

Phrase: "We"

Phrase: "have"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that apoE4"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0052201:ApoE4 [Amino Acid, Peptide, or Protein]
  1000   C2984964:APOE4 [Laboratory Procedure]

Phrase: "or"

Phrase: "apoE4 fragments"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0332255:fragments [Functional Concept]
   861   C0486805:Fragments [Body Substance]
   827 E C1708096:Fragment [Qualitative Concept]

Phrase: "are"

Phrase: "much more effective than apoE3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1280519:effective [Qualitative Concept]
   760   C1704419:Effective [Qualitative Concept]

Phrase: "in stimulating abnormal phosphorylation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0031715:Phosphorylation [Molecular Function]
   827   C1158886:Phosphorylation [Molecular Function]

Phrase: "of tau"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1720655:Tau [Intellectual Product]
  1000   C1947974:Tau [Research Activity]

Phrase: "in transgenic mice"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0025936:Mice, Transgenic [Mammal]
   861   C0003069:Transgenic [Animal]
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]

Phrase: "(28,"

Phrase: "29,"

Phrase: "40"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439509:/40 [Temporal Concept]

Phrase: ")."
Processing 00000000.tx.27: Because tau normally binds to and stabilizes microtubules and stimulates their assembly by polymerizing tubulin, hyperphosphorylation may prevent tau from interacting with these structures, leading to their destabilization and NFT formation (4, 41). 

Phrase: "Because"

Phrase: "tau normally"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1720655:Tau [Intellectual Product]
   861   C1947974:Tau [Research Activity]

Phrase: "binds to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C1145667:Bind [Activity]
   833   C1167622:bind [Molecular Function]

Phrase: "and"

Phrase: "stabilizes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0184512:stabilize [Qualitative Concept]

Phrase: "microtubules"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0026046:Microtubules [Cell Component]

Phrase: "and"

Phrase: "stimulates"

Phrase: "their assembly by polymerizing tubulin,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   797   C2611809:tubulin assembly [Molecular Function]
   760   C1706853:Assembly [Activity]
   760   C1879748:Assembly [Manufactured Object]

Phrase: "hyperphosphorylation"

Phrase: "may"

Phrase: "prevent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0309872:PREVENT [Pharmacologic Substance]

Phrase: "tau from interacting"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1720655:Tau [Intellectual Product]
   790   C1947974:Tau [Research Activity]

Phrase: "with these structures,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0678594:structures [Spatial Concept]

Phrase: "leading to their destabilization"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
   770   C0332152:Leading [Temporal Concept]
   770   C1522538:Leading [Functional Concept]
   737 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   737 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   737 E C2348269:Lead [Element, Ion, or Isotope]
   737 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "NFT formation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0220781:formation [Biologic Function]
   861   C0439634:formation [Spatial Concept]
   861   C1522492:Formation [Functional Concept]

Phrase: "(4,"

Phrase: "41"

Phrase: ")."
Processing 00000000.tx.28: Many kinases may be involved in tau phosphorylation in vitro and in vivo (4253), including glycogen synthase kinase-3 (GSK-3), cyclin-dependent kinase-5 (Cdk-5) and its activators, the phosphorylated (active) form of extracellular signal-regulated kinase (p-Erk), microtubule-affinity regulating kinase, and fyn kinase. 

Phrase: "Many kinases"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0031727:Kinases [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "may"

Phrase: "be"

Phrase: "involved in tau phosphorylation"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0031715:Phosphorylation [Molecular Function]
   770   C1158886:Phosphorylation [Molecular Function]
   770   C1314939:Involved [Functional Concept]
   770   C1720655:Tau [Intellectual Product]
   770   C1947974:Tau [Research Activity]

Phrase: "in vitro"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]

Phrase: "and"

Phrase: "in vivo"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "(4253"

Phrase: ")"

Phrase: ","

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "glycogen synthase kinase-3 (GSK-3),"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   923   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   812   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "cyclin-dependent kinase-5 (Cdk-5)"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
  1000   C0249586:Cyclin-Dependent Kinase 5 [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1332735:CYCLIN-DEPENDENT KINASE 5 [Gene or Genome]
   923   C0243045:Cyclin-Dependent Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0072108:Cyclin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0079183:Cyclin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0851827:Dependent [Qualitative Concept]
   812   C1150565:cyclin [Molecular Function]
   812   C1701901:Dependent [Qualitative Concept]
   812   C3244310:dependent [Functional Concept]

Phrase: "and"

Phrase: "its activators,"

Phrase: "the phosphorylated"

Phrase: "(active"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205177:Active [Functional Concept]

Phrase: ")"

Phrase: "form of extracellular signal-regulated kinase"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   861   C0600388:Extracellular Signal Regulated Kinases [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0752312:Extracellular Signal-Regulated Kinases [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0348078:Form [Qualitative Concept]
   753   C0376315:Form [Manufactured Object]
   753   C0521119:Extracellular [Cell Component]
   753   C0851285:Regulated [Governmental or Regulatory Activity]
   753   C1522492:Form [Functional Concept]
   753   C1710082:Signal [Phenomenon or Process]

Phrase: "(p-Erk"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: ","

Phrase: "microtubule-affinity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1510827:Affinity [Natural Phenomenon or Process]

Phrase: "regulating"

Phrase: "kinase,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "fyn kinase."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.29: Zinc, which is highly concentrated in synaptic vesicles in the mossy fiber zone of the hippocampus and may also be involved in AD pathogenesis (54), can activate some of these kinases, including Erk (5562). 

Phrase: "Zinc,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0043481:Zinc [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C2348288:Zinc [Element, Ion, or Isotope]

Phrase: "which"

Phrase: "is"

Phrase: "highly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205250:Highly [Qualitative Concept]

Phrase: "concentrated in synaptic vesicles"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   833   C0039065:Synaptic Vesicles [Cell Component]
   770   C0333262:VESICLES [Acquired Abnormality]
   770   C1880165:Concentrated [Biomedical or Dental Material]
   737 E C1622418:vesicle [Cell Component]
   737 E C1880310:Concentrate [Manufactured Object]
   737 E C2003864:Concentrate [Substance]

Phrase: "in the mossy fiber zone"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C1710706:Zone [Spatial Concept]
   755 E C1564799:Zonal [Organic Chemical,Pharmacologic Substance]
   734   C0596975:mossy fiber [Cell Component]

Phrase: "of the hippocampus"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0019564:Hippocampus [Body Part, Organ, or Organ Component]
  1000   C0949582:Hippocampus [Fish]
  1000   C1029104:Hippocampus [Fish]
  1000   C1284077:Hippocampus [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "may"

Phrase: "also"

Phrase: "be"

Phrase: "involved in AD pathogenesis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0543483:pathogenesis [Functional Concept]
   770   C0699748:Pathogenesis [Pathologic Function]
   770   C1314939:Involved [Functional Concept]

Phrase: "(54"

Phrase: ")"

Phrase: ","

Phrase: "can"

Phrase: "activate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515877:Activate [Functional Concept]
  1000   C1879547:Activate [Activity]

Phrase: "some of these kinases,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0031727:Kinases [Amino Acid, Peptide, or Protein,Enzyme]
   770   C0205392:Some [Quantitative Concept]
   770   C3540770:Some [Intellectual Product]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "Erk (5562"

Phrase: ")."
Processing 00000000.tx.30: How apoE4 stimulates tau phosphorylation is largely unknown. 

Phrase: "How apoE4"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0052201:ApoE4 [Amino Acid, Peptide, or Protein]
   861   C2984964:APOE4 [Laboratory Procedure]

Phrase: "stimulates"

Phrase: "tau phosphorylation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0031715:Phosphorylation [Molecular Function]
   861   C1158886:Phosphorylation [Molecular Function]

Phrase: "is"

Phrase: "largely unknown."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439673:Unknown [Qualitative Concept]
Processing 00000000.tx.31: In this study, we investigated the mechanisms by which apoE4 elicits abnormal phosphorylation of tau in transgenic mice. 

Phrase: "In this study,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "we"

Phrase: "investigated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigated [Functional Concept]

Phrase: "the mechanisms by which apoE4"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0441712:Mechanisms [Functional Concept]
   726 E C1706376:Mechanism [Manufactured Object]

Phrase: "elicits"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449265:elicit [Qualitative Concept]

Phrase: "abnormal phosphorylation of tau"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0031715:Phosphorylation [Molecular Function]
   770   C1158886:Phosphorylation [Molecular Function]

Phrase: "in transgenic mice."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0025936:Mice, Transgenic [Mammal]
   861   C0003069:Transgenic [Animal]
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]
Processing 00000000.tx.32: Here we report that apoE4 increases zinc-induced Erk activation in neuronal cells and enhances tau phosphorylation, especially in the hippocampus, in transgenic mice.  

Phrase: "Here"

Phrase: "we"

Phrase: "report"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0684224:Report [Intellectual Product]
  1000   C0700287:Report [Health Care Activity]
  1000   C3273238:Report [Intellectual Product]

Phrase: "that apoE4"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0052201:ApoE4 [Amino Acid, Peptide, or Protein]
  1000   C2984964:APOE4 [Laboratory Procedure]

Phrase: "increases"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "zinc-induced Erk activation in neuronal cells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   774   C1326120:activation cells [Cell Function]
   748   C1879547:Activation [Activity]

Phrase: "and"

Phrase: "enhances"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2349975:Enhance [Activity]

Phrase: "tau phosphorylation,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0031715:Phosphorylation [Molecular Function]
   861   C1158886:Phosphorylation [Molecular Function]

Phrase: "especially in the hippocampus,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0019564:Hippocampus [Body Part, Organ, or Organ Component]
   770   C0949582:Hippocampus [Fish]
   770   C1029104:Hippocampus [Fish]
   770   C1284077:Hippocampus [Body Part, Organ, or Organ Component]

Phrase: "in transgenic mice."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0025936:Mice, Transgenic [Mammal]
   861   C0003069:Transgenic [Animal]
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]
Processing 00000000.tx.33: EXPERIMENTAL PROCEDURES TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES  ReagentsMinimum essential medium, N2 medium supplements, and fetal bovine serum were from Invitrogen. 

Phrase: "EXPERIMENTAL PROCEDURES TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   791   C0557061:Discussion [Therapeutic or Preventive Procedure]
   791   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "ReagentsMinimum essential medium,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0009458:Medium [Intellectual Product]
   827   C0439536:Medium [Quantitative Concept]
   827   C1705217:Medium [Substance]
   827   C3244283:medium [Intellectual Product]

Phrase: "N2 medium supplements,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   793   C0242295:Supplement [Food]
   793   C1947943:Supplement [Intellectual Product]
   793   C2348609:Supplement [Functional Concept]

Phrase: "and"

Phrase: "fetal bovine serum"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   827   C0007452:Bovine [Mammal]
   827   C0015965:Fetal [Embryonic Structure]
   827   C0229671:Serum [Body Substance]
   827   C0521457:Fetal [Functional Concept]
   827   C1140701:bovine [Mammal]
   827   C1546774:Serum [Intellectual Product]
   827   C1550100:Serum [Body Substance]

Phrase: "were from Invitrogen."
Processing 00000000.tx.34: Polyclonal goat anti-human apoE was from Calbiochem. 

Phrase: "Polyclonal goat anti-human apoE"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0523511:APOE [Laboratory Procedure]
   804   C1412481:APOE [Gene or Genome]

Phrase: "was from Calbiochem."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0043194:WAS [Disease or Syndrome]
   790   C0258432:WAS [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C1421478:WAS [Gene or Genome]
Processing 00000000.tx.35: The phosphorylation-dependent monoclonal tau antibodies AT8 (p-Ser-202) and AT270 (p-Thr-181) were from Endogen (Woburn, MA). 

Phrase: "The phosphorylation-dependent monoclonal tau antibodies AT8"

Phrase: "(p-Ser-202"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "and"

Phrase: "AT270"

Phrase: "(p-Thr-181"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0040005:Thr [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "were from Endogen"

Phrase: "(Woburn,"

Phrase: "MA"

Phrase: ")."
Processing 00000000.tx.36: The phosphorylation-dependent monoclonal Erk(p-Thr-202/Tyr-204) antibody E10, the phosphorylation-independent polyclonal Erk antibody, the Erk pathway inhibitor U0126, and the phosphorylation-dependent monoclonal GSK-3(p-Tyr-279/Tyr-216) antibody 5G-2F were from Cell Signaling (Charlottesville, VA). 

Phrase: "The phosphorylation-dependent monoclonal Erk(p-Thr-202/Tyr-204"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   791   C0031715:Phosphorylation [Molecular Function]
   791   C0040005:Thr [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   791   C0041484:TYR [Amino Acid, Peptide, or Protein,Enzyme]
   791   C0041485:TYR [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   791   C0746619:monoclonal [Finding]
   791   C0851827:Dependent [Qualitative Concept]
   791   C1158886:Phosphorylation [Molecular Function]
   791   C1421250:TYR [Gene or Genome]
   791   C1701901:Dependent [Qualitative Concept]
   791   C3244310:dependent [Functional Concept]

Phrase: ")"

Phrase: "antibody E10,"

Phrase: "the phosphorylation-independent polyclonal Erk antibody,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   853   C0312586:Polyclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   804   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   804   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "the Erk pathway inhibitor U0126,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0755562:U0126 [Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "the phosphorylation-dependent monoclonal GSK-3"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   877   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   845   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   818   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   795   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   795   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   795   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(p-Tyr-279/Tyr-216"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   853   C0077599:Tyr-Tyr [Amino Acid, Peptide, or Protein]
   804   C0041484:TYR [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0041485:TYR [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   804   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   804   C1421250:TYR [Gene or Genome]
   804   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "antibody 5G-2F"

Phrase: "were from Cell Signaling"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   833   C0037083:Cell Signaling [Cell Function]
           Signaling
   770   C0007634:Cell [Cell]
   770   C1269647:Cell [Cell]
   770   C1704653:Cell [Medical Device]
   770   C1948049:Cell [Spatial Concept]
   770   C3537152:signaling [Biologic Function]

Phrase: "(Charlottesville,"

Phrase: "VA)."
Processing 00000000.tx.37: The phosphorylation-dependent Cdk5(p-Tyr-15) monoclonal antibody and the polyclonal p35 and p25 antibodies were from Santa Cruz Biotechnology (Santa Cruz, CA). 

Phrase: "The phosphorylation-dependent Cdk5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0249586:CDK5 [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1332735:CDK5 [Gene or Genome]

Phrase: "(p-Tyr-15"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0041484:TYR [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0041485:TYR [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C1421250:TYR [Gene or Genome]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "monoclonal antibody"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0003250:Monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   861   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   861   C0746619:monoclonal [Finding]

Phrase: "and"

Phrase: "the polyclonal p35"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3539715:p35 [Gene or Genome]

Phrase: "and"

Phrase: "p25 antibodies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "were from Santa Cruz Biotechnology"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0005574:Biotechnology [Biomedical Occupation or Discipline]

Phrase: "(Santa Cruz,"

Phrase: "CA)."
Processing 00000000.tx.38: The anti-rabbit, anti-mouse, and anti-goat IgGs coupled to fluorescein, rhodamine, or Cy5 were from Vector Laboratories (Burlingame, CA). 

Phrase: "The anti-rabbit, anti-mouse,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0025914:Mouse [Mammal]
   812   C0025929:mouse [Mammal]
   812   C0026809:Mouse [Mammal]

Phrase: "and"

Phrase: "anti-goat IgGs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   896   C0051979:anti-IgG [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "coupled to fluorescein,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0060520:Fluorescein [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   790   C1948027:Coupled [Functional Concept]
   756 E C0010222:couple [Family Group]

Phrase: "rhodamine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0600322:Rhodamine [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "or"

Phrase: "Cy5"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0250829:Cy5 [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "were from Vector Laboratories"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   770   C0022877:Laboratories [Manufactured Object,Organization]
   770   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   770   C0442335:Vector [Spatial Concept]
   770   C1619828:Laboratories [Intellectual Product]
   770   C1705099:Vector [Idea or Concept]
   737 E C3244292:laboratory [Functional Concept]

Phrase: "(Burlingame,"

Phrase: "CA)."
Processing 00000000.tx.39: Horseradish peroxidase-coupled anti-rabbit, anti-mouse, and anti-goat IgG were from Dako (Carpinteria, CA). 

Phrase: "Horseradish peroxidase-coupled anti-rabbit, anti-mouse,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   795   C0025914:Mouse [Mammal]
   795   C0025929:mouse [Mammal]
   795   C0026809:Mouse [Mammal]

Phrase: "and"

Phrase: "anti-goat IgG"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   913   C0051979:anti-IgG [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0018019:goat [Mammal]
   827   C1265549:goat [Mammal]
   827   C1510458:Goat [Mammal]

Phrase: "were from Dako"

Phrase: "(Carpinteria,"

Phrase: "CA)."
Processing 00000000.tx.40: ECL was from Amersham Biosciences. 

Phrase: "ECL"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1332684:ECL [Gene or Genome]

Phrase: "was from Amersham Biosciences."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0043194:WAS [Disease or Syndrome]
   770   C0258432:WAS [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C1421478:WAS [Gene or Genome]
Processing 00000000.tx.41: Transgenic Mice Expressing ApoE3 or ApoE4 in NeuronsWe studied transgenic mice expressing human apoE3 or apoE4 in central nervous system neurons under the control of a neuron-specific enolase (NSE) promoter on a mouse apoE-deficient background (29, 30, 63). 

Phrase: "Transgenic Mice"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0025936:Mice, Transgenic [Mammal]
   861   C0003069:Transgenic [Animal]
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]

Phrase: "Expressing"

Phrase: "ApoE3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0052199:Apo E3 [Amino Acid, Peptide, or Protein]

Phrase: "or"

Phrase: "ApoE4 in NeuronsWe"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0052201:ApoE4 [Amino Acid, Peptide, or Protein]
   790   C2984964:APOE4 [Laboratory Procedure]

Phrase: "studied"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0557651:Study [Manufactured Object]
   966   C2603343:Study [Research Activity]

Phrase: "transgenic mice"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0025936:Mice, Transgenic [Mammal]
   861   C0003069:Transgenic [Animal]
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]

Phrase: "expressing"

Phrase: "human apoE3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0052199:Apo E3 [Amino Acid, Peptide, or Protein]

Phrase: "or"

Phrase: "apoE4 in central nervous system neurons"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0052201:ApoE4 [Amino Acid, Peptide, or Protein]
   753   C2984964:APOE4 [Laboratory Procedure]

Phrase: "under the control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "of a neuron-specific enolase (NSE) promoter"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   756   C1414404:ENOLASE, NEURON-SPECIFIC [Gene or Genome]
   756   C1880904:Neuron-Specific Enolase [Amino Acid, Peptide, or Protein,Enzyme,Neuroreactive Substance or Biogenic Amine]

Phrase: "on a mouse apoE-deficient background"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1706907:Background [Conceptual Entity]

Phrase: "(29,"

Phrase: "30,"

Phrase: "63"

Phrase: ")."
Processing 00000000.tx.42: All NSE-apoE transgenic mice had been backcrossed more than 15 times with apoE-deficient mice (C57BL/6J-ApoetmlUnc; Jackson Laboratory, Bar Harbor, ME). 

Phrase: "All NSE-apoE transgenic mice"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0025936:Mice, Transgenic [Mammal]
   799   C0003069:Transgenic [Animal]
   799   C0025914:Mice [Mammal]
   799   C0025929:mice [Mammal]
   799   C0026809:Mice [Mammal]

Phrase: "had"

Phrase: "been"

Phrase: "backcrossed"

Phrase: "more than 15 times"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0040223:times [Temporal Concept]
   770   C0205172:More [Functional Concept]
   770   C1632851:Times [Quantitative Concept]
   737 E C3541383:Time [Temporal Concept]

Phrase: "with apoE-deficient mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]

Phrase: "(C57BL/6J-ApoetmlUnc"

Phrase: "; Jackson Laboratory,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0022877:Laboratory [Manufactured Object,Organization]
   861   C3244292:laboratory [Functional Concept]

Phrase: "Bar Harbor,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0475311:Harbor [Manufactured Object]

Phrase: "ME"

Phrase: ")."
Processing 00000000.tx.43: Because apoE4-induced behavioral deficits in NSE-apoE mice are gender dependent (30, 31), only female transgenic mice were used. 

Phrase: "Because"

Phrase: "apoE4-induced behavioral deficits in NSE-apoE mice"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   739   C2987487:deficits [Qualitative Concept]
   706 E C0162429:Deficit, NOS [Disease or Syndrome]

Phrase: "are"

Phrase: "gender"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0079399:Gender [Organism Attribute]
  1000   C0804628:Gender [Clinical Attribute]
  1000   C1522384:Gender [Organism Attribute]

Phrase: "dependent"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0851827:Dependent [Qualitative Concept]
  1000   C1701901:Dependent [Qualitative Concept]
  1000   C3244310:dependent [Functional Concept]

Phrase: "(30,"

Phrase: "31"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "only female transgenic mice"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0025936:Mice, Transgenic [Mammal]
   812   C0003069:Transgenic [Animal]
   812   C0025914:Mice [Mammal]
   812   C0025929:mice [Mammal]
   812   C0026809:Mice [Mammal]

Phrase: "were"

Phrase: "used."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.44: Mice were kept under a 12-h light/12-h dark cycle with free access to sterile water and food (PicoLab Rodent Diet 20, No. 5053; PMI Nutrition International, St. Louis, MO). 

Phrase: "Mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mice [Mammal]
  1000   C0025929:mice [Mammal]
  1000   C0026809:Mice [Mammal]

Phrase: "were"

Phrase: "kept under a 12-h light/12-h dark cycle"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   777   C2718082:Light-Dark Cycle [Temporal Concept]
           Light Cycle
   739   C0023693:Light [Natural Phenomenon or Process]
   739   C0033727:H+ [Element, Ion, or Isotope]
   739   C0332582:Dark [Qualitative Concept]
   739   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   739   C0441932:H+ [Classification]
   739   C0564385:/h [Quantitative Concept]
   739   C1306462:Light [Functional Concept]
   739   C1511572:Cycle [Temporal Concept]
   739   C1881376:Light [Qualitative Concept]
   706   C0333118:Keep [Functional Concept]

Phrase: "with free access"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0444454:Access [Spatial Concept]
   861   C1554204:access [Idea or Concept]

Phrase: "to sterile water"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0359299:sterile water [Inorganic Chemical,Pharmacologic Substance]
   861   C0043047:Water [Inorganic Chemical,Pharmacologic Substance]
   861   C0232920:Sterile [Qualitative Concept]
   861   C0599638:WATER [Substance]
   861   C0678108:Sterile [Pathologic Function]
   861   C1550678:Water [Inorganic Chemical]
   789 E C0443350:Watery [Qualitative Concept]

Phrase: "and"

Phrase: "food"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0016452:Food [Food]

Phrase: "(PicoLab Rodent Diet 20,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   812   C0012155:Diet [Food]
   812   C0035804:Rodent [Mammal]
   812   C1442959:Diet [Organism Function]
   812   C1519433:DIET [Therapeutic or Preventive Procedure]
   812   C2983588:DIET [Food]
   741 E C2699635:DIETARY [Functional Concept]

Phrase: "No. 5053"

Phrase: "; PMI Nutrition International, St. Louis,"

Phrase: "MO"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3538743:MO [Idea or Concept]

Phrase: ")."
Processing 00000000.tx.45: Genotyping of Transgenic MiceMice were genotyped by PCR of DNA purified from tail clips (29, 30, 63). 

Phrase: "Genotyping of Transgenic MiceMice"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1285573:Genotyping [Laboratory Procedure]

Phrase: "were"

Phrase: "genotyped by PCR of DNA"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   760   C0677874:pCR [Finding]
   726   C0017431:Genotype [Organism Attribute]

Phrase: "purified from tail clips"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0039259:Tail [Body Part, Organ, or Organ Component]
   770   C0175722:Clip [Medical Device]
   770   C1705205:Clip [Medical Device]
   770   C1998793:Purified [Functional Concept]

Phrase: "(29,"

Phrase: "30,"

Phrase: "63"

Phrase: ")."
Processing 00000000.tx.46: Because APOE intron 3 was included in the apoE4 but not the apoE3 construct, the amplicon generated with intron 3-spanning primers (forward primer: nucleotides 31583175; 

Phrase: "Because"

Phrase: "APOE intron 3"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   913   C0052199:Apo E-3 [Amino Acid, Peptide, or Protein]
   827   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0021920:Intron [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0523511:APOE [Laboratory Procedure]
   827   C1412481:APOE [Gene or Genome]

Phrase: "was"

Phrase: "included in the apoE4"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   770   C0052201:ApoE4 [Amino Acid, Peptide, or Protein]
   770   C0332257:included [Functional Concept]
   770   C2984964:APOE4 [Laboratory Procedure]
   770   C3538986:INCLUDED [Gene or Genome]
   737 E C1552866:include [Idea or Concept]
   737 E C2700399:Include [Activity]

Phrase: "but"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "the apoE3 construct,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2827421:Construct [Classification]

Phrase: "the amplicon"

Phrase: "generated with intron 3-spanning primers"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0021920:Intron [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   753   C3146294:Generated [Activity]
   719   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]
   719   C1711300:Span [Conceptual Entity]
   719   C2700613:Span [Quantitative Concept]

Phrase: "(forward primer"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1953382:Forward primer [Cell]
   861   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: ":"

Phrase: "nucleotides 31583175"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0028630:Nucleotides [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: ";"
Processing 00000000.tx.47: reverse primer: nucleotides 38153834; 

Phrase: "reverse primer"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1953384:Reverse primer [Amino Acid, Peptide, or Protein]
   861   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: ":"

Phrase: "nucleotides 38153834"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0028630:Nucleotides [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: ";"
Processing 00000000.tx.48: GenBankTM accession number M10065 [GenBank] ) was 670 bp in apoE4 mice and 100 bp in apoE3 mice. 

Phrase: "GenBankTM accession number M10065"

Phrase: "[GenBank"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0598211:GenBank [Intellectual Product]

Phrase: "]"

Phrase: ")"

Phrase: "was"

Phrase: "670 bp in apoE4 mice"

Phrase: "and"

Phrase: "100 bp in apoE3 mice."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   797   C2715713:BP 100 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.49: PCR reactions were run on a PTC-100 programmable thermal controller (MJ Research, Watertown, MA), and the products were analyzed on 1.5% agarose gels. 

Phrase: "PCR reactions"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0443286:Reaction [Functional Concept]
   827   C1114821:Reaction [Clinical Attribute]

Phrase: "were"

Phrase: "run on"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0035953:run [Daily or Recreational Activity]
   861   C0600140:run [Finding]
   861   C1704688:Run [Functional Concept]
   861   C2346414:Run [Finding]

Phrase: "a PTC-100 programmable thermal controller"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0180112:Controller [Medical Device]

Phrase: "(MJ Research,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0035168:research [Research Activity]
   861   C0242481:Research [Research Activity]

Phrase: "Watertown,"

Phrase: "MA"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "the products"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1514468:Products [Entity]
   966 E C1704444:Product [Quantitative Concept]

Phrase: "were"

Phrase: "analyzed on 1.5% agarose gels."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   773   C1706746:Agarose Gel [Research Device]
   753   C0017243:Gels [Biomedical or Dental Material]
   753   C0036681:Agarose [Carbohydrate]
   753   C0936012:Analyzed [Research Activity]
   719 E C1382104:Gel [Substance]
Processing 00000000.tx.50: To assess the Apoe knockout status of the mice, total plasma cholesterol levels were measured with a kit (Abbott Laboratories, Abbott Park, IL) as described (64). 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "assess"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1516048:Assess [Activity]

Phrase: "the Apoe knockout status of the mice,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0449438:Status [Qualitative Concept]

Phrase: "total plasma cholesterol levels"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   861   C0201950:cholesterol levels [Laboratory Procedure]
           Total Cholesterol
   861   C0428466:cholesterol levels [Laboratory or Test Result]
   812   C0441889:Levels [Qualitative Concept]
   779 E C0456079:Level [Classification]
   779 E C1547707:Level [Geographic Area]
   779 E C2946261:Level [Pharmacologic Substance]
   708   C0543421:Total cholesterol [Steroid]

Phrase: "were"

Phrase: "measured with a kit (Abbott Laboratories,"
Meta Candidates (Total=14; Excluded=3; Pruned=0; Remaining=11)
   790   C1546858:Abbott Laboratories [Health Care Related Organization]
   753   C0022877:Laboratories [Manufactured Object,Organization]
   753   C0331761:Abbott [Health Care Related Organization]
   753   C0444706:Measured [Qualitative Concept]
   753   C0812225:KIT [Medical Device]
   753   C1150635:KIT [Molecular Function]
   753   C1619828:Laboratories [Intellectual Product]
   753   C1705212:Kit [Medical Device]
   753   C1705213:KIT [Medical Device]
   753   C3273202:Kit [Manufactured Object]
   753   C3541902:MEASURED [Diagnostic Procedure]
   719 E C0079809:Measure [Quantitative Concept]
   719 E C0242485:Measure [Functional Concept]
   719 E C3244292:laboratory [Functional Concept]

Phrase: "Abbott Park,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0562547:Park [Manufactured Object]
   861   C3160718:PARK [Disease or Syndrome]

Phrase: "IL)"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0020898:IL [Geographic Area]
  1000   C0021764:IL [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0022271:IL [Geographic Area]

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "(64"

Phrase: ")."
Processing 00000000.tx.51: Western Blotting and Quantitative Analyses of p-Erk and p-tau in Mouse Brain LysatesBrains from hemizygous NSE-apoE3 or NSE-apoE4 transgenic mice on a mouse apoE-null background were collected after a 2-min transcardial perfusion with PBS. 

Phrase: "Western Blotting"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0005863:Western Blotting [Laboratory Procedure,Molecular Biology Research Technique]
   983 E C0949466:Western Blot [Laboratory Procedure]
   861   C1705493:Western [Spatial Concept]

Phrase: "and"

Phrase: "Quantitative Analyses of p-Erk"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   726   C0002778:Analysis [Laboratory Procedure]
   726   C0936012:Analysis [Research Activity]
   726   C1524024:analysis [Functional Concept]

Phrase: "and"

Phrase: "p-tau in Mouse Brain LysatesBrains"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1720655:Tau [Intellectual Product]
   753   C1947974:Tau [Research Activity]

Phrase: "from hemizygous NSE-apoE3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0052199:Apo E3 [Amino Acid, Peptide, or Protein]
   717   C1414404:ENOLASE, NEURON-SPECIFIC [Gene or Genome]
   717   C1880904:Neuron-Specific Enolase [Amino Acid, Peptide, or Protein,Enzyme,Neuroreactive Substance or Biogenic Amine]

Phrase: "or"

Phrase: "NSE-apoE4 transgenic mice"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0025936:Mice, Transgenic [Mammal]
   799   C0003069:Transgenic [Animal]
   799   C0025914:Mice [Mammal]
   799   C0025929:mice [Mammal]
   799   C0026809:Mice [Mammal]

Phrase: "on a mouse apoE-null background"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1706907:Background [Conceptual Entity]

Phrase: "were"

Phrase: "collected after a 2-min transcardial perfusion"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0031001:Perfusion [Therapeutic or Preventive Procedure]
   748   C0702093:/min [Temporal Concept]
   748   C1516695:Collected [Idea or Concept]
   748   C1516698:Collected [Functional Concept]

Phrase: "with PBS."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1720830:PBS [Disease or Syndrome]
  1000   C1823521:PBS [Gene or Genome]
Processing 00000000.tx.52: One hemibrain or dissected regions (cortex, hippocampus, and cerebellum) were homogenized and analyzed for apoE, p-tau, Erk, p-Erk, p25, p35, Cdk-5, and GSK-3 by Western blot as described (26, 28, 29). 

Phrase: "One hemibrain"

Phrase: "or"

Phrase: "dissected regions"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0017446:Region [Geographic Area]
   827   C0205147:Region [Spatial Concept]
   777 E C0205276:Regional [Spatial Concept]
   777 E C1947913:Regional [Spatial Concept]

Phrase: "(cortex,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0007776:Cortex [Body Part, Organ, or Organ Component]
  1000   C1176472:Cortex [Body Part, Organ, or Organ Component]
  1000   C2700441:Cortex [Plant]

Phrase: "hippocampus,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0019564:Hippocampus [Body Part, Organ, or Organ Component]
  1000   C0949582:Hippocampus [Fish]
  1000   C1029104:Hippocampus [Fish]
  1000   C1284077:Hippocampus [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "cerebellum"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0007765:Cerebellum [Body Part, Organ, or Organ Component]
  1000   C1268981:Cerebellum [Body Part, Organ, or Organ Component]
  1000   C1707522:Cerebellum [Tissue]

Phrase: ")"

Phrase: "were"

Phrase: "homogenized"

Phrase: "and"

Phrase: "analyzed for apoE,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C0523511:APOE [Laboratory Procedure]
   790   C0936012:Analyzed [Research Activity]
   790   C1412481:APOE [Gene or Genome]

Phrase: "p-tau,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1720655:Tau [Intellectual Product]
   861   C1947974:Tau [Research Activity]

Phrase: "Erk,"

Phrase: "p-Erk,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C2603361:P' [Clinical Attribute]

Phrase: "p25,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3539715:p25 [Gene or Genome]

Phrase: "p35,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3539715:p35 [Gene or Genome]

Phrase: "Cdk-5,"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
  1000   C0249586:Cyclin-Dependent Kinase 5 [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1332735:CYCLIN-DEPENDENT KINASE 5 [Gene or Genome]
   923   C0243045:Cyclin-Dependent Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0072108:Cyclin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0079183:Cyclin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0851827:Dependent [Qualitative Concept]
   812   C1150565:cyclin [Molecular Function]
   812   C1701901:Dependent [Qualitative Concept]
   812   C3244310:dependent [Functional Concept]

Phrase: "and"

Phrase: "GSK-3 by Western blot"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   853   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   814   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   778   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   748   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "as described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "(26,"

Phrase: "28,"

Phrase: "29"

Phrase: ")."
Processing 00000000.tx.53: Values are reported in arbitrary units. 

Phrase: "Values"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0042295:Values [Qualitative Concept]
   966 E C1522609:Value [Quantitative Concept]

Phrase: "are"

Phrase: "reported in arbitrary units."
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   799   C0439183:Arbitrary unit [Quantitative Concept]
   770   C0439148:Units [Quantitative Concept]
   770   C0684224:Reported [Intellectual Product]
   770   C0700287:Reported [Health Care Activity]
   770   C1264693:*Arbitrary [Quantitative Concept]
   770   C1519795:Units [Quantitative Concept]
   770   C3496591:Reported [Clinical Attribute]
   737 E C1704753:Unit [Manufactured Object]
   737 E C1880519:Unit [Quantitative Concept]
   737 E C3273238:Report [Intellectual Product]
Processing 00000000.tx.54: ImmunohistochemistryThe other hemibrain was fixed in 3% paraformaldehyde, sectioned, and stained with anti-apoE, anti-p-tau, and anti-p-Erk (26, 28, 29, 63). 

Phrase: "ImmunohistochemistryThe"

Phrase: "other hemibrain"

Phrase: "was"

Phrase: "fixed in 3% paraformaldehyde,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0070066:Paraformaldehyde [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]
   770   C0231441:Fixed [Finding]
   770   C0443218:Fixed [Qualitative Concept]
   770   C2827483:Fixed [Body Substance]

Phrase: "sectioned"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0205155:Section [Spatial Concept]
   966   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   966   C1522472:Section [Substance]
   966   C1552923:Section [Quantitative Concept]
   966   C1705191:Section [Physical Object]

Phrase: ","

Phrase: "and"

Phrase: "stained with anti-apoE,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0523511:APOE [Laboratory Procedure]
   770   C1412481:APOE [Gene or Genome]
   770   C2986582:Stained [Qualitative Concept]
   737 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: "anti-p-tau,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1720655:Tau [Intellectual Product]
   827   C1947974:Tau [Research Activity]

Phrase: "and"

Phrase: "anti-p-Erk (26,"

Phrase: "28,"

Phrase: "29,"

Phrase: "63"

Phrase: ")."
Processing 00000000.tx.55: Vibratome sections were incubated in 0.3% H2O2 in PBS for 20 min to quench endogenous peroxidase activity. 

Phrase: "Vibratome sections"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0205155:Section [Spatial Concept]
   827   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   827   C1522472:Section [Substance]
   827   C1552923:Section [Quantitative Concept]
   827   C1705191:Section [Physical Object]

Phrase: "were"

Phrase: "incubated in 0.3% H2O2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0020281:H2O2 [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   760   C1439852:Incubated [Laboratory Procedure]

Phrase: "in PBS"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1720830:PBS [Disease or Syndrome]
  1000   C1823521:PBS [Gene or Genome]

Phrase: "for 20 min"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]

Phrase: "to"

Phrase: "quench"

Phrase: "endogenous peroxidase activity."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C1151518:peroxidase activity [Molecular Function]
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]
Processing 00000000.tx.56: To facilitate penetration of antibodies, sections used for immunoperoxidase staining were preincubated for 4 min in 1 g/ml proteinase K in a buffer containing 250 mM NaCl, 25 mM EDTA, 50 mM Tris-HCl, pH 8. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "facilitate"

Phrase: "penetration of antibodies,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0205321:Penetration [Functional Concept]

Phrase: "sections"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0205155:Section [Spatial Concept]
   966   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   966   C1522472:Section [Substance]
   966   C1552923:Section [Quantitative Concept]
   966   C1705191:Section [Physical Object]

Phrase: "used for immunoperoxidase staining"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   833   C0021067:Immunoperoxidase Staining [Laboratory Procedure]
           Immunoperoxidase
   770   C0487602:Staining [Laboratory Procedure]
   770   C1273517:used [Finding]
   770   C1704680:Staining [Finding]
   737 E C0042153:use [Functional Concept]
   737 E C0457083:Use [Functional Concept]
   737 E C1947944:Use [Intellectual Product]

Phrase: "were"

Phrase: "preincubated for 4 min"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0702093:/min [Temporal Concept]

Phrase: "in 1 g/ml proteinase K"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   840   C0059256:Proteinase K [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0030946:Proteinase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   804   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   804   C1622131:proteinase [Molecular Function]
   804   C1708601:K' [Quantitative Concept]
   804   C1947941:Proteinase [Enzyme]

Phrase: "in a buffer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "250 mM NaCl,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   827   C1959973:% NaCl [Quantitative Concept]

Phrase: "25 mM EDTA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0013618:EDTA [Organic Chemical,Pharmacologic Substance]

Phrase: "50 mM Tris-HCl,"

Phrase: "pH 8."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0020283:[pH] [Quantitative Concept]
   861   C0450407:ph+ [Finding]
   861   C0450408:ph++ [Finding]
   861   C0450409:ph+++ [Finding]
Processing 00000000.tx.57: To block nonspecific reactions, all sections were incubated for 1 h in 15% normal serum from the same species that produced the secondary antibodies (Jackson ImmunoResearch, West Grove, PA) in PBS or for 7 min in Superblock (Scytec, Logan, UT), followed by a 1-h incubation in PBS with primary antibody (anti-apoE, anti-p-tau, anti-p-Erk, or anti-Erk). 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "block"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0028778:Block [Pathologic Function]
  1000   C0332206:Block [Functional Concept]
  1000   C1533157:Block [Substance]
  1000   C1706084:Block [Geographic Area]
  1000   C2828370:Block [Quantitative Concept]

Phrase: "nonspecific reactions,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   983   C0221738:NONSPECIFIC REACTION [Finding]
   827   C0443286:Reaction [Functional Concept]
   827   C1114821:Reaction [Clinical Attribute]

Phrase: "all sections"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0205155:Section [Spatial Concept]
   966   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   966   C1522472:Section [Substance]
   966   C1552923:Section [Quantitative Concept]
   966   C1705191:Section [Physical Object]

Phrase: "were"

Phrase: "incubated for 1 h"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   819   C0700308:h 1 [Element, Ion, or Isotope]
   770   C0033727:H+ [Element, Ion, or Isotope]
   770   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441932:H+ [Classification]
   770   C0564385:/h [Quantitative Concept]
   770   C1439852:Incubated [Laboratory Procedure]

Phrase: "in 15% normal serum"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   827   C0205307:Normal [Qualitative Concept]
   827   C0229671:Serum [Body Substance]
   827   C0439166:% normal [Quantitative Concept]
   827   C1546774:Serum [Intellectual Product]
   827   C1550100:Serum [Body Substance]
   827   C2347086:% Normal [Quantitative Concept]

Phrase: "from the same species"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1705920:Species [Conceptual Entity]

Phrase: "that"

Phrase: "produced"

Phrase: "the secondary antibodies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(Jackson ImmunoResearch,"

Phrase: "West Grove,"

Phrase: "PA) in PBS"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C1720830:PBS [Disease or Syndrome]
   790   C1823521:PBS [Gene or Genome]
   790   C3541314:PA [Idea or Concept]

Phrase: "or for 7 min"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0702093:/min [Temporal Concept]

Phrase: "in Superblock"

Phrase: "(Scytec,"

Phrase: "Logan,"

Phrase: "UT"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0042124:UT [Geographic Area]

Phrase: ")"

Phrase: ","

Phrase: "followed by a 1-h incubation"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   790   C0332283:Followed by [Temporal Concept]
           followed
   783   C0700308:h 1 [Element, Ion, or Isotope]
   753   C0033727:H+ [Element, Ion, or Isotope]
   753   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0441932:H+ [Classification]
   753   C0564385:/h [Quantitative Concept]
   719 E C1719822:Follow [Intellectual Product]

Phrase: "in PBS"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1720830:PBS [Disease or Syndrome]
  1000   C1823521:PBS [Gene or Genome]

Phrase: "with primary antibody"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   861   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(anti-apoE,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0523511:APOE [Laboratory Procedure]
   861   C1412481:APOE [Gene or Genome]

Phrase: "anti-p-tau,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1720655:Tau [Intellectual Product]
   827   C1947974:Tau [Research Activity]

Phrase: "anti-p-Erk,"

Phrase: "or"

Phrase: "anti-Erk"

Phrase: ")."
Processing 00000000.tx.58: Sections were washed three times in PBS and incubated for 1 h with the corresponding secondary antibodies labeled with fluorescein (Jackson ImmunoResearch) or biotin (Vector). 

Phrase: "Sections"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0205155:Section [Spatial Concept]
   966   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   966   C1522472:Section [Substance]
   966   C1552923:Section [Quantitative Concept]
   966   C1705191:Section [Physical Object]

Phrase: "were"

Phrase: "washed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1548982:Washed [Idea or Concept]
   966 E C0441648:Wash [Activity]

Phrase: "three times in PBS"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0040223:times [Temporal Concept]
   770   C1632851:Times [Quantitative Concept]
   737 E C3541383:Time [Temporal Concept]

Phrase: "and"

Phrase: "incubated for 1 h"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   819   C0700308:h 1 [Element, Ion, or Isotope]
   770   C0033727:H+ [Element, Ion, or Isotope]
   770   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441932:H+ [Classification]
   770   C0564385:/h [Quantitative Concept]
   770   C1439852:Incubated [Laboratory Procedure]

Phrase: "with the corresponding secondary antibodies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   793 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "labeled with fluorescein"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0060520:Fluorescein [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   790   C1708632:Labeled [Qualitative Concept]
   756 E C0181496:Label [Manufactured Object]
   756 E C2827499:Label [Governmental or Regulatory Activity]

Phrase: "(Jackson ImmunoResearch"

Phrase: ")"

Phrase: "or"

Phrase: "biotin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0005575:Biotin [Organic Chemical,Pharmacologic Substance,Vitamin]
  1000   C2700256:Biotin [Laboratory Procedure]

Phrase: "(Vector"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
  1000   C0442335:Vector [Spatial Concept]
  1000   C1705099:Vector [Idea or Concept]

Phrase: ")."
Processing 00000000.tx.59: After three washes in PBS, the sections were mounted in VectaShield (Vector) and viewed with a Radiance 2000 laser-scanning confocal system (Bio-Rad) mounted on an Optiphot-2 microscope (Nikon, Tokyo, Japan). 

Phrase: "After three washes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0441648:Wash [Activity]

Phrase: "in PBS,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1720830:PBS [Disease or Syndrome]
  1000   C1823521:PBS [Gene or Genome]

Phrase: "the sections"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0205155:Section [Spatial Concept]
   966   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   966   C1522472:Section [Substance]
   966   C1552923:Section [Quantitative Concept]
   966   C1705191:Section [Physical Object]

Phrase: "were"

Phrase: "mounted in VectaShield"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0449878:mounted [Finding]
   756 E C0181909:Mount [Medical Device]

Phrase: "(Vector"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
  1000   C0442335:Vector [Spatial Concept]
  1000   C1705099:Vector [Idea or Concept]

Phrase: ")"

Phrase: "and"

Phrase: "viewed with a Radiance 2000 laser-"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0023089:Laser [Manufactured Object]
   753   C0458142:Laser [Phenomenon or Process]
   753   C1023865:Laser [Plant]
   753   C1706315:Laser [Medical Device]
   719   C0449911:View [Spatial Concept]

Phrase: "scanning"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0034606:Scanning [Diagnostic Procedure]
  1000   C0441633:Scanning [Diagnostic Procedure]
   966 E C2826292:SCAN [Finding]

Phrase: "confocal system"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0449913:System [Functional Concept]
   861   C1553451:System [Manufactured Object]
   861   C1704459:System [Medical Device]
   789 E C0205373:Systemic [Functional Concept]

Phrase: "(Bio-Rad)"

Phrase: "mounted on an Optiphot-2 microscope"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   753   C0181839:Microscope [Medical Device]
   753   C0449878:mounted [Finding]
   753   C1706379:Microscope [Medical Device]
   719 E C0181909:Mount [Medical Device]

Phrase: "(Nikon,"

Phrase: "Tokyo,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0040371:Tokyo [Geographic Area]

Phrase: "Japan"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0022341:Japan [Geographic Area]

Phrase: ")."
Processing 00000000.tx.60: For immunoperoxidase staining, secondary antibody binding was detected with the ABC-Elite kit (Vector). 

Phrase: "For immunoperoxidase staining,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0021067:Immunoperoxidase Staining [Laboratory Procedure]
   861   C0487602:Staining [Laboratory Procedure]
   861   C1704680:Staining [Finding]

Phrase: "secondary antibody binding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0243122:binding [Functional Concept]
   827   C1145667:Binding [Activity]
   827   C1167622:Binding [Molecular Function]

Phrase: "was"

Phrase: "detected with the ABC-Elite kit (Vector"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   748   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   748   C0442335:Vector [Spatial Concept]
   748   C0442726:Detected [Finding]
   748   C0812225:KIT [Medical Device]
   748   C1150635:KIT [Molecular Function]
   748   C1511790:Detected [Therapeutic or Preventive Procedure]
   748   C1705099:Vector [Idea or Concept]
   748   C1705212:Kit [Medical Device]
   748   C1705213:KIT [Medical Device]
   748   C3273202:Kit [Manufactured Object]

Phrase: ")."
Processing 00000000.tx.61: Six sections of each brain were stained for each antibody. 

Phrase: "Six sections of each brain"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   726   C0205155:Section [Spatial Concept]
   726   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   726   C1522472:Section [Substance]
   726   C1552923:Section [Quantitative Concept]
   726   C1705191:Section [Physical Object]

Phrase: "were"

Phrase: "stained for each antibody."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   770   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   770   C2986582:Stained [Qualitative Concept]
   737 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]
Processing 00000000.tx.62: Generation of Neuro-2a Cells Stably Expressing Human ApoENeuro-2a cells (American Type Culture Collection, Manassas, VA) were transfected with 17 kb of human apoE genomic DNA encoding apoE3 or apoE4 and a plasmid containing the neomycin resistance gene by the LipofectAMINE method (40). 

Phrase: "Generation of Neuro-2a Cells Stably"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0079411:Generation [Temporal Concept]
   753   C3146294:Generation [Activity]

Phrase: "Expressing"

Phrase: "Human ApoENeuro-2a cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   902   C0427861:Human cells [Laboratory or Test Result]
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "(American Type Culture Collection,"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
  1000   C0598079:American Type Culture Collection [Intellectual Product]
   812   C0010453:Culture [Idea or Concept]
   812   C0220814:culture [Functional Concept]
   812   C0332307:Type [Qualitative Concept]
   812   C0430400:Culture [Laboratory Procedure]
   812   C0596070:American [Population Group]
   812   C1516698:Collection [Functional Concept]
   812   C1547052:*Type [Quantitative Concept]
   812   C1704814:Collection [Idea or Concept]
   812   C2242979:Culture [Laboratory Procedure]
   741 E C1516695:Collected [Idea or Concept]

Phrase: "Manassas,"

Phrase: "VA)"

Phrase: "were"

Phrase: "transfected with 17 kb of human apoE genomic DNA encoding apoE3"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   756   C3272453:Genomic DNA [Nucleic Acid, Nucleoside, or Nucleotide]
   738   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   738   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   738   C0017428:Genomic [Gene or Genome]
   738   C0052199:Apo E3 [Amino Acid, Peptide, or Protein]
   738   C0086418:Human [Human]
   738   C0523511:APOE [Laboratory Procedure]
   738   C0887950:genomic [Biomedical Occupation or Discipline]
   738   C1412481:APOE [Gene or Genome]
   738   C1547699:Encoding [Idea or Concept]
   738   C2700640:Encoding [Activity]

Phrase: "or"

Phrase: "apoE4"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0052201:ApoE4 [Amino Acid, Peptide, or Protein]
  1000   C2984964:APOE4 [Laboratory Procedure]

Phrase: "and"

Phrase: "a plasmid"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0032136:Plasmid [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "the neomycin resistance gene by the LipofectAMINE method"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   800   C1366752:Neomycin resistance gene [Gene or Genome]
   770   C2945710:resistance gene [Gene or Genome]
   744   C0017337:Gene [Gene or Genome]

Phrase: "(40"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439509:/40 [Temporal Concept]

Phrase: ")."
Processing 00000000.tx.63: The apoE genomic DNA construct consists of 5 kb of 5'-flanking region, four exons, three introns, and 8 kb of 3'-flanking region. 

Phrase: "The apoE genomic DNA construct"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0012931:DNA Construct [Nucleic Acid, Nucleoside, or Nucleotide]
   812   C2827421:Construct [Classification]

Phrase: "consists of 5 kb of 5'-flanking region,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C0017446:Region [Geographic Area]
   744   C0205147:Region [Spatial Concept]
   744   C0230171:flanking [Body Location or Region]
   744   C0332529:CONSIST [Qualitative Concept]

Phrase: "four exons,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0015295:Exons [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "three introns,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0021920:Introns [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and"

Phrase: "8 kb of 3'-flanking region."
Processing 00000000.tx.64: Stably transfected cells were selected by growth in minimal essential medium containing 10% fetal bovine serum and 400 g/ml G418 for more than 2 weeks and cloned with a cell sorter (40). 

Phrase: "Stably transfected cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "selected by growth"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0018270:'growth' NOS [Organism Function]
   790   C0220844:growth [Physiologic Function]
   790   C1621966:Growth [Organ or Tissue Function]
   790   C2911660:Growth [Activity]
   756   C1707391:Select [Activity]

Phrase: "in minimal essential medium"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   827   C0009458:Medium [Intellectual Product]
   827   C0205224:Essential [Qualitative Concept]
   827   C0439536:Medium [Quantitative Concept]
   827   C0547040:Minimal [Qualitative Concept]
   827   C1524031:MINIMAL [Qualitative Concept]
   827   C1705217:Medium [Substance]
   827   C2945599:Minimal [Qualitative Concept]
   827   C3244283:medium [Intellectual Product]
   755 E C1552614:minimum [Idea or Concept]
   755 E C2826545:MINIMUM [Quantitative Concept]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "10% fetal bovine serum"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   812   C0007452:Bovine [Mammal]
   812   C0015965:Fetal [Embryonic Structure]
   812   C0229671:Serum [Body Substance]
   812   C0521457:Fetal [Functional Concept]
   812   C1140701:bovine [Mammal]
   812   C1546774:Serum [Intellectual Product]
   812   C1550100:Serum [Body Substance]

Phrase: "and"

Phrase: "400 g/ml G418 for more"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0052009:G418 [Antibiotic,Organic Chemical]

Phrase: "than 2 weeks"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1442457:2 Weeks [Temporal Concept]
   861   C0439230:weeks [Temporal Concept]
   827 E C0332174:/week [Temporal Concept]

Phrase: "and"

Phrase: "cloned with a cell sorter"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   806   C1140606:SORTER, CELL [Medical Device]
   781   C0009013:Cell Clone [Cell]
           cloned
   760   C0007634:Cell [Cell]
   760   C0879123:sorter [Medical Device]
   760   C1269647:Cell [Cell]
   760   C1704653:Cell [Medical Device]
   760   C1948049:Cell [Spatial Concept]
   726 E C1522642:Clone [Tissue]

Phrase: "(40"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439509:/40 [Temporal Concept]

Phrase: ")."
Processing 00000000.tx.65: Cell lines stably expressing similar levels of apoE3 or apoE4, as determined by reverse transcriptase-PCR and anti-apoE Western blotting, were used in this study. 

Phrase: "Cell lines stably"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   901   C0007600:Cell lines [Cell]
   827   C0007634:Cell [Cell]
   827   C0205132:lines [Spatial Concept]
   827   C1269647:Cell [Cell]
   827   C1704653:Cell [Medical Device]
   827   C1948049:Cell [Spatial Concept]
   793 E C1550648:Line [Substance]
   793 E C1552960:Line [Quantitative Concept]

Phrase: "expressing"

Phrase: "similar levels of apoE3"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   770   C0441889:Levels [Qualitative Concept]
   737 E C0456079:Level [Classification]
   737 E C1547707:Level [Geographic Area]
   737 E C2946261:Level [Pharmacologic Substance]

Phrase: "or"

Phrase: "apoE4,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0052201:ApoE4 [Amino Acid, Peptide, or Protein]
  1000   C2984964:APOE4 [Laboratory Procedure]

Phrase: "as"

Phrase: "determined by reverse transcriptase-PCR"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   862   C0599161:Reverse Transcriptase PCR [Molecular Biology Research Technique]
   806   C0035379:Reverse Transcriptase [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   760   C0040646:Transcriptase [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0677874:pCR [Finding]
   760   C1555029:Reverse [Idea or Concept]
   760   C2257077:transcriptase [Genetic Function]

Phrase: "and"

Phrase: "anti-apoE Western blotting,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0005863:Western Blotting [Laboratory Procedure,Molecular Biology Research Technique]
   844 E C0949466:Western Blot [Laboratory Procedure]
   812   C1705493:Western [Spatial Concept]

Phrase: "were"

Phrase: "used in this study."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   802   C0869040:study use [Research Activity]
   770   C0557651:Study [Manufactured Object]
   770   C1273517:used [Finding]
   770   C2603343:Study [Research Activity]
   737 E C0042153:use [Functional Concept]
   737 E C0457083:Use [Functional Concept]
   737 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.66: Neo-transfected Neuro-2a cells were used as controls. 

Phrase: "Neo-transfected Neuro-2a cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   804   C0007634:Cells [Cell]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "used as controls."
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   790   C1273517:used [Finding]
   756 E C0042153:use [Functional Concept]
   756   C0243148:control [Qualitative Concept]
   756 E C0457083:Use [Functional Concept]
   756   C1550141:Control [Substance]
   756   C1882979:Control [Conceptual Entity]
   756 E C1947944:Use [Intellectual Product]
   756   C2587213:Control [Functional Concept]
   756   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.67: Western Blot Analysis of Cell LysatesStably transfected Neuro-2a cells expressing Neo, apoE3, or apoE4 were grown to 80% confluence in 6-well plates, incubated with ZnCl2 (50200 M) in the presence or absence of the Erk pathway inhibitor U0126 (10 M) for 24 h, harvested, and lysed in ice-cold lysis buffer (50 mM Tris-HCl, pH 8.0, 150 mM NaCl, 0.1% SDS, 1% Nonidet P-40, 0.5% sodium deoxycholate, and a mixture of protease and phosphatase inhibitors) for 30 min. 

Phrase: "Western Blot Analysis of Cell LysatesStably"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   833   C0949466:Western blot analysis [Laboratory Procedure]
           Western Blot
   790   C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   753   C0002778:Analysis [Laboratory Procedure]
   753   C0936012:Analysis [Research Activity]
   753   C1524024:analysis [Functional Concept]
   753   C1705493:Western [Spatial Concept]

Phrase: "transfected"

Phrase: "Neuro-2a cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "expressing"

Phrase: "Neo,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1366752:NEO [Gene or Genome]

Phrase: "apoE3,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0052199:Apo E3 [Amino Acid, Peptide, or Protein]

Phrase: "or"

Phrase: "apoE4"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0052201:ApoE4 [Amino Acid, Peptide, or Protein]
  1000   C2984964:APOE4 [Laboratory Procedure]

Phrase: "were"

Phrase: "grown to 80% confluence"

Phrase: "in 6-well"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205170:Well [Qualitative Concept]
   861   C3146287:Well [Manufactured Object]

Phrase: "plates"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0005971:Plate [Medical Device]
  1000   C1139930:plate [Medical Device]
  1000   C3537155:Plate [Manufactured Object]

Phrase: ","

Phrase: "incubated with ZnCl2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0078774:ZnCl2 [Hazardous or Poisonous Substance,Inorganic Chemical,Pharmacologic Substance]
   790   C1439852:Incubated [Laboratory Procedure]

Phrase: "(50200"

Phrase: "M) in the presence"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0392148:Presence [Therapeutic or Preventive Procedure]
   770   C0441923:M+ [Intellectual Product]

Phrase: "or"

Phrase: "absence of the Erk pathway inhibitor U0126"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0332197:absence [Quantitative Concept]
   748   C1689985:Absence [Anatomical Abnormality]

Phrase: "(10"

Phrase: "M) for 24 h,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   819   C2348952:H/m [Quantitative Concept]
   770   C0033727:H+ [Element, Ion, or Isotope]
   770   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441923:M+ [Intellectual Product]
   770   C0441932:H+ [Classification]
   770   C0564385:/h [Quantitative Concept]

Phrase: "harvested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1512335:Harvest [Health Care Activity]

Phrase: ","

Phrase: "and"

Phrase: "lysed in ice-cold lysis buffer"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   790   C0456963:Ice cold [Qualitative Concept]
   753   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   753   C0009264:Cold [Natural Phenomenon or Process]
   753   C0009443:Cold [Disease or Syndrome]
   753   C0020746:Ice [Inorganic Chemical]
   753   C0024348:Lysis [Pathologic Function]
           lysed
   753   C0234192:Cold [Physiologic Function]
   753   C1536403:lysis [Cell Function]

Phrase: "(50 mM Tris-HCl,"

Phrase: "pH 8.0,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: "150 mM NaCl,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   827   C1959973:% NaCl [Quantitative Concept]

Phrase: "0.1% SDS,"

Phrase: "1% Nonidet P-40,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   923   C0068941:Nonidet P-40 [Organic Chemical,Pharmacologic Substance]
   812   C0068940:nonidet [Organic Chemical,Pharmacologic Substance]
   812   C0439509:/40 [Temporal Concept]

Phrase: "0.5% sodium deoxycholate,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0037500:SODIUM DESOXYCHOLATE [Pharmacologic Substance,Steroid]
   812   C0037473:Sodium [Biologically Active Substance,Element, Ion, or Isotope]
   812   C0086123:Deoxycholate [Hormone,Pharmacologic Substance,Steroid]
   812   C0597484:Sodium+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "and"

Phrase: "a mixture of protease"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0439962:Mixture [Substance]

Phrase: "and"

Phrase: "phosphatase inhibitors"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   983   C0597217:phosphatase inhibitor [Pharmacologic Substance]
   861   C0243077:inhibitors [Chemical Viewed Functionally]
   827 E C1999216:Inhibitor [Qualitative Concept]

Phrase: ")"

Phrase: "for 30 min."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0456693:/30 min [Temporal Concept]
  1000   C1442458:30 min [Temporal Concept]
   861   C0702093:/min [Temporal Concept]
Processing 00000000.tx.68: After centrifugation at 35,000 rpm for 30 min, proteins (100 g) in the supernatant were subjected to SDS-PAGE and detected by anti-apoE, anti-Erk, anti-p-Erk, or anti-p-tau Western blotting as described above. 

Phrase: "After centrifugation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0007703:Centrifugation [Laboratory Procedure]

Phrase: "at 35,000 rpm"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0582523:rpm [Quantitative Concept]

Phrase: "for 30 min,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0456693:/30 min [Temporal Concept]
  1000   C1442458:30 min [Temporal Concept]
   861   C0702093:/min [Temporal Concept]

Phrase: "proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(100 g) in the supernatant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0439267:g% [Quantitative Concept]

Phrase: "were"

Phrase: "subjected to SDS-PAGE"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   833   C0600209:SDS-PAGE [Laboratory Procedure,Research Activity]
   770   C1704732:Page [Intellectual Product]
   737   C0681850:Subject [Group]
   737   C1550501:{Subject} [Idea or Concept]
   737   C1706203:Subject [Idea or Concept]
   737   C2349001:Subject [Human]
   737   C2697811:Subject [Functional Concept]

Phrase: "and"

Phrase: "detected by anti-apoE,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0442726:Detected [Finding]
   770   C0523511:APOE [Laboratory Procedure]
   770   C1412481:APOE [Gene or Genome]
   770   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "anti-Erk,"

Phrase: "anti-p-Erk,"

Phrase: "or"

Phrase: "anti-p-tau Western blotting as described above."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0005863:Western Blotting [Laboratory Procedure,Molecular Biology Research Technique]
   754 E C0949466:Western Blot [Laboratory Procedure]
   744   C1705493:Western [Spatial Concept]
Processing 00000000.tx.69: Statistical AnalysisResults are reported as mean  S.D. 

Phrase: "Statistical AnalysisResults"

Phrase: "are"

Phrase: "reported as mean  S.D."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   760   C0444504:Mean [Quantitative Concept]
   760   C0684224:Reported [Intellectual Product]
   760   C0700287:Reported [Health Care Activity]
   760   C2347634:Mean [Quantitative Concept]
   760   C2348143:Mean [Quantitative Concept]
   760   C3496591:Reported [Clinical Attribute]
   726 E C3273238:Report [Intellectual Product]
Processing 00000000.tx.70: Differences were evaluated by t test or analysis of variance.  

Phrase: "Differences"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   966   C1705241:*Difference [Quantitative Concept]
   966   C1705242:Difference [Qualitative Concept]
   916 E C0443199:Differential [Qualitative Concept]

Phrase: "were"

Phrase: "evaluated by t test"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0022885:Test [Laboratory Procedure]
   770   C0039593:Test [Functional Concept]
   770   C0220825:Evaluated [Functional Concept]
   770   C0392366:test [Intellectual Product]

Phrase: "or"

Phrase: "analysis of variance."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0002780:Analysis of Variance [Quantitative Concept]
           Variance Analysis
   790   C0002778:Analysis [Laboratory Procedure]
   790   C0936012:Analysis [Research Activity]
   790   C1524024:analysis [Functional Concept]
Processing 00000000.tx.71: RESULTS TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES  Age-dependent Accumulation of p-tau and p-Erk Is Increased in NSE-ApoE4 MiceBrain homogenates of 3- to 21-month-old NSE-apoE3 or NSE-apoE4 mice, which expressed similar levels of human apoE in brains (apoE3, 331  52 ng/mg protein; apoE4, 316  58 ng/mg protein) were analyzed by Western blotting with monoclonal antibody AT8, which recognizes p-tau isoforms with molecular masses of 5560 kDa. 

Phrase: "RESULTS TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0557061:Discussion [Therapeutic or Preventive Procedure]
   793   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Age-dependent Accumulation of p-tau"

Phrase: "and"

Phrase: "p-Erk"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C2603361:P' [Clinical Attribute]

Phrase: "Is"

Phrase: "Increased in NSE-ApoE4 MiceBrain"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   814   C1414404:ENOLASE, NEURON-SPECIFIC [Gene or Genome]
   814   C1880904:Neuron-Specific Enolase [Amino Acid, Peptide, or Protein,Enzyme,Neuroreactive Substance or Biogenic Amine]
   748   C0027882:Neuron [Cell]
   748   C0031691:ENOLASE [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0052201:ApoE4 [Amino Acid, Peptide, or Protein]
   748   C0205217:Increased [Quantitative Concept]
   748   C0205369:Specific [Qualitative Concept]
   748   C0442805:Increased [Functional Concept]
   748   C1552740:specific [Intellectual Product]
   748   C2984964:APOE4 [Laboratory Procedure]

Phrase: "homogenates of 3-"

Phrase: "to 21-month-old NSE-apoE3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C0052199:Apo E3 [Amino Acid, Peptide, or Protein]

Phrase: "or"

Phrase: "NSE-apoE4 mice,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   804   C0025914:Mice [Mammal]
   804   C0025929:mice [Mammal]
   804   C0026809:Mice [Mammal]
   717   C1414404:ENOLASE, NEURON-SPECIFIC [Gene or Genome]
   717   C1880904:Neuron-Specific Enolase [Amino Acid, Peptide, or Protein,Enzyme,Neuroreactive Substance or Biogenic Amine]

Phrase: "which"

Phrase: "expressed"

Phrase: "similar levels of human apoE"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   760   C0441889:Levels [Qualitative Concept]
   726 E C0456079:Level [Classification]
   726 E C1547707:Level [Geographic Area]
   726 E C2946261:Level [Pharmacologic Substance]

Phrase: "in brains"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0006104:Brains [Body Part, Organ, or Organ Component]
   966 E C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "(apoE3,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0052199:Apo E3 [Amino Acid, Peptide, or Protein]

Phrase: "331  52 ng/mg protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "; apoE4,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0052201:ApoE4 [Amino Acid, Peptide, or Protein]
  1000   C2984964:APOE4 [Laboratory Procedure]

Phrase: "316  58 ng/mg protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ")"

Phrase: "were"

Phrase: "analyzed by Western blotting"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   833   C0005863:Western Blotting [Laboratory Procedure,Molecular Biology Research Technique]
   816 E C0949466:Western Blot [Laboratory Procedure]
   770   C0936012:Analyzed [Research Activity]
   770   C1705493:Western [Spatial Concept]

Phrase: "with monoclonal antibody AT8,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C0003250:Monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "which"

Phrase: "recognizes"

Phrase: "p-tau isoforms with molecular masses of 5560 kDa."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0597298:Isoforms [Amino Acid, Peptide, or Protein]
Processing 00000000.tx.72: The levels of p-tau were much higher in NSE-apoE4 mice (Fig. 1A). 

Phrase: "The levels of p-tau"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   760   C0441889:Levels [Qualitative Concept]
   726 E C0456079:Level [Classification]
   726 E C1547707:Level [Geographic Area]
   726 E C2946261:Level [Pharmacologic Substance]

Phrase: "were"

Phrase: "much higher in NSE-apoE4 mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   711   C0205250:High [Qualitative Concept]
   711   C1299351:High [Qualitative Concept]
   711   C2700149:HIGH [Intellectual Product]

Phrase: "(Fig. 1A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450344:1A [Intellectual Product]
   861   C1553633:1a [Medical Device]

Phrase: ")."
Processing 00000000.tx.73: Semi-quantitative analysis of 3- to 21-month-old mice revealed considerably greater age-dependent accumulation of p-tau (all isoforms together) in NSE-apoE4 mice, especially aged mice (Fig. 1B). 

Phrase: "Semi-quantitative analysis of 3-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0936012:Analysis [Research Activity]
   760   C1524024:analysis [Functional Concept]

Phrase: "to 21-month-old mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0025914:Mice [Mammal]
   812   C0025929:mice [Mammal]
   812   C0026809:Mice [Mammal]

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "considerably greater age-dependent accumulation of p-tau"

Phrase: "("

Phrase: "all isoforms together"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0597298:Isoforms [Amino Acid, Peptide, or Protein]

Phrase: ")"

Phrase: "in NSE-apoE4 mice,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   804   C0025914:Mice [Mammal]
   804   C0025929:mice [Mammal]
   804   C0026809:Mice [Mammal]
   717   C1414404:ENOLASE, NEURON-SPECIFIC [Gene or Genome]
   717   C1880904:Neuron-Specific Enolase [Amino Acid, Peptide, or Protein,Enzyme,Neuroreactive Substance or Biogenic Amine]

Phrase: "especially aged mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]

Phrase: "(Fig. 1B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450345:1B [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.74: View larger version (41K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(41K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.75: 1. 

Phrase: "1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]
Processing 00000000.tx.76: Age-dependent accumulation of p-tau in the brains of NSE-apoE4 mice. 

Phrase: "Age-dependent accumulation of p-tau"

Phrase: "in the brains"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0006104:Brains [Body Part, Organ, or Organ Component]
   966 E C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "of NSE-apoE4 mice."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   804   C0025914:Mice [Mammal]
   804   C0025929:mice [Mammal]
   804   C0026809:Mice [Mammal]
   717   C1414404:ENOLASE, NEURON-SPECIFIC [Gene or Genome]
   717   C1880904:Neuron-Specific Enolase [Amino Acid, Peptide, or Protein,Enzyme,Neuroreactive Substance or Biogenic Amine]
Processing 00000000.tx.77: A, p-tau in brain homogenates (150 g of total protein) of three NSE-apoE3 or NSE-apoE4 mice at 9 months of age was detected by Western blotting with monoclonal antibody AT8. 

Phrase: "A,"

Phrase: "p-tau in brain homogenates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1720655:Tau [Intellectual Product]
   760   C1947974:Tau [Research Activity]

Phrase: "(150 g of total protein"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   797   C0060916:protein g [Amino Acid, Peptide, or Protein]
   797   C0086376:G-Protein [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0439267:g% [Quantitative Concept]

Phrase: ")"

Phrase: "of three NSE-apoE3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0052199:Apo E3 [Amino Acid, Peptide, or Protein]
   717   C1414404:ENOLASE, NEURON-SPECIFIC [Gene or Genome]
   717   C1880904:Neuron-Specific Enolase [Amino Acid, Peptide, or Protein,Enzyme,Neuroreactive Substance or Biogenic Amine]

Phrase: "or"

Phrase: "NSE-apoE4 mice at 9 months of age"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   739   C0025914:Mice [Mammal]
   739   C0025929:mice [Mammal]
   739   C0026809:Mice [Mammal]

Phrase: "was"

Phrase: "detected by Western blotting"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   833   C0005863:Western Blotting [Laboratory Procedure,Molecular Biology Research Technique]
   816 E C0949466:Western Blot [Laboratory Procedure]
   770   C0442726:Detected [Finding]
   770   C1511790:Detected [Therapeutic or Preventive Procedure]
   770   C1705493:Western [Spatial Concept]

Phrase: "with monoclonal antibody AT8."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C0003250:Monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.78: B, quantitative analysis of p-tau (all isoforms) in brain homogenates of NSE-apoE3 and NSE-apoE4 mice at 321 months of age (n = 46 per genotype and age; p <0.01, apoE3 versus apoE4 mice at 721 months).  

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "quantitative analysis of p-tau"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0392762:Quantitative [Quantitative Concept]
   760   C0936012:Analysis [Research Activity]
   760   C1524024:analysis [Functional Concept]

Phrase: "("

Phrase: "all isoforms"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0597298:Isoforms [Amino Acid, Peptide, or Protein]

Phrase: ")"

Phrase: "in brain homogenates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0006104:Brain [Body Part, Organ, or Organ Component]
   861   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "of NSE-apoE3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0052199:Apo E3 [Amino Acid, Peptide, or Protein]
   756   C1414404:ENOLASE, NEURON-SPECIFIC [Gene or Genome]
   756   C1880904:Neuron-Specific Enolase [Amino Acid, Peptide, or Protein,Enzyme,Neuroreactive Substance or Biogenic Amine]

Phrase: "and"

Phrase: "NSE-apoE4 mice at 321 months"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0025914:Mice [Mammal]
   744   C0025929:mice [Mammal]
   744   C0026809:Mice [Mammal]

Phrase: "of age (n = 46"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0001779:Age [Organism Attribute]

Phrase: "per genotype"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017431:Genotype [Organism Attribute]

Phrase: "and"

Phrase: "age"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001779:Age [Organism Attribute]

Phrase: "; p <0.01,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "apoE3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0052199:Apo E3 [Amino Acid, Peptide, or Protein]

Phrase: "versus"

Phrase: "apoE4 mice at 721 months"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0025914:Mice [Mammal]
   760   C0025929:mice [Mammal]
   760   C0026809:Mice [Mammal]

Phrase: ")."
Processing 00000000.tx.79: Immunoblotting of brain sections from 5- to 18-month-old mice revealed age-dependent accumulation of p-Erk, especially p-Erk2, that was significantly greater in NSE-apoE4 mice, although total Erk levels were similar (Fig. 2A). 

Phrase: "Immunoblotting of brain sections"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0020985:Immunoblotting [Laboratory Procedure]

Phrase: "from 5-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "to 18-month-old mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0025914:Mice [Mammal]
   812   C0025929:mice [Mammal]
   812   C0026809:Mice [Mammal]

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "age-dependent accumulation of p-Erk,"

Phrase: "especially p-Erk2,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0170168:ERK-2 [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1150579:ERK2 [Molecular Function]

Phrase: "that"

Phrase: "was"

Phrase: "significantly greater in NSE-apoE4 mice,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   744   C0443228:greater [Quantitative Concept]
   744   C1704243:Greater [Quantitative Concept]
   711 E C0549177:Great [Quantitative Concept]

Phrase: "although"

Phrase: "total Erk levels"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   827   C0441889:Levels [Qualitative Concept]
   793 E C0456079:Level [Classification]
   793 E C1547707:Level [Geographic Area]
   793 E C2946261:Level [Pharmacologic Substance]

Phrase: "were"

Phrase: "similar"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2348205:Similar [Qualitative Concept]

Phrase: "(Fig. 2A"

Phrase: ")."
Processing 00000000.tx.80: The ratios of p-Erk to Erk were also significantly higher in NSE-apoE4 mice at all ages (Fig. 2B). 

Phrase: "The ratios of p-Erk"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   760   C0456603:Ratios [Quantitative Concept]
   760   C1610540:*Ratios [Quantitative Concept]
   726 E C1547037:Ratio [Intellectual Product]

Phrase: "to Erk"

Phrase: "were"

Phrase: "also significantly higher in NSE-apoE4 mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   708   C0205250:High [Qualitative Concept]
   708   C1299351:High [Qualitative Concept]
   708   C2700149:HIGH [Intellectual Product]

Phrase: "at all ages"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001779:Age [Organism Attribute]

Phrase: "(Fig. 2B"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450354:2b [Intellectual Product]
   861   C1706096:2B [Research Activity]

Phrase: ")."
Processing 00000000.tx.81: No age- or isoform-specific differences were seen in other candidate tau kinases or their activators, including active GSK-3/ (Fig. 2C), active Cdk-5 (data not shown), p35 (Fig. 2D), and p25 (data not shown). 

Phrase: "No age-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001779:Age [Organism Attribute]

Phrase: "or"

Phrase: "isoform-specific differences"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   793   C1705241:*Difference [Quantitative Concept]
   793   C1705242:Difference [Qualitative Concept]
   743 E C0443199:Differential [Qualitative Concept]

Phrase: "were"

Phrase: "seen in other candidate tau kinases"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   753   C0031727:Kinases [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0205397:Seen [Qualitative Concept]
   753   C1720655:Tau [Intellectual Product]
   753   C1947974:Tau [Research Activity]
   719 E C0042789:see [Organism Function]
   719 E C1947903:See [Activity]

Phrase: "or"

Phrase: "their activators,"

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "active GSK-3/"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   937   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   884   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   840   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   804   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(Fig. 2C"

Phrase: ")"

Phrase: ","

Phrase: "active Cdk-5"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   937   C0249586:Cyclin-Dependent Kinase 5 [Amino Acid, Peptide, or Protein,Enzyme]
   937   C1332735:CYCLIN-DEPENDENT KINASE 5 [Gene or Genome]
   884   C0243045:Cyclin-Dependent Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0072108:Cyclin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0079183:Cyclin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0205177:Active [Functional Concept]
   804   C0851827:Dependent [Qualitative Concept]
   804   C1150565:cyclin [Molecular Function]
   804   C1701901:Dependent [Qualitative Concept]
   804   C3244310:dependent [Functional Concept]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "p35"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3539715:p35 [Gene or Genome]

Phrase: "(Fig. 2D"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1705052:2D [Spatial Concept]
   861   C2986796:2D [Functional Concept]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "p25"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3539715:p25 [Gene or Genome]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.82: View larger version (54K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(54K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.83: 2. 

Phrase: "2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]
Processing 00000000.tx.84: Age-dependent accumulation of p-Erk in the brains of NSE-apoE4 mice. 

Phrase: "Age-dependent accumulation of p-Erk"

Phrase: "in the brains"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0006104:Brains [Body Part, Organ, or Organ Component]
   966 E C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "of NSE-apoE4 mice."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   804   C0025914:Mice [Mammal]
   804   C0025929:mice [Mammal]
   804   C0026809:Mice [Mammal]
   717   C1414404:ENOLASE, NEURON-SPECIFIC [Gene or Genome]
   717   C1880904:Neuron-Specific Enolase [Amino Acid, Peptide, or Protein,Enzyme,Neuroreactive Substance or Biogenic Amine]
Processing 00000000.tx.85: A, total Erk and p-Erk levels in brain homogenates (150 g of total protein) of NSE-apoE3 or NSE-apoE4 mice at 518 months of age were detected by Western blotting with polyclonal anti-Erk or monoclonal anti-p-Erk. 

Phrase: "A,"

Phrase: "total Erk"

Phrase: "and"

Phrase: "p-Erk levels in brain homogenates"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   753   C0441889:Levels [Qualitative Concept]
   719 E C0456079:Level [Classification]
   719 E C1547707:Level [Geographic Area]
   719 E C2946261:Level [Pharmacologic Substance]

Phrase: "(150 g of total protein"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   797   C0060916:protein g [Amino Acid, Peptide, or Protein]
   797   C0086376:G-Protein [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0439267:g% [Quantitative Concept]

Phrase: ")"

Phrase: "of NSE-apoE3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0052199:Apo E3 [Amino Acid, Peptide, or Protein]
   756   C1414404:ENOLASE, NEURON-SPECIFIC [Gene or Genome]
   756   C1880904:Neuron-Specific Enolase [Amino Acid, Peptide, or Protein,Enzyme,Neuroreactive Substance or Biogenic Amine]

Phrase: "or"

Phrase: "NSE-apoE4 mice at 518 months of age"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   739   C0025914:Mice [Mammal]
   739   C0025929:mice [Mammal]
   739   C0026809:Mice [Mammal]

Phrase: "were"

Phrase: "detected by Western blotting"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   833   C0005863:Western Blotting [Laboratory Procedure,Molecular Biology Research Technique]
   816 E C0949466:Western Blot [Laboratory Procedure]
   770   C0442726:Detected [Finding]
   770   C1511790:Detected [Therapeutic or Preventive Procedure]
   770   C1705493:Western [Spatial Concept]

Phrase: "with polyclonal anti-Erk"

Phrase: "or"

Phrase: "monoclonal anti-p-Erk."
Processing 00000000.tx.86: B, quantitative analysis of the ratio of p-Erk (p-Erk1 + p-Erk2) to Erk (Erk1 + Erk2) in brain homogenates (n = 45 mice per genotype and age; p <0.01, apoE3 versus apoE4 mice at any age). 

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "quantitative analysis of the ratio"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0392762:Quantitative [Quantitative Concept]
   760   C0936012:Analysis [Research Activity]
   760   C1524024:analysis [Functional Concept]

Phrase: "of p-Erk (p-Erk1 + p-Erk2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C0170168:ERK-2 [Amino Acid, Peptide, or Protein,Enzyme]
   799   C1150579:ERK2 [Molecular Function]

Phrase: ")"

Phrase: "to Erk (Erk1 + Erk2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0170168:ERK-2 [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1150579:ERK2 [Molecular Function]

Phrase: ")"

Phrase: "in brain homogenates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0006104:Brain [Body Part, Organ, or Organ Component]
   861   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "(n = 45 mice per genotype"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0025914:Mice [Mammal]
   760   C0025929:mice [Mammal]
   760   C0026809:Mice [Mammal]

Phrase: "and"

Phrase: "age"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001779:Age [Organism Attribute]

Phrase: "; p <0.01,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "apoE3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0052199:Apo E3 [Amino Acid, Peptide, or Protein]

Phrase: "versus"

Phrase: "apoE4 mice at any age"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0025914:Mice [Mammal]
   760   C0025929:mice [Mammal]
   760   C0026809:Mice [Mammal]

Phrase: ")."
Processing 00000000.tx.87: C, phosphorylated (active) GSK-3 and GSK-3 in brain homogenates (150 g of total protein) were detected by Western blotting with phosphorylation-dependent GSK-3(Tyr-279)/GSK-3(Tyr-216) monoclonal antibody. 

Phrase: "C,"

Phrase: "phosphorylated"

Phrase: "(active"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205177:Active [Functional Concept]

Phrase: ")"

Phrase: "GSK-3"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   923   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   812   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "GSK-3 in brain homogenates"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   853   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   814   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   778   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   748   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(150 g of total protein"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   797   C0060916:protein g [Amino Acid, Peptide, or Protein]
   797   C0086376:G-Protein [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0439267:g% [Quantitative Concept]

Phrase: ")"

Phrase: "were"

Phrase: "detected by Western blotting"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   833   C0005863:Western Blotting [Laboratory Procedure,Molecular Biology Research Technique]
   816 E C0949466:Western Blot [Laboratory Procedure]
   770   C0442726:Detected [Finding]
   770   C1511790:Detected [Therapeutic or Preventive Procedure]
   770   C1705493:Western [Spatial Concept]

Phrase: "with phosphorylation-dependent GSK-3"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   901   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   799   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   799   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   799   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(Tyr-279"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0041484:TYR [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0041485:TYR [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   861   C1421250:TYR [Gene or Genome]

Phrase: ")"

Phrase: "/GSK-3"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   923   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   812   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(Tyr-216"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0041484:TYR [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0041485:TYR [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   861   C1421250:TYR [Gene or Genome]

Phrase: ")"

Phrase: "monoclonal antibody."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0003250:Monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   861   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   861   C0746619:monoclonal [Finding]
Processing 00000000.tx.88: D, p35 in brain homogenates (200 g of total protein) was detected by Western blotting with polyclonal anti-p35.  

Phrase: "D,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "p35 in brain homogenates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C3539715:p35 [Gene or Genome]

Phrase: "(200 g of total protein"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   797   C0060916:protein g [Amino Acid, Peptide, or Protein]
   797   C0086376:G-Protein [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0439267:g% [Quantitative Concept]

Phrase: ")"

Phrase: "was"

Phrase: "detected by Western blotting"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   833   C0005863:Western Blotting [Laboratory Procedure,Molecular Biology Research Technique]
   816 E C0949466:Western Blot [Laboratory Procedure]
   770   C0442726:Detected [Finding]
   770   C1511790:Detected [Therapeutic or Preventive Procedure]
   770   C1705493:Western [Spatial Concept]

Phrase: "with polyclonal anti-p35."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C3539715:p35 [Gene or Genome]
Processing 00000000.tx.89: Accumulation of p-tau and p-Erk Is Brain Region- and ApoE Isoform-dependentNext, we assessed the brain region specificity of the increases in p-tau and p-Erk in 9-month-old mice. 

Phrase: "Accumulation of p-tau"

Phrase: "and"

Phrase: "p-Erk"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C2603361:P' [Clinical Attribute]

Phrase: "Is"

Phrase: "Brain Region-"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C1273723:Brain region [Body Location or Region]
   861   C0006104:Brain [Body Part, Organ, or Organ Component]
   861   C0017446:Region [Geographic Area]
   861   C0205147:Region [Spatial Concept]
   861   C1269537:Brain [Body Part, Organ, or Organ Component]
   789 E C0205276:Regional [Spatial Concept]
   789 E C1947913:Regional [Spatial Concept]

Phrase: "and"

Phrase: "ApoE Isoform-dependentNext,"

Phrase: "we"

Phrase: "assessed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1516048:Assessed [Activity]

Phrase: "the brain region specificity of the increases"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0037791:Specificity [Quantitative Concept]
   748   C1511884:Specificity [Quantitative Concept]

Phrase: "in p-tau"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1720655:Tau [Intellectual Product]
   861   C1947974:Tau [Research Activity]

Phrase: "and"

Phrase: "p-Erk in 9-month-old mice."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   748   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.90: Homogenates of neocortex, hippocampus, and cerebellum were subjected to SDS-PAGE and analyzed by anti-p-tau and anti-p-Erk Western blotting. 

Phrase: "Homogenates of neocortex,"

Phrase: "hippocampus,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0019564:Hippocampus [Body Part, Organ, or Organ Component]
  1000   C0949582:Hippocampus [Fish]
  1000   C1029104:Hippocampus [Fish]
  1000   C1284077:Hippocampus [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "cerebellum"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0007765:Cerebellum [Body Part, Organ, or Organ Component]
  1000   C1268981:Cerebellum [Body Part, Organ, or Organ Component]
  1000   C1707522:Cerebellum [Tissue]

Phrase: "were"

Phrase: "subjected to SDS-PAGE"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   833   C0600209:SDS-PAGE [Laboratory Procedure,Research Activity]
   770   C1704732:Page [Intellectual Product]
   737   C0681850:Subject [Group]
   737   C1550501:{Subject} [Idea or Concept]
   737   C1706203:Subject [Idea or Concept]
   737   C2349001:Subject [Human]
   737   C2697811:Subject [Functional Concept]

Phrase: "and"

Phrase: "analyzed by anti-p-tau"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0936012:Analyzed [Research Activity]
   760   C1720655:Tau [Intellectual Product]
   760   C1947974:Tau [Research Activity]

Phrase: "and"

Phrase: "anti-p-Erk Western blotting."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   840   C0005863:Western Blotting [Laboratory Procedure,Molecular Biology Research Technique]
   823 E C0949466:Western Blot [Laboratory Procedure]
   804   C1705493:Western [Spatial Concept]
Processing 00000000.tx.91: The p-tau and p-Erk levels were highest in the hippocampus, intermediate in the neocortex, and lowest in the cerebellum and were 2-fold higher in NSE-apoE4 mice in all three regions (Fig. 3, A and B). 

Phrase: "The p-tau"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1720655:Tau [Intellectual Product]
   861   C1947974:Tau [Research Activity]

Phrase: "and"

Phrase: "p-Erk levels"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   827   C0441889:Levels [Qualitative Concept]
   793 E C0456079:Level [Classification]
   793 E C1547707:Level [Geographic Area]
   793 E C2946261:Level [Pharmacologic Substance]

Phrase: "were"

Phrase: "highest in the hippocampus,"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   770   C1522410:Highest [Qualitative Concept]
   737 E C0205250:High [Qualitative Concept]
   737 E C1299351:High [Qualitative Concept]
   737 E C2700149:HIGH [Intellectual Product]

Phrase: "intermediate in the neocortex,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0205103:Intermediate [Spatial Concept]
   770   C1550465:intermediate [Idea or Concept]
   770   C2827755:INTERMEDIATE [Laboratory or Test Result]

Phrase: "and"

Phrase: "lowest in the cerebellum"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   770   C1708760:Lowest [Qualitative Concept]
   737 E C0205251:low [Qualitative Concept]
   737 E C1299352:Low [Qualitative Concept]
   737 E C1550472:low [Idea or Concept]

Phrase: "and"

Phrase: "were"

Phrase: "2-fold"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332462:Fold [Spatial Concept]
   861   C1880834:FOLD [Phenomenon or Process]

Phrase: "higher in NSE-apoE4 mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   714   C0205250:High [Qualitative Concept]
   714   C1299351:High [Qualitative Concept]
   714   C2700149:HIGH [Intellectual Product]

Phrase: "in all three regions"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0017446:Region [Geographic Area]
   827   C0205147:Region [Spatial Concept]
   777 E C0205276:Regional [Spatial Concept]
   777 E C1947913:Regional [Spatial Concept]

Phrase: "(Fig. 3,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "A"

Phrase: "and"

Phrase: "B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.92: View larger version (18K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(18K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.93: 3. 

Phrase: "3."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]
Processing 00000000.tx.94: Brain region- and apoE isoform-dependent accumulation of p-tau and p-Erk. 

Phrase: "Brain region-"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C1273723:Brain region [Body Location or Region]
   861   C0006104:Brain [Body Part, Organ, or Organ Component]
   861   C0017446:Region [Geographic Area]
   861   C0205147:Region [Spatial Concept]
   861   C1269537:Brain [Body Part, Organ, or Organ Component]
   789 E C0205276:Regional [Spatial Concept]
   789 E C1947913:Regional [Spatial Concept]

Phrase: "and"

Phrase: "apoE isoform-dependent accumulation of p-tau"

Phrase: "and"

Phrase: "p-Erk."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.95: Quantitative analyses of p-tau (A) and the ratio of p-Erk (p-Erk1 + p-Erk2) to Erk (Erk1 + Erk2) (B) in homogenates (150 g of total protein) of different regions of brains of NSE-apoE3 or NSE-apoE4 mice at 9 month of age as determined by anti-p-tau and anti-p-Erk or anti-Erk, (n = 35 per genotype; p <0.01, apoE3 versus apoE4 mice for the neocortex and hippocampus; p <0.05, apoE3 versus apoE4 mice for the cerebellum).  

Phrase: "Quantitative analyses of p-tau"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   726   C0002778:Analysis [Laboratory Procedure]
   726   C0936012:Analysis [Research Activity]
   726   C1524024:analysis [Functional Concept]

Phrase: "(A)"

Phrase: "and"

Phrase: "the ratio of p-Erk (p-Erk1 + p-Erk2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0456603:Ratio [Quantitative Concept]
   742   C1547037:Ratio [Intellectual Product]

Phrase: ")"

Phrase: "to Erk (Erk1 + Erk2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0170168:ERK-2 [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1150579:ERK2 [Molecular Function]

Phrase: ")"

Phrase: "(B) in homogenates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C2347469:/B [Quantitative Concept]

Phrase: "(150 g of total protein"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   797   C0060916:protein g [Amino Acid, Peptide, or Protein]
   797   C0086376:G-Protein [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0439267:g% [Quantitative Concept]

Phrase: ")"

Phrase: "of different regions"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0017446:Region [Geographic Area]
   827   C0205147:Region [Spatial Concept]
   777 E C0205276:Regional [Spatial Concept]
   777 E C1947913:Regional [Spatial Concept]

Phrase: "of brains"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0006104:Brains [Body Part, Organ, or Organ Component]
   966 E C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "of NSE-apoE3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0052199:Apo E3 [Amino Acid, Peptide, or Protein]
   756   C1414404:ENOLASE, NEURON-SPECIFIC [Gene or Genome]
   756   C1880904:Neuron-Specific Enolase [Amino Acid, Peptide, or Protein,Enzyme,Neuroreactive Substance or Biogenic Amine]

Phrase: "or"

Phrase: "NSE-apoE4 mice at 9 month of age"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   739   C0025914:Mice [Mammal]
   739   C0025929:mice [Mammal]
   739   C0026809:Mice [Mammal]

Phrase: "as"

Phrase: "determined by anti-p-tau"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1720655:Tau [Intellectual Product]
   760   C1947974:Tau [Research Activity]

Phrase: "and"

Phrase: "anti-p-Erk"

Phrase: "or"

Phrase: "anti-Erk,"

Phrase: "(n = 35 per genotype"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0017431:Genotype [Organism Attribute]
   770   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441922:N+ [Intellectual Product]
   770   C1553036:[n] [Quantitative Concept]

Phrase: "; p <0.01,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "apoE3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0052199:Apo E3 [Amino Acid, Peptide, or Protein]

Phrase: "versus"

Phrase: "apoE4 mice for the neocortex"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0025914:Mice [Mammal]
   760   C0025929:mice [Mammal]
   760   C0026809:Mice [Mammal]

Phrase: "and"

Phrase: "hippocampus"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0019564:Hippocampus [Body Part, Organ, or Organ Component]
  1000   C0949582:Hippocampus [Fish]
  1000   C1029104:Hippocampus [Fish]
  1000   C1284077:Hippocampus [Body Part, Organ, or Organ Component]

Phrase: "; p <0.05,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "apoE3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0052199:Apo E3 [Amino Acid, Peptide, or Protein]

Phrase: "versus"

Phrase: "apoE4 mice for the cerebellum"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   781   C1522278:Mouse Cerebellum [Tissue]
   760   C0025914:Mice [Mammal]
   760   C0025929:mice [Mammal]
   760   C0026809:Mice [Mammal]

Phrase: ")."
Processing 00000000.tx.96: p-Erk- and p-tau-positive Neurons Are Prominent in the CA3 Region and the Dentate Gyrus of the Hippocampus in NSE-ApoE4 MiceImmunostaining of brain sections from 18 to 21-month-old mice with anti-p-Erk antibodies revealed p-Erk-positive neurons predominantly in the CA3 region (Fig. 4A) and hilus of the dentate gyrus (Fig. 4B) in NSE-apoE4 mice. 

Phrase: "p-Erk-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C2603361:P' [Clinical Attribute]

Phrase: "and"

Phrase: "p-tau-positive Neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0027882:Neurons [Cell]
   729 E C0521390:Neuronal [Immunologic Factor]

Phrase: "Are"

Phrase: "Prominent in the CA3 Region"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0205402:Prominent [Qualitative Concept]

Phrase: "and"

Phrase: "the Dentate Gyrus of the Hippocampus"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   864   C0152314:Dentate gyrus of hippocampus [Body Part, Organ, or Organ Component]
           Dentate Gyrus
   790   C1281026:Dentate gyrus [Body Part, Organ, or Organ Component]
   783   C0228249:Gyrus Hippocampus [Body Part, Organ, or Organ Component]

Phrase: "in NSE-ApoE4 MiceImmunostaining"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   717   C1414404:ENOLASE, NEURON-SPECIFIC [Gene or Genome]
   717   C1880904:Neuron-Specific Enolase [Amino Acid, Peptide, or Protein,Enzyme,Neuroreactive Substance or Biogenic Amine]

Phrase: "of brain sections"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   861   C0006104:Brain [Body Part, Organ, or Organ Component]
   861   C1269537:Brain [Body Part, Organ, or Organ Component]
   827   C0205155:Section [Spatial Concept]
   827   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   827   C1522472:Section [Substance]
   827   C1552923:Section [Quantitative Concept]
   827   C1705191:Section [Physical Object]

Phrase: "from 18"

Phrase: "to 21-month-old mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0025914:Mice [Mammal]
   812   C0025929:mice [Mammal]
   812   C0026809:Mice [Mammal]

Phrase: "with anti-p-Erk antibodies"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   902   C1624602:Anti-Antibodies [Amino Acid, Peptide, or Protein,Immunologic Factor]
   886 E C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   779 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "p-Erk-positive neurons predominantly in the CA3 region"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0027882:Neurons [Cell]

Phrase: "(Fig. 4A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450373:4a [Intellectual Product]
   861   C1553636:4a [Medical Device]

Phrase: ")"

Phrase: "and"

Phrase: "hilus of the dentate gyrus"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   891   C1134421:Hilus of Dentate Gyrus [Body Part, Organ, or Organ Component]
           Dentate gyrus hilus

Phrase: "(Fig. 4B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450375:4b [Intellectual Product]

Phrase: ")"

Phrase: "in NSE-apoE4 mice."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   804   C0025914:Mice [Mammal]
   804   C0025929:mice [Mammal]
   804   C0026809:Mice [Mammal]
   717   C1414404:ENOLASE, NEURON-SPECIFIC [Gene or Genome]
   717   C1880904:Neuron-Specific Enolase [Amino Acid, Peptide, or Protein,Enzyme,Neuroreactive Substance or Biogenic Amine]
Processing 00000000.tx.97: Such neurons were detected much less frequently in NSE-apoE3 mice (Fig. 4C). 

Phrase: "Such neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0027882:Neurons [Cell]
   916 E C0521390:Neuronal [Immunologic Factor]

Phrase: "were"

Phrase: "detected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442726:Detected [Finding]
  1000   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "much less frequently in NSE-apoE3 mice"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   790   C1414404:ENOLASE, NEURON-SPECIFIC [Gene or Genome]
   790   C1880904:Neuron-Specific Enolase [Amino Acid, Peptide, or Protein,Enzyme,Neuroreactive Substance or Biogenic Amine]
   742   C0025914:Mice [Mammal]
   742   C0025929:mice [Mammal]
   742   C0026809:Mice [Mammal]
   742   C0027882:Neuron [Cell]
   742   C0031691:ENOLASE [Amino Acid, Peptide, or Protein,Enzyme]
   742   C0052199:Apo E3 [Amino Acid, Peptide, or Protein]
   742   C0205369:Specific [Qualitative Concept]
   742   C0332183:Frequently [Temporal Concept]
   742   C1552740:specific [Intellectual Product]

Phrase: "(Fig. 4C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450376:4c [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.98: Immunostaining with monoclonal antibody AT8 revealed p-tau-positive neurons, some containing p-tau-positive inclusions in the CA3 region (Fig. 4D, arrowheads) and hilus (Fig. 4E) in the same NSE-apoE4 mice. 

Phrase: "Immunostaining with monoclonal antibody AT8"

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "p-tau-positive neurons,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0027882:Neurons [Cell]
   729 E C0521390:Neuronal [Immunologic Factor]

Phrase: "some"

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "p-tau-positive inclusions in the CA3 region"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   711   C1512693:Inclusion [Qualitative Concept]

Phrase: "(Fig. 4D, arrowheads"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C1080898:Arrowheads [Plant]
   793 E C0453107:Arrowhead [Food]

Phrase: ")"

Phrase: "and"

Phrase: "hilus"

Phrase: "(Fig. 4E"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450378:4e [Intellectual Product]

Phrase: ")"

Phrase: "in the same NSE-apoE4 mice."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   799   C0025914:Mice [Mammal]
   799   C0025929:mice [Mammal]
   799   C0026809:Mice [Mammal]
Processing 00000000.tx.99: Again, such p-tau-positive neurons were detected much less frequently in age-matched NSE-apoE3 mice (Fig. 4F). 

Phrase: "Again,"

Phrase: "such p-tau-positive neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0027882:Neurons [Cell]
   729 E C0521390:Neuronal [Immunologic Factor]

Phrase: "were"

Phrase: "detected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442726:Detected [Finding]
  1000   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "much less frequently in age-matched NSE-apoE3 mice"
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   775   C1414404:ENOLASE, NEURON-SPECIFIC [Gene or Genome]
   775   C1880904:Neuron-Specific Enolase [Amino Acid, Peptide, or Protein,Enzyme,Neuroreactive Substance or Biogenic Amine]
   738   C0001779:Age [Organism Attribute]
   738   C0025914:Mice [Mammal]
   738   C0025929:mice [Mammal]
   738   C0026809:Mice [Mammal]
   738   C0027882:Neuron [Cell]
   738   C0031691:ENOLASE [Amino Acid, Peptide, or Protein,Enzyme]
   738   C0052199:Apo E3 [Amino Acid, Peptide, or Protein]
   738   C0150103:matched [Research Activity]
   738   C0205369:Specific [Qualitative Concept]
   738   C0332183:Frequently [Temporal Concept]
   738   C1552740:specific [Intellectual Product]
   738   C1708943:Matched [Qualitative Concept]

Phrase: "(Fig. 4F"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450379:4f [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.100: These results suggest that Erk activation is associated with increased phosphorylation and aggregation of tau. 

Phrase: "These results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that Erk activation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1879547:Activation [Activity]

Phrase: "is"

Phrase: "associated with increased phosphorylation"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   770   C0031715:Phosphorylation [Molecular Function]
   770   C0205217:Increased [Quantitative Concept]
   770   C0442805:Increased [Functional Concept]
   770   C1158886:Phosphorylation [Molecular Function]
   737 E C0750490:Associate [Idea or Concept]
   737 E C1706221:Associate [Professional or Occupational Group]

Phrase: "and"

Phrase: "aggregation of tau."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0332621:Aggregation [Functional Concept]
   790   C0439168:% aggregation [Quantitative Concept]
   718 E C0205418:Aggregate [Qualitative Concept]
Processing 00000000.tx.101: View larger version (67K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(67K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.102: 4. 

Phrase: "4."
Processing 00000000.tx.103: Detection of p-Erk- and p-tau-positive neurons in the CA3 region and hilus of the dentate gyrus of the hippocampus. 

Phrase: "Detection of p-Erk-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1511790:Detection [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "p-tau-positive neurons in the CA3 region"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0027882:Neurons [Cell]

Phrase: "and"

Phrase: "hilus of the dentate gyrus of the hippocampus."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   819   C1134421:Hilus of Dentate Gyrus [Body Part, Organ, or Organ Component]
           Dentate gyrus hilus
Processing 00000000.tx.104: Brain sections from 18 to 21-month-old NSE-apoE4 mice were immunostained with monoclonal anti-p-Erk (A and B, immunofluorescence staining) or anti-p-tau (AT8) (D and E, immunoperoxidase staining; arrowheads indicate p-tau-containing inclusions). 

Phrase: "Brain sections from 18"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0006104:Brain [Body Part, Organ, or Organ Component]
   770   C1269537:Brain [Body Part, Organ, or Organ Component]
   737   C0205155:Section [Spatial Concept]
   737   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   737   C1522472:Section [Substance]
   737   C1552923:Section [Quantitative Concept]
   737   C1705191:Section [Physical Object]

Phrase: "to 21-month-old NSE-apoE4 mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   793   C0025914:Mice [Mammal]
   793   C0025929:mice [Mammal]
   793   C0026809:Mice [Mammal]

Phrase: "were"

Phrase: "immunostained with monoclonal anti-p-Erk (A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   774   C0432616:Anti A [Amino Acid, Peptide, or Protein,Immunologic Factor]
   748   C0746619:monoclonal [Finding]

Phrase: "and"

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "immunofluorescence staining"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0487602:Staining [Laboratory Procedure]
   861   C1704680:Staining [Finding]

Phrase: ")"

Phrase: "or"

Phrase: "anti-p-tau"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1720655:Tau [Intellectual Product]
   827   C1947974:Tau [Research Activity]

Phrase: "(AT8"

Phrase: ")"

Phrase: "(D"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "E,"

Phrase: "immunoperoxidase staining"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0021067:Immunoperoxidase Staining [Laboratory Procedure]
   861   C0487602:Staining [Laboratory Procedure]
   861   C1704680:Staining [Finding]

Phrase: "; arrowheads"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1080898:Arrowheads [Plant]
   966 E C0453107:Arrowhead [Food]

Phrase: "indicate"

Phrase: "p-tau-containing inclusions"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   923   C3280374:Tau-containing inclusions [Finding]
   779   C1512693:Inclusion [Qualitative Concept]

Phrase: ")."
Processing 00000000.tx.105: Quantitative analyses of neurons positive for p-Erk (C) or p-tau (F) in 18 to 21-month-old NSE-apoE4 (E4) and NSE-apoE3 (E3) mice (n = 45 per genotype; p <0.01, apoE3 versus apoE4 mice).  

Phrase: "Quantitative analyses of neurons positive"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   726   C0002778:Analysis [Laboratory Procedure]
   726   C0936012:Analysis [Research Activity]
   726   C1524024:analysis [Functional Concept]

Phrase: "for p-Erk ("
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C2603361:P' [Clinical Attribute]

Phrase: "C)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "or"

Phrase: "p-tau"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1720655:Tau [Intellectual Product]
   861   C1947974:Tau [Research Activity]

Phrase: "(F) in 18"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   790   C0439133:(f) [Intellectual Product]
   790   C1553038:[f] [Quantitative Concept]

Phrase: "to 21-month-old NSE-apoE4"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   795   C0052201:ApoE4 [Amino Acid, Peptide, or Protein]
   795   C2984964:APOE4 [Laboratory Procedure]

Phrase: "(E4"

Phrase: ")"

Phrase: "and"

Phrase: "NSE-apoE3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0052199:Apo E3 [Amino Acid, Peptide, or Protein]
   756   C1414404:ENOLASE, NEURON-SPECIFIC [Gene or Genome]
   756   C1880904:Neuron-Specific Enolase [Amino Acid, Peptide, or Protein,Enzyme,Neuroreactive Substance or Biogenic Amine]

Phrase: "(E3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1537525:E3 [Gene or Genome]

Phrase: ")"

Phrase: "mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mice [Mammal]
  1000   C0025929:mice [Mammal]
  1000   C0026809:Mice [Mammal]

Phrase: "(n = 45 per genotype"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0017431:Genotype [Organism Attribute]
   770   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441922:N+ [Intellectual Product]
   770   C1553036:[n] [Quantitative Concept]

Phrase: "; p <0.01,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "apoE3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0052199:Apo E3 [Amino Acid, Peptide, or Protein]

Phrase: "versus"

Phrase: "apoE4 mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]

Phrase: ")."
Processing 00000000.tx.106: ApoE4 Potentiates Zinc-induced Erk Activation in Neuro-2a CellsThe CA3 region and the hilus contain the mossy fiber system of the hippocampus, which contains high levels of zinc (54). 

Phrase: "ApoE4"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0052201:ApoE4 [Amino Acid, Peptide, or Protein]
  1000   C2984964:APOE4 [Laboratory Procedure]

Phrase: "Potentiates"

Phrase: "Zinc-induced Erk Activation in Neuro-2a CellsThe CA3 region"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C1879547:Activation [Activity]

Phrase: "and"

Phrase: "the hilus"

Phrase: "contain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "the mossy fiber system of the hippocampus,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0449913:System [Functional Concept]
   748   C1553451:System [Manufactured Object]
   748   C1704459:System [Medical Device]

Phrase: "which"

Phrase: "contains"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "high levels of zinc"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
   819   C0729826:levels zinc [Laboratory or Test Result]
   802 E C0373748:Zinc level [Laboratory Procedure]
   770   C0441889:Levels [Qualitative Concept]
   737 E C0456079:Level [Classification]
   737 E C1547707:Level [Geographic Area]
   737 E C2946261:Level [Pharmacologic Substance]

Phrase: "(54"

Phrase: ")."
Processing 00000000.tx.107: To determine whether zinc participates in apoE4-associated Erk activation and tau phosphorylation, we treated stably transfected Neuro-2a cells expressing similar levels of apoE3 and apoE4 (40) (Fig. 5A) with zinc. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "determine"

Phrase: "whether"

Phrase: "zinc"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0043481:Zinc [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C2348288:Zinc [Element, Ion, or Isotope]

Phrase: "participates in apoE4-associated Erk activation"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   753   C0052201:ApoE4 [Amino Acid, Peptide, or Protein]
   753   C0332281:Associated [Qualitative Concept]
   753   C1879547:Activation [Activity]
   753   C2984964:APOE4 [Laboratory Procedure]
   719 E C0750490:Associate [Idea or Concept]
   719 E C1706221:Associate [Professional or Occupational Group]

Phrase: "and"

Phrase: "tau phosphorylation,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0031715:Phosphorylation [Molecular Function]
   861   C1158886:Phosphorylation [Molecular Function]

Phrase: "we"

Phrase: "treated"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332293:treated [Therapeutic or Preventive Procedure]
  1000   C1522326:Treated [Functional Concept]
   966 E C1292734:TREAT [Functional Concept]

Phrase: "stably transfected Neuro-2a cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   804   C0007634:Cells [Cell]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]

Phrase: "expressing"

Phrase: "similar levels of apoE3"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   770   C0441889:Levels [Qualitative Concept]
   737 E C0456079:Level [Classification]
   737 E C1547707:Level [Geographic Area]
   737 E C2946261:Level [Pharmacologic Substance]

Phrase: "and"

Phrase: "apoE4"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0052201:ApoE4 [Amino Acid, Peptide, or Protein]
  1000   C2984964:APOE4 [Laboratory Procedure]

Phrase: "(40"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439509:/40 [Temporal Concept]

Phrase: ")"

Phrase: "(Fig. 5A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553637:5a [Medical Device]

Phrase: ")"

Phrase: "with zinc."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0043481:Zinc [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C2348288:Zinc [Element, Ion, or Isotope]
Processing 00000000.tx.108: Neo-transfected Neuro-2a cells were used as controls. 

Phrase: "Neo-transfected Neuro-2a cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   804   C0007634:Cells [Cell]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "used as controls."
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   790   C1273517:used [Finding]
   756 E C0042153:use [Functional Concept]
   756   C0243148:control [Qualitative Concept]
   756 E C0457083:Use [Functional Concept]
   756   C1550141:Control [Substance]
   756   C1882979:Control [Conceptual Entity]
   756 E C1947944:Use [Intellectual Product]
   756   C2587213:Control [Functional Concept]
   756   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.109: At a concentration of 200 M, ZnCl2 activated Erk, especially p-Erk2, to a significantly greater extent in apoE4-expressing cells than in apoE3-expressing or Neo-expressing cells but did not alter the total (unphosphorylated) Erk level (Fig. 5B). 

Phrase: "At a concentration"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0086045:Concentration [Mental Process]
  1000   C1446561:Concentration [Quantitative Concept]
   928 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "of 200 M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "ZnCl2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0078774:ZnCl2 [Hazardous or Poisonous Substance,Inorganic Chemical,Pharmacologic Substance]

Phrase: "activated"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1879547:Activated [Activity]
   966 E C1515877:Activate [Functional Concept]

Phrase: "Erk,"

Phrase: "especially p-Erk2,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0170168:ERK-2 [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1150579:ERK2 [Molecular Function]

Phrase: "to a significantly greater extent"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   884   C1555603:Great extent [Qualitative Concept]
   827   C0439792:Extent [Spatial Concept]

Phrase: "in apoE4-expressing cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "than"

Phrase: "in apoE3-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0052199:Apo E3 [Amino Acid, Peptide, or Protein]

Phrase: "expressing"

Phrase: "or"

Phrase: "Neo-expressing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1366752:NEO [Gene or Genome]

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "but"

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "alter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   916   C0392747:Altered [Functional Concept]

Phrase: "the total"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439175:% total [Quantitative Concept]
  1000   C0439810:Total [Qualitative Concept]

Phrase: "(unphosphorylated"

Phrase: ")"

Phrase: "Erk level"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0441889:Level [Qualitative Concept]
   861   C0456079:Level [Classification]
   861   C1547707:Level [Geographic Area]
   861   C2946261:Level [Pharmacologic Substance]

Phrase: "(Fig. 5B"

Phrase: ")."
Processing 00000000.tx.110: Thus, the ratio of p-Erk to Erk was much higher in ZnCl2-treated than control cells and was 2-fold higher in cells expressing apoE4 (Fig. 5C). 

Phrase: "Thus,"

Phrase: "the ratio of p-Erk"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0456603:Ratio [Quantitative Concept]
   760   C1547037:Ratio [Intellectual Product]

Phrase: "to Erk"

Phrase: "was"

Phrase: "much higher in ZnCl2-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   737   C0205250:High [Qualitative Concept]
   737   C1299351:High [Qualitative Concept]
   737   C2700149:HIGH [Intellectual Product]

Phrase: "treated than control cells"
Meta Candidates (Total=13; Excluded=4; Pruned=0; Remaining=9)
   770   C0007634:Cells [Cell]
   770   C0243148:control [Qualitative Concept]
   770   C0332293:treated [Therapeutic or Preventive Procedure]
   770   C1522326:Treated [Functional Concept]
   770   C1550141:Control [Substance]
   770   C1882979:Control [Conceptual Entity]
   770   C2587213:Control [Functional Concept]
   770   C3274648:Control [Qualitative Concept]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1292734:TREAT [Functional Concept]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "was"

Phrase: "2-fold"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332462:Fold [Spatial Concept]
   861   C1880834:FOLD [Phenomenon or Process]

Phrase: "higher in cells"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   756   C0205250:High [Qualitative Concept]
   756   C1299351:High [Qualitative Concept]
   756   C2700149:HIGH [Intellectual Product]
   706 E C0489786:Height [Organism Attribute]

Phrase: "expressing"

Phrase: "apoE4"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0052201:ApoE4 [Amino Acid, Peptide, or Protein]
  1000   C2984964:APOE4 [Laboratory Procedure]

Phrase: "(Fig. 5C"

Phrase: ")."
Processing 00000000.tx.111: View larger version (40K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(40K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.112: 5. 

Phrase: "5."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]
Processing 00000000.tx.113: ApoE4 potentiates zinc-induced Erk activation in stably transfected Neuro-2a (N2a) cells. 

Phrase: "ApoE4"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0052201:ApoE4 [Amino Acid, Peptide, or Protein]
  1000   C2984964:APOE4 [Laboratory Procedure]

Phrase: "potentiates"

Phrase: "zinc-induced Erk activation in stably transfected Neuro-2a (N2a) cells."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   757   C1326120:activation cells [Cell Function]
   739   C1879547:Activation [Activity]
Processing 00000000.tx.114: A, anti-apoE Western blotting showed similar levels of expression of apoE3 and apoE4 in stably transfected Neuro-2a cells (73  11 and 80  9 ng apoE/mg cell protein/24 h). 

Phrase: "A,"

Phrase: "anti-apoE Western blotting"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0005863:Western Blotting [Laboratory Procedure,Molecular Biology Research Technique]
   844 E C0949466:Western Blot [Laboratory Procedure]
   812   C1705493:Western [Spatial Concept]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "similar levels of expression of apoE3"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   767   C3244092:expression level [Idea or Concept]
   753   C0441889:Levels [Qualitative Concept]
   719 E C0456079:Level [Classification]
   719 E C1547707:Level [Geographic Area]
   719 E C2946261:Level [Pharmacologic Substance]

Phrase: "and"

Phrase: "apoE4 in stably transfected Neuro-2a cells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0052201:ApoE4 [Amino Acid, Peptide, or Protein]
   748   C2984964:APOE4 [Laboratory Procedure]

Phrase: "(73  11"

Phrase: "and"

Phrase: "80  9 ng apoE/mg cell protein/24 h"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   866   C1827103:ng/h [Quantitative Concept]
   846   C0439423:mg/24.h [Quantitative Concept]
   842   C0439421:mg/h [Quantitative Concept]
   791   C0033727:H+ [Element, Ion, or Isotope]
   791   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   791   C0441932:H+ [Classification]
   791   C0564385:/h [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.115: B, lysates of Neuro-2a cells treated with different concentrations of ZnCl2 for 24 h were analyzed by anti-Erk and anti-p-Erk Western blotting. 

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "lysates of Neuro-2a cells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   764   C1881488:Cell Lysate [Physical Object]
           Lysate

Phrase: "treated with different concentrations of ZnCl2"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   790   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   753   C0078774:ZnCl2 [Hazardous or Poisonous Substance,Inorganic Chemical,Pharmacologic Substance]
   753   C0086045:Concentrations [Mental Process]
   753   C1522326:Treated [Functional Concept]
   753   C1705242:Different [Qualitative Concept]
   719 E C1292734:TREAT [Functional Concept]
   719 E C1446561:Concentration [Quantitative Concept]

Phrase: "for 24 h"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "were"

Phrase: "analyzed by anti-Erk"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0936012:Analyzed [Research Activity]

Phrase: "and"

Phrase: "anti-p-Erk Western blotting."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   840   C0005863:Western Blotting [Laboratory Procedure,Molecular Biology Research Technique]
   823 E C0949466:Western Blot [Laboratory Procedure]
   804   C1705493:Western [Spatial Concept]
Processing 00000000.tx.116: C, quantitative analysis of the ratio of p-Erk (p-Erk1 + p-Erk2) to Erk (Erk1 + Erk2) in lysates of Neuro-2a cells treated with ZnCl2 (n = 6 per genotype and treatment; p <0.001, Neo or apoE3 versus apoE4 at 200 M ZnCl2).  

Phrase: "C,"

Phrase: "quantitative analysis of the ratio"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0392762:Quantitative [Quantitative Concept]
   760   C0936012:Analysis [Research Activity]
   760   C1524024:analysis [Functional Concept]

Phrase: "of p-Erk (p-Erk1 + p-Erk2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C0170168:ERK-2 [Amino Acid, Peptide, or Protein,Enzyme]
   799   C1150579:ERK2 [Molecular Function]

Phrase: ")"

Phrase: "to Erk (Erk1 + Erk2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0170168:ERK-2 [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1150579:ERK2 [Molecular Function]

Phrase: ")"

Phrase: "in lysates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1881488:Lysate [Physical Object]

Phrase: "of Neuro-2a cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "treated with ZnCl2"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   882   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   790   C0078774:ZnCl2 [Hazardous or Poisonous Substance,Inorganic Chemical,Pharmacologic Substance]
   790   C1522326:Treated [Functional Concept]
   756 E C1292734:TREAT [Functional Concept]

Phrase: "(n = 6 per genotype"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0017431:Genotype [Organism Attribute]
   770   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441922:N+ [Intellectual Product]
   770   C1553036:[n] [Quantitative Concept]

Phrase: "and"

Phrase: "treatment"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0039798:treatment [Functional Concept]
  1000   C0087111:Treatment [Therapeutic or Preventive Procedure]
  1000   C1522326:Treatment [Functional Concept]
  1000   C1533734:Treatment [Therapeutic or Preventive Procedure]
  1000   C1705169:Treatment [Conceptual Entity]
  1000   C3538994:TREATMENT [Research Activity]

Phrase: "; p <0.001,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "Neo"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1366752:NEO [Gene or Genome]

Phrase: "or"

Phrase: "apoE3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0052199:Apo E3 [Amino Acid, Peptide, or Protein]

Phrase: "versus"

Phrase: "apoE4 at 200 M ZnCl2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0052201:ApoE4 [Amino Acid, Peptide, or Protein]
   760   C2984964:APOE4 [Laboratory Procedure]

Phrase: ")."
Processing 00000000.tx.117: Potentiation of Zinc-induced Erk Activation by ApoE4 Is Associated with a More Pronounced Increase in Phosphorylation and Aggregation of tau in Neuro-2a CellsWe next assessed the effect of zinc-induced Erk activation on p-tau levels in Neuro-2a cells expressing apoE3 or apoE4. 

Phrase: "Potentiation of Zinc-induced Erk Activation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0279023:Potentiation [Therapeutic or Preventive Procedure]

Phrase: "by ApoE4"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0052201:ApoE4 [Amino Acid, Peptide, or Protein]
  1000   C2984964:APOE4 [Laboratory Procedure]

Phrase: "Is"

Phrase: "Associated with a More Pronounced Increase"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   790   C0332281:Associated with [Qualitative Concept]
           Associated
   753   C0442805:Increase [Functional Concept]
   719 E C0750490:Associate [Idea or Concept]
   719 E C1706221:Associate [Professional or Occupational Group]

Phrase: "in Phosphorylation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0031715:Phosphorylation [Molecular Function]
  1000   C1158886:Phosphorylation [Molecular Function]

Phrase: "and"

Phrase: "Aggregation of tau"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0332621:Aggregation [Functional Concept]
   790   C0439168:% aggregation [Quantitative Concept]
   718 E C0205418:Aggregate [Qualitative Concept]

Phrase: "in Neuro-2a CellsWe next"

Phrase: "assessed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1516048:Assessed [Activity]

Phrase: "the effect of zinc-induced Erk activation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1280500:Effect [Qualitative Concept]
   748   C2348382:Effect [Qualitative Concept]

Phrase: "on p-tau levels"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   827   C0441889:Levels [Qualitative Concept]
   793 E C0456079:Level [Classification]
   793 E C1547707:Level [Geographic Area]
   793 E C2946261:Level [Pharmacologic Substance]

Phrase: "in Neuro-2a cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "expressing"

Phrase: "apoE3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0052199:Apo E3 [Amino Acid, Peptide, or Protein]

Phrase: "or"

Phrase: "apoE4."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0052201:ApoE4 [Amino Acid, Peptide, or Protein]
  1000   C2984964:APOE4 [Laboratory Procedure]
Processing 00000000.tx.118: As shown by Western blotting, the levels of monomeric p-tau isoforms (molecular mass 6080 kDa) and SDS-resistant p-tau aggregates (molecular mass >100 kDa) after treatment with zinc were higher in apoE4-expressing cells than in apoE3-expressing or Neo-expressing cells (Fig. 6A). 

Phrase: "As"

Phrase: "shown by Western blotting,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   833   C0005863:Western Blotting [Laboratory Procedure,Molecular Biology Research Technique]
   816 E C0949466:Western Blot [Laboratory Procedure]
   770   C1705493:Western [Spatial Concept]
   737   C1547282:Show [Intellectual Product]

Phrase: "the levels of monomeric p-tau isoforms"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   748   C0441889:Levels [Qualitative Concept]
   714 E C0456079:Level [Classification]
   714 E C1547707:Level [Geographic Area]
   714 E C2946261:Level [Pharmacologic Substance]

Phrase: "(molecular mass 6080 kDa)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1532717:kDa [Quantitative Concept]

Phrase: "and"

Phrase: "SDS-resistant p-tau aggregates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0205418:aggregates [Qualitative Concept]

Phrase: "(molecular mass"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C3152252:Molecular Mass [Quantitative Concept]
           Mass
   861   C0577559:Mass [Finding]
   861   C1306372:*Mass [Quantitative Concept]

Phrase: ">100 kDa)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1532717:kDa [Quantitative Concept]

Phrase: "after"

Phrase: "treatment with zinc"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0039798:treatment [Functional Concept]
   790   C0087111:Treatment [Therapeutic or Preventive Procedure]
   790   C1522326:Treatment [Functional Concept]
   790   C1533734:Treatment [Therapeutic or Preventive Procedure]
   790   C1705169:Treatment [Conceptual Entity]
   790   C3538994:TREATMENT [Research Activity]

Phrase: "were"

Phrase: "higher in apoE4-expressing cells"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   726   C0205250:High [Qualitative Concept]
   726   C1299351:High [Qualitative Concept]
   726   C2700149:HIGH [Intellectual Product]

Phrase: "than"

Phrase: "in apoE3-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0052199:Apo E3 [Amino Acid, Peptide, or Protein]

Phrase: "expressing"

Phrase: "or"

Phrase: "Neo-expressing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1366752:NEO [Gene or Genome]

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "(Fig. 6A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553638:6a [Medical Device]

Phrase: ")."
Processing 00000000.tx.119: Densitometric analysis showed 3-fold more p-tau in the apoE4 cells (Fig. 6B). 

Phrase: "Densitometric analysis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0936012:Analysis [Research Activity]
   861   C1524024:analysis [Functional Concept]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "3-fold more p-tau in the apoE4 cells"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   762   C2362079:TAU 3 [Immunologic Factor]
   742   C1720655:Tau [Intellectual Product]
   742   C1947974:Tau [Research Activity]

Phrase: "(Fig. 6B"

Phrase: ")."
Processing 00000000.tx.120: View larger version (56K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(56K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.121: 6. 

Phrase: "6."
Processing 00000000.tx.122: Potentiation of zinc-induced activation of Erk by apoE4 is associated with a more pronounced increase in phosphorylation and aggregation of tau in Neuro-2a (N2a) cells. 

Phrase: "Potentiation of zinc-induced activation of Erk"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0279023:Potentiation [Therapeutic or Preventive Procedure]

Phrase: "by apoE4"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0052201:ApoE4 [Amino Acid, Peptide, or Protein]
  1000   C2984964:APOE4 [Laboratory Procedure]

Phrase: "is"

Phrase: "associated with a more pronounced increase"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   790   C0332281:Associated with [Qualitative Concept]
           Associated
   753   C0442805:Increase [Functional Concept]
   719 E C0750490:Associate [Idea or Concept]
   719 E C1706221:Associate [Professional or Occupational Group]

Phrase: "in phosphorylation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0031715:Phosphorylation [Molecular Function]
  1000   C1158886:Phosphorylation [Molecular Function]

Phrase: "and"

Phrase: "aggregation of tau"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0332621:Aggregation [Functional Concept]
   790   C0439168:% aggregation [Quantitative Concept]
   718 E C0205418:Aggregate [Qualitative Concept]

Phrase: "in Neuro-2a"

Phrase: "(N2a"

Phrase: ")"

Phrase: "cells."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.123: A, p-tau in lysates of Neuro-2a cells stably expressing Neo, apoE3, or apoE4 treated with ZnCl2 for 24 h were analyzed by anti-p-tau (AT8) Western blotting. 

Phrase: "A,"

Phrase: "p-tau in lysates of Neuro-2a cells stably"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C1720655:Tau [Intellectual Product]
   742   C1947974:Tau [Research Activity]

Phrase: "expressing"

Phrase: "Neo,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1366752:NEO [Gene or Genome]

Phrase: "apoE3,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0052199:Apo E3 [Amino Acid, Peptide, or Protein]

Phrase: "or"

Phrase: "apoE4"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0052201:ApoE4 [Amino Acid, Peptide, or Protein]
  1000   C2984964:APOE4 [Laboratory Procedure]

Phrase: "treated with ZnCl2"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   882   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   790   C0078774:ZnCl2 [Hazardous or Poisonous Substance,Inorganic Chemical,Pharmacologic Substance]
   790   C1522326:Treated [Functional Concept]
   756 E C1292734:TREAT [Functional Concept]

Phrase: "for 24 h"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "were"

Phrase: "analyzed by anti-p-tau"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0936012:Analyzed [Research Activity]
   760   C1720655:Tau [Intellectual Product]
   760   C1947974:Tau [Research Activity]

Phrase: "(AT8"

Phrase: ")"

Phrase: "Western blotting."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0005863:Western Blotting [Laboratory Procedure,Molecular Biology Research Technique]
   983 E C0949466:Western Blot [Laboratory Procedure]
   861   C1705493:Western [Spatial Concept]
Processing 00000000.tx.124: B, quantitative analysis of p-tau in lysates of Neuro-2a cells stably expressing Neo, apoE3, or apoE4 treated with ZnCl2 (n = 6 per genotype and treatment; p <0.05, Neo or apoE3 versus apoE4 for control; p <0.001, Neo or apoE3 versus apoE4 at 200 M ZnCl2; p <0.01, Neo or apoE3 versus apoE4 at 200 M ZnCl2 + 10 M U0126). 

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "quantitative analysis of p-tau"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0392762:Quantitative [Quantitative Concept]
   760   C0936012:Analysis [Research Activity]
   760   C1524024:analysis [Functional Concept]

Phrase: "in lysates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1881488:Lysate [Physical Object]

Phrase: "of Neuro-2a cells stably"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "expressing"

Phrase: "Neo,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1366752:NEO [Gene or Genome]

Phrase: "apoE3,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0052199:Apo E3 [Amino Acid, Peptide, or Protein]

Phrase: "or"

Phrase: "apoE4"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0052201:ApoE4 [Amino Acid, Peptide, or Protein]
  1000   C2984964:APOE4 [Laboratory Procedure]

Phrase: "treated with ZnCl2"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   882   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   790   C0078774:ZnCl2 [Hazardous or Poisonous Substance,Inorganic Chemical,Pharmacologic Substance]
   790   C1522326:Treated [Functional Concept]
   756 E C1292734:TREAT [Functional Concept]

Phrase: "(n = 6 per genotype"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0017431:Genotype [Organism Attribute]
   770   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441922:N+ [Intellectual Product]
   770   C1553036:[n] [Quantitative Concept]

Phrase: "and"

Phrase: "treatment"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0039798:treatment [Functional Concept]
  1000   C0087111:Treatment [Therapeutic or Preventive Procedure]
  1000   C1522326:Treatment [Functional Concept]
  1000   C1533734:Treatment [Therapeutic or Preventive Procedure]
  1000   C1705169:Treatment [Conceptual Entity]
  1000   C3538994:TREATMENT [Research Activity]

Phrase: "; p <0.05,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "Neo"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1366752:NEO [Gene or Genome]

Phrase: "or"

Phrase: "apoE3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0052199:Apo E3 [Amino Acid, Peptide, or Protein]

Phrase: "versus"

Phrase: "apoE4 for control"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0052201:ApoE4 [Amino Acid, Peptide, or Protein]
   790   C2984964:APOE4 [Laboratory Procedure]

Phrase: "; p <0.001,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "Neo"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1366752:NEO [Gene or Genome]

Phrase: "or"

Phrase: "apoE3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0052199:Apo E3 [Amino Acid, Peptide, or Protein]

Phrase: "versus"

Phrase: "apoE4 at 200 M ZnCl2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0052201:ApoE4 [Amino Acid, Peptide, or Protein]
   760   C2984964:APOE4 [Laboratory Procedure]

Phrase: "; p <0.01,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "Neo"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1366752:NEO [Gene or Genome]

Phrase: "or"

Phrase: "apoE3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0052199:Apo E3 [Amino Acid, Peptide, or Protein]

Phrase: "versus"

Phrase: "apoE4 at 200 M ZnCl2 + 10 M U0126"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0052201:ApoE4 [Amino Acid, Peptide, or Protein]
   744   C2984964:APOE4 [Laboratory Procedure]

Phrase: ")."
Processing 00000000.tx.125: C, Erk and p-Erk in lysates of Neuro-2a cells stably expressing Neo, apoE3, or apoE4 treated with ZnCl2 for 24 h were analyzed by Western blotting. 

Phrase: "C,"

Phrase: "Erk"

Phrase: "and"

Phrase: "p-Erk in lysates of Neuro-2a cells stably"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   745   C1179870:P cell [Cell]
   742   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   742   C2603361:P' [Clinical Attribute]

Phrase: "expressing"

Phrase: "Neo,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1366752:NEO [Gene or Genome]

Phrase: "apoE3,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0052199:Apo E3 [Amino Acid, Peptide, or Protein]

Phrase: "or"

Phrase: "apoE4"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0052201:ApoE4 [Amino Acid, Peptide, or Protein]
  1000   C2984964:APOE4 [Laboratory Procedure]

Phrase: "treated with ZnCl2"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   882   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   790   C0078774:ZnCl2 [Hazardous or Poisonous Substance,Inorganic Chemical,Pharmacologic Substance]
   790   C1522326:Treated [Functional Concept]
   756 E C1292734:TREAT [Functional Concept]

Phrase: "for 24 h"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "were"

Phrase: "analyzed by Western blotting."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   833   C0005863:Western Blotting [Laboratory Procedure,Molecular Biology Research Technique]
   816 E C0949466:Western Blot [Laboratory Procedure]
   770   C0936012:Analyzed [Research Activity]
   770   C1705493:Western [Spatial Concept]
Processing 00000000.tx.126: D, quantitative analysis of the ratio of p-Erk (p-Erk1 + p-Erk2) to Erk (Erk1 + Erk2) in lysates of Neuro-2a cells stably expressing Neo, apoE3, or apoE4 treated with ZnCl2 (n = 6 per genotype and treatment; p <0.001, Neo or apoE3 versus apoE4 at 200 M ZnCl2; p <0.05, Neo or apoE3 versus apoE4 at 200 M ZnCl2 + 10 M U0126).  

Phrase: "D,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "quantitative analysis of the ratio"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0392762:Quantitative [Quantitative Concept]
   760   C0936012:Analysis [Research Activity]
   760   C1524024:analysis [Functional Concept]

Phrase: "of p-Erk (p-Erk1 + p-Erk2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C0170168:ERK-2 [Amino Acid, Peptide, or Protein,Enzyme]
   799   C1150579:ERK2 [Molecular Function]

Phrase: ")"

Phrase: "to Erk (Erk1 + Erk2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0170168:ERK-2 [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1150579:ERK2 [Molecular Function]

Phrase: ")"

Phrase: "in lysates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1881488:Lysate [Physical Object]

Phrase: "of Neuro-2a cells stably"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "expressing"

Phrase: "Neo,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1366752:NEO [Gene or Genome]

Phrase: "apoE3,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0052199:Apo E3 [Amino Acid, Peptide, or Protein]

Phrase: "or"

Phrase: "apoE4"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0052201:ApoE4 [Amino Acid, Peptide, or Protein]
  1000   C2984964:APOE4 [Laboratory Procedure]

Phrase: "treated with ZnCl2"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   882   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   790   C0078774:ZnCl2 [Hazardous or Poisonous Substance,Inorganic Chemical,Pharmacologic Substance]
   790   C1522326:Treated [Functional Concept]
   756 E C1292734:TREAT [Functional Concept]

Phrase: "(n = 6 per genotype"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0017431:Genotype [Organism Attribute]
   770   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441922:N+ [Intellectual Product]
   770   C1553036:[n] [Quantitative Concept]

Phrase: "and"

Phrase: "treatment"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0039798:treatment [Functional Concept]
  1000   C0087111:Treatment [Therapeutic or Preventive Procedure]
  1000   C1522326:Treatment [Functional Concept]
  1000   C1533734:Treatment [Therapeutic or Preventive Procedure]
  1000   C1705169:Treatment [Conceptual Entity]
  1000   C3538994:TREATMENT [Research Activity]

Phrase: "; p <0.001,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "Neo"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1366752:NEO [Gene or Genome]

Phrase: "or"

Phrase: "apoE3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0052199:Apo E3 [Amino Acid, Peptide, or Protein]

Phrase: "versus"

Phrase: "apoE4 at 200 M ZnCl2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0052201:ApoE4 [Amino Acid, Peptide, or Protein]
   760   C2984964:APOE4 [Laboratory Procedure]

Phrase: "; p <0.05,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "Neo"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1366752:NEO [Gene or Genome]

Phrase: "or"

Phrase: "apoE3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0052199:Apo E3 [Amino Acid, Peptide, or Protein]

Phrase: "versus"

Phrase: "apoE4 at 200 M ZnCl2 + 10 M U0126"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0052201:ApoE4 [Amino Acid, Peptide, or Protein]
   744   C2984964:APOE4 [Laboratory Procedure]

Phrase: ")."
Processing 00000000.tx.127: Finally, we measured tau phosphorylation after inhibition of zinc-induced Erk activation in apoE-expressing Neuro-2a cells with U0126, a specific inhibitor of the upstream Erk kinase (MEK). 

Phrase: "Finally,"

Phrase: "we"

Phrase: "measured"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0444706:Measured [Qualitative Concept]
  1000   C3541902:MEASURED [Diagnostic Procedure]
   966 E C0079809:Measure [Quantitative Concept]
   966 E C0242485:Measure [Functional Concept]

Phrase: "tau phosphorylation after inhibition of zinc-induced Erk activation"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   784   C1519062:inhibition of phosphorylation [Molecular Function]
           Phosphorylation Inhibition
   781   C2248185:activation of phosphorylation [Cell Function]
   742   C0031715:Phosphorylation [Molecular Function]
   742   C1158886:Phosphorylation [Molecular Function]

Phrase: "in apoE-expressing Neuro-2a cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   804   C0007634:Cells [Cell]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]

Phrase: "with U0126,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0755562:U0126 [Organic Chemical,Pharmacologic Substance]

Phrase: "a specific inhibitor of the upstream Erk kinase"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   767   C1171350:Kinase Inhibitor [Pharmacologic Substance]
   767   C3537023:kinase inhibitor [Molecular Function]
   767   C3537035:kinase inhibitor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   744   C1999216:Inhibitor [Qualitative Concept]

Phrase: "(MEK"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0752313:mek [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: ")."
Processing 00000000.tx.128: Zinc-induced activation of Erk was blocked almost completely (Fig. 6, C and D), and p-tau levels were reduced nearly to baseline levels (Fig. 6, A and B) in Neo-, apoE3-, and apoE4-expressing cells. 

Phrase: "Zinc-induced activation of Erk"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1879547:Activation [Activity]

Phrase: "was"

Phrase: "blocked"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0028778:Blocked [Pathologic Function]
  1000   C0332206:Blocked [Functional Concept]
  1000   C2983591:BLOCKED [Research Activity]
   966 E C1533157:Block [Substance]
   966 E C1706084:Block [Geographic Area]
   966 E C2828370:Block [Quantitative Concept]

Phrase: "almost completely"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205197:Completely [Qualitative Concept]

Phrase: "(Fig. 6,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "C"

Phrase: "and"

Phrase: "D)"

Phrase: ","

Phrase: "and"

Phrase: "p-tau levels"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   827   C0441889:Levels [Qualitative Concept]
   793 E C0456079:Level [Classification]
   793 E C1547707:Level [Geographic Area]
   793 E C2946261:Level [Pharmacologic Substance]

Phrase: "were"

Phrase: "reduced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392756:Reduced [Qualitative Concept]

Phrase: "nearly to baseline levels"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   770   C0168634:baseline [Biomedical or Dental Material]
   770   C0441889:Levels [Qualitative Concept]
   770   C1442488:Baseline [Quantitative Concept]
   737 E C0456079:Level [Classification]
   737 E C1547707:Level [Geographic Area]
   737 E C2946261:Level [Pharmacologic Substance]

Phrase: "(Fig. 6,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "A"

Phrase: "and"

Phrase: "B) in Neo-, apoE3-,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "apoE4-expressing cells."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.129: Thus, Erk appears to be the major (or only) kinase responsible for increased phosphorylation of tau by apoE4 and zinc in Neuro-2a cells.  

Phrase: "Thus,"

Phrase: "Erk"

Phrase: "appears"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "the major"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205164:Major [Qualitative Concept]

Phrase: "("

Phrase: "or"

Phrase: "only"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205171:Only [Quantitative Concept]
  1000   C1720467:Only [Intellectual Product]

Phrase: ")"

Phrase: "kinase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "responsible for increased phosphorylation of tau"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1273518:Responsible [Finding]

Phrase: "by apoE4"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0052201:ApoE4 [Amino Acid, Peptide, or Protein]
  1000   C2984964:APOE4 [Laboratory Procedure]

Phrase: "and"

Phrase: "zinc in Neuro-2a cells."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0043481:Zinc [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   760   C2348288:Zinc [Element, Ion, or Isotope]
Processing 00000000.tx.130: DISCUSSION TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES  This study shows that apoE4 stimulates tau phosphorylation by activating the Erk pathway in transgenic mice and in cultured neuronal cells. 

Phrase: "DISCUSSION TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION"

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "This study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "shows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that apoE4"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0052201:ApoE4 [Amino Acid, Peptide, or Protein]
  1000   C2984964:APOE4 [Laboratory Procedure]

Phrase: "stimulates"

Phrase: "tau phosphorylation by activating"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0031715:Phosphorylation [Molecular Function]
   770   C1158886:Phosphorylation [Molecular Function]

Phrase: "the Erk pathway in transgenic mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C3179234:ERK Pathway [Cell Function,Molecular Function]
   753   C1704259:Pathway [Molecular Function]
   753   C1705987:Pathway [Conceptual Entity]

Phrase: "and in cultured neuronal cells."
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   797   C0007600:cultured cells [Cell]
   797   C0007635:Cultured Cells [Cell]
   797   C3282338:Cells, Cultured [Cell]
   760   C0007634:Cells [Cell]
   760   C0521390:Neuronal [Immunologic Factor]
   760   C1515981:And [Idea or Concept]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.131: Erk activation increased with age in the brains of mice expressing apoE3 or apoE4 in neurons. 

Phrase: "Erk activation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1879547:Activation [Activity]

Phrase: "increased with age"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0001779:Age [Organism Attribute]
   790   C0205217:Increased [Quantitative Concept]
   790   C0442805:Increased [Functional Concept]
   718 E C1517378:Gain [Quantitative Concept]

Phrase: "in the brains"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0006104:Brains [Body Part, Organ, or Organ Component]
   966 E C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "of mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mice [Mammal]
  1000   C0025929:mice [Mammal]
  1000   C0026809:Mice [Mammal]

Phrase: "expressing"

Phrase: "apoE3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0052199:Apo E3 [Amino Acid, Peptide, or Protein]

Phrase: "or"

Phrase: "apoE4 in neurons."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0052201:ApoE4 [Amino Acid, Peptide, or Protein]
   790   C2984964:APOE4 [Laboratory Procedure]
Processing 00000000.tx.132: The increases were most pronounced in the hippocampus, particularly in the CA3 region and the hilus of the dentate gyrus, and were significantly greater in the apoE4-expressing mice, resulting in increased phosphorylation and aggregation of tau. 

Phrase: "The increases"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442805:increases [Functional Concept]

Phrase: "were"

Phrase: "most"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205393:Most [Quantitative Concept]

Phrase: "pronounced in the hippocampus,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0019564:Hippocampus [Body Part, Organ, or Organ Component]
   770   C0949582:Hippocampus [Fish]
   770   C1029104:Hippocampus [Fish]
   770   C1284077:Hippocampus [Body Part, Organ, or Organ Component]

Phrase: "particularly in the CA3 region"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0017446:Region [Geographic Area]
   760   C0205147:Region [Spatial Concept]

Phrase: "and"

Phrase: "the hilus of the dentate gyrus,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   858   C1134421:Hilus of Dentate Gyrus [Body Part, Organ, or Organ Component]
           Dentate gyrus hilus

Phrase: "and"

Phrase: "were"

Phrase: "significantly greater in the apoE4-expressing mice,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   748   C0443228:greater [Quantitative Concept]
   748   C1704243:Greater [Quantitative Concept]
   714 E C0549177:Great [Quantitative Concept]

Phrase: "resulting in increased phosphorylation"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   833   C0332294:Resulting in [Functional Concept]
   770   C0031715:Phosphorylation [Molecular Function]
   770   C0205217:Increased [Quantitative Concept]
   770   C0442805:Increased [Functional Concept]
   770   C0678226:resulting [Functional Concept]
   770   C1158886:Phosphorylation [Molecular Function]
   737 E C1274040:Result [Functional Concept]
   737 E C1546471:Result [Idea or Concept]
   737 E C2825142:Result [Finding]

Phrase: "and"

Phrase: "aggregation of tau."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0332621:Aggregation [Functional Concept]
   790   C0439168:% aggregation [Quantitative Concept]
   718 E C0205418:Aggregate [Qualitative Concept]
Processing 00000000.tx.133: ApoE4 also increased zinc-induced Erk activation in neuronal cells, leading to enhanced tau phosphorylation that was significantly reduced by a specific Erk pathway inhibitor (U0126). 

Phrase: "ApoE4 also increased zinc-induced Erk activation in neuronal cells,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   757   C1326120:activation cells [Cell Function]
   739   C1879547:Activation [Activity]

Phrase: "leading to enhanced tau phosphorylation"
Meta Candidates (Total=11; Excluded=4; Pruned=0; Remaining=7)
   760   C0031715:Phosphorylation [Molecular Function]
   760   C0332152:Leading [Temporal Concept]
   760   C1158886:Phosphorylation [Molecular Function]
   760   C1522538:Leading [Functional Concept]
   760   C1720655:Tau [Intellectual Product]
   760   C1947974:Tau [Research Activity]
   760   C2349975:Enhanced [Activity]
   726 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   726 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   726 E C2348269:Lead [Element, Ion, or Isotope]
   726 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "that"

Phrase: "was"

Phrase: "significantly"

Phrase: "reduced by a specific Erk pathway inhibitor"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   778   C3179234:ERK Pathway [Cell Function,Molecular Function]
   748   C0205369:Specific [Qualitative Concept]
   748   C0392756:Reduced [Qualitative Concept]
   748   C1552740:specific [Intellectual Product]
   748   C1704259:Pathway [Molecular Function]
   748   C1705987:Pathway [Conceptual Entity]
   748   C1999216:Inhibitor [Qualitative Concept]

Phrase: "(U0126"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0755562:U0126 [Organic Chemical,Pharmacologic Substance]

Phrase: ")."
Processing 00000000.tx.134: These findings suggest that apoE4 and zinc act in concert to activate Erk and subsequently cause tau phosphorylation in transgenic mice and may be relevant to the pathogenesis of AD. 

Phrase: "These findings"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2607943:findings [Functional Concept]
  1000   C2926606:Findings [Clinical Attribute]
  1000   C3539655:Findings [Intellectual Product]
   966 E C0037088:Finding [Sign or Symptom]
   966 E C0243095:Finding [Finding]
   966 E C2825141:Finding [Finding]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that apoE4"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0052201:ApoE4 [Amino Acid, Peptide, or Protein]
  1000   C2984964:APOE4 [Laboratory Procedure]

Phrase: "and"

Phrase: "zinc"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0043481:Zinc [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C2348288:Zinc [Element, Ion, or Isotope]

Phrase: "act in concert to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0079613:ACT [Therapeutic or Preventive Procedure]

Phrase: "activate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515877:Activate [Functional Concept]
  1000   C1879547:Activate [Activity]

Phrase: "Erk"

Phrase: "and"

Phrase: "subsequently"

Phrase: "cause"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015127:cause [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "tau phosphorylation in transgenic mice"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0031715:Phosphorylation [Molecular Function]
   760   C1158886:Phosphorylation [Molecular Function]

Phrase: "and"

Phrase: "may"

Phrase: "be"

Phrase: "relevant to the pathogenesis of AD."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C2347946:Relevant [Qualitative Concept]
Processing 00000000.tx.135: Several lines of evidence suggest that Erk is involved in tau phosphorylation. 

Phrase: "Several lines of evidence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   770   C0205132:lines [Spatial Concept]
   737 E C1550648:Line [Substance]
   737 E C1552960:Line [Quantitative Concept]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that Erk"

Phrase: "is"

Phrase: "involved in tau phosphorylation."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0031715:Phosphorylation [Molecular Function]
   770   C1158886:Phosphorylation [Molecular Function]
   770   C1314939:Involved [Functional Concept]
   770   C1720655:Tau [Intellectual Product]
   770   C1947974:Tau [Research Activity]
Processing 00000000.tx.136: Erk is associated with neuronal microtubules in rodent and bovine brains (6567), and p-Erk is increased in a subpopulation of neurons containing p-tau and NFTs and in dystrophic neurites in senile plaques in AD brains (46, 6871). 

Phrase: "Erk"

Phrase: "is"

Phrase: "associated with neuronal microtubules"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   770   C0026046:Microtubules [Cell Component]
   770   C0521390:Neuronal [Immunologic Factor]
   737 E C0750490:Associate [Idea or Concept]
   737 E C1706221:Associate [Professional or Occupational Group]

Phrase: "in rodent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0035804:Rodent [Mammal]

Phrase: "and"

Phrase: "bovine brains"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0006104:Brains [Body Part, Organ, or Organ Component]
   861   C0007452:Bovine [Mammal]
   861   C1140701:bovine [Mammal]
   827 E C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "(6567"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "p-Erk"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C2603361:P' [Clinical Attribute]

Phrase: "is"

Phrase: "increased in a subpopulation of neurons"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0027882:Neurons [Cell]
   753   C0205217:Increased [Quantitative Concept]
   753   C0442805:Increased [Functional Concept]
   753   C1257890:Subpopulation [Population Group]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "p-tau"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1720655:Tau [Intellectual Product]
   861   C1947974:Tau [Research Activity]

Phrase: "and"

Phrase: "NFTs"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0085400:Neurofibrillary Tangles [Acquired Abnormality]
   966 E C3543859:neurofibrillary tangle [Cell Component]

Phrase: "and in dystrophic neurites"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C2674684:Dystrophic neurites [Finding]
   770   C0085103:Neurites [Cell Component]
   770   C0333607:Dystrophic [Functional Concept]
   770   C1515981:And [Idea or Concept]

Phrase: "in senile plaques"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
  1000   C0333463:Senile Plaques [Acquired Abnormality]
           plaques
   861   C0392079:Senile [Finding]
   827 E C0011389:Plaque [Disease or Syndrome]
   827 E C0332461:Plaque [Finding]
   805 E C0231337:Old age [Finding]
   805 E C1999167:Old age [Population Group]

Phrase: "in AD brains"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0006104:Brains [Body Part, Organ, or Organ Component]
   827 E C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "(46,"

Phrase: "6871"

Phrase: ")."
Processing 00000000.tx.137: In addition, stress-induced tau phosphorylation is associated with increased p-Erk immunoreactivity in neurons (72). 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "stress-induced tau phosphorylation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0031715:Phosphorylation [Molecular Function]
   812   C1158886:Phosphorylation [Molecular Function]

Phrase: "is"

Phrase: "associated with increased p-Erk immunoreactivity"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   790   C0332281:Associated with [Qualitative Concept]
           Associated
   753   C0205217:Increased [Quantitative Concept]
   753   C0442805:Increased [Functional Concept]
   753   C0597879:immunoreactivity [Molecular Function]
   719 E C0750490:Associate [Idea or Concept]
   719 E C1706221:Associate [Professional or Occupational Group]

Phrase: "in neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0027882:Neurons [Cell]
   916 E C0521390:Neuronal [Immunologic Factor]

Phrase: "(72"

Phrase: ")."
Processing 00000000.tx.138: Finally, p-Erk phosphorylates serines in Lys-Ser-Pro repeats in tau in vitro (7375). 

Phrase: "Finally,"

Phrase: "p-Erk"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C2603361:P' [Clinical Attribute]

Phrase: "phosphorylates"

Phrase: "serines in Lys-Ser-Pro"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C0036720:Serine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "repeats in tau"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0205341:Repeat [Functional Concept]
   790   C1547730:Repeat [Temporal Concept]
   790   C1705914:Repeat [Conceptual Entity]
   790   C1720655:Tau [Intellectual Product]
   790   C1947974:Tau [Research Activity]

Phrase: "in vitro"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]

Phrase: "(7375"

Phrase: ")."
Processing 00000000.tx.139: In human and rhesus monkey brains, anti-Erk immunostaining showed that Erk levels are highest in the CA3 region, the mossy fiber zone, and the granule cell layer of the dentate gyrus (68, 76). 

Phrase: "In human"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086418:Human [Human]

Phrase: "and"

Phrase: "rhesus monkey brains,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0006104:Brains [Body Part, Organ, or Organ Component]
   793 E C1269537:Brain [Body Part, Organ, or Organ Component]
   734   C0024400:Rhesus Monkey [Mammal]

Phrase: "anti-Erk immunostaining"

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that Erk levels"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0441889:Levels [Qualitative Concept]
   827 E C0456079:Level [Classification]
   827 E C1547707:Level [Geographic Area]
   827 E C2946261:Level [Pharmacologic Substance]

Phrase: "are"

Phrase: "highest in the CA3 region,"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   760   C1522410:Highest [Qualitative Concept]
   726 E C0205250:High [Qualitative Concept]
   726 E C1299351:High [Qualitative Concept]
   726 E C2700149:HIGH [Intellectual Product]

Phrase: "the mossy fiber zone,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C1710706:Zone [Spatial Concept]
   755 E C1564799:Zonal [Organic Chemical,Pharmacologic Substance]
   734   C0596975:mossy fiber [Cell Component]

Phrase: "and"

Phrase: "the granule cell layer of the dentate gyrus"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   850   C2334667:granular layer of the dentate gyrus [Body Part, Organ, or Organ Component]
           Granular layer of dentate gyrus
   819   C2330890:Layer of dentate gyrus [Body Part, Organ, or Organ Component]
           Dentate gyrus layer
   744   C0934502:Layer [Body Part, Organ, or Organ Component]
   744   C1522408:Layer [Qualitative Concept]
   744   C1561599:Layer [Intellectual Product]
   731   C0221923:Granular Layer [Tissue]

Phrase: "(68,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450387:68 [Intellectual Product]

Phrase: "76"

Phrase: ")."
Processing 00000000.tx.140: These are the areas where we observed the greatest increases in p-Erk (the current study) and p-tau (Ref. 29 and the current study) in NSE-apoE4 mice, supporting anatomically the relationship between Erk activation and tau phosphorylation. 

Phrase: "These"

Phrase: "are"

Phrase: "the areas where"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0205146:areas [Spatial Concept]
   827 E C0017446:Area [Geographic Area]

Phrase: "we"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "the greatest increases in p-Erk ("
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0442805:increases [Functional Concept]

Phrase: "the current study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]

Phrase: ")"

Phrase: "and"

Phrase: "p-tau"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1720655:Tau [Intellectual Product]
   861   C1947974:Tau [Research Activity]

Phrase: "(Ref. 29"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1425988:REF [Gene or Genome]

Phrase: "and"

Phrase: "the current study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]

Phrase: ")"

Phrase: "in NSE-apoE4 mice,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   804   C0025914:Mice [Mammal]
   804   C0025929:mice [Mammal]
   804   C0026809:Mice [Mammal]
   717   C1414404:ENOLASE, NEURON-SPECIFIC [Gene or Genome]
   717   C1880904:Neuron-Specific Enolase [Amino Acid, Peptide, or Protein,Enzyme,Neuroreactive Substance or Biogenic Amine]

Phrase: "supporting"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0183683:Support [Medical Device]
   966   C1521721:Support [Conceptual Entity]

Phrase: "anatomically"

Phrase: "the relationship between Erk activation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0439849:Relationship [Qualitative Concept]
   760   C1705630:Relationship [Idea or Concept]
   760   C1706279:Relationship [Idea or Concept]
   760   C3540605:Relationship [Intellectual Product]

Phrase: "and"

Phrase: "tau phosphorylation."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0031715:Phosphorylation [Molecular Function]
   861   C1158886:Phosphorylation [Molecular Function]
Processing 00000000.tx.141: The possibility that apoE4 and zinc act in concert to activate Erk and cause tau phosphorylation is intriguing. 

Phrase: "The possibility"

Phrase: "that apoE4"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0052201:ApoE4 [Amino Acid, Peptide, or Protein]
  1000   C2984964:APOE4 [Laboratory Procedure]

Phrase: "and"

Phrase: "zinc"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0043481:Zinc [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C2348288:Zinc [Element, Ion, or Isotope]

Phrase: "act in concert to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0079613:ACT [Therapeutic or Preventive Procedure]

Phrase: "activate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515877:Activate [Functional Concept]
  1000   C1879547:Activate [Activity]

Phrase: "Erk"

Phrase: "and"

Phrase: "cause tau phosphorylation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0031715:Phosphorylation [Molecular Function]
   827   C1158886:Phosphorylation [Molecular Function]

Phrase: "is"

Phrase: "intriguing."
Processing 00000000.tx.142: Zinc appears to participate in the regulation of N-methyl-D-aspartate receptor activity (55, 7781). 

Phrase: "Zinc"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0043481:Zinc [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C2348288:Zinc [Element, Ion, or Isotope]

Phrase: "appears"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "participate in the regulation of N-methyl-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0851285:Regulation [Governmental or Regulatory Activity]
   748   C1327622:Regulation [Biologic Function]

Phrase: "D-"

Phrase: "aspartate receptor activity"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   901   C1152633:receptor activity [Molecular Function]
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]
   734   C0052536:receptor, aspartate [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "(55,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450382:55 [Intellectual Product]

Phrase: "7781"

Phrase: ")."
Processing 00000000.tx.143: Zinc also activates many kinases (including protein kinases A and C, calmodulin-dependent kinase, ribosomal S6 protein kinase, and Erk (5562)) and may contribute to neuronal death due to transient global ischemia or traumatic brain injury (8286). 

Phrase: "Zinc also"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0043481:Zinc [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   861   C2348288:Zinc [Element, Ion, or Isotope]

Phrase: "activates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515877:Activate [Functional Concept]
  1000   C1879547:Activate [Activity]

Phrase: "many kinases"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0031727:Kinases [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "("

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "protein kinases"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0033640:Protein Kinases [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0031727:Kinases [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "A"

Phrase: "and"

Phrase: "C,"

Phrase: "calmodulin-dependent kinase,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   913   C0006776:Calmodulin-Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "ribosomal S6 protein kinase,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   875   C0035552:Ribosomal Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   875   C0073337:S6 Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   875   C1622856:ribosomal protein [Genetic Function]
   861   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "Erk (5562"

Phrase: ")"

Phrase: ")"

Phrase: "and"

Phrase: "may"

Phrase: "contribute to neuronal death"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   797   C2754100:neuron death [Cell Function]
   770   C0011065:Death [Organism Function]
   770   C0521390:Neuronal [Immunologic Factor]
   770   C1306577:Death, NOS [Finding]
   770   C1880177:Contribute [Activity]

Phrase: "due to transient global ischemia"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   913   C0022118:Transient ischaemia [Disease or Syndrome]
   827   C0022116:Ischaemia [Disease or Syndrome]
   827   C0205246:Global [Spatial Concept]
   827   C2348867:Global [Qualitative Concept]
   755 E C0015392:globe [Body Part, Organ, or Organ Component]
   755 E C0475224:Ischaemic [Functional Concept]
   755 E C1280202:Globe [Body Part, Organ, or Organ Component]

Phrase: "or"

Phrase: "traumatic brain injury"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
  1000   C0876926:Traumatic Brain Injury [Injury or Poisoning]
   913   C0043250:Traumatic Injury [Injury or Poisoning]
   913   C0043251:traumatic injury [Injury or Poisoning]
   913   C3263723:Traumatic injury [Injury or Poisoning]
           Injury
   901   C0270611:Brain Injury [Injury or Poisoning]
   827   C0006104:Brain [Body Part, Organ, or Organ Component]
   827   C0332663:Traumatic [Functional Concept]
   827   C1269537:Brain [Body Part, Organ, or Organ Component]
   827   C3263722:Injury [Injury or Poisoning]

Phrase: "(8286"

Phrase: ")."
Processing 00000000.tx.144: Increased zinc concentrations (>300 M) have been found in AD brains (8789) and in the serum of AD patients with an APOE 4 allele (90). 

Phrase: "Increased zinc concentrations"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0086045:Concentrations [Mental Process]
   793 E C1446561:Concentration [Quantitative Concept]
   743 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "("

Phrase: ">300"

Phrase: "M)"

Phrase: "have"

Phrase: "been"

Phrase: "found in AD brains"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   770   C0006104:Brains [Body Part, Organ, or Organ Component]
   770   C0150312:Found [Quantitative Concept]
   737 E C0243095:Find [Finding]
   737 E C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "(8789"

Phrase: ")"

Phrase: "and in the serum of AD patients"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   748   C0030705:Patients [Patient or Disabled Group]
   748   C0229671:Serum [Body Substance]
   748   C1515981:And [Idea or Concept]
   748   C1546774:Serum [Intellectual Product]
   748   C1550100:Serum [Body Substance]

Phrase: "with an APOE 4 allele"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C3642141:APOE*4 Allele [Gene or Genome]
   827   C0002085:Allele [Gene or Genome]
   734   C0052201:Apo E-4 [Amino Acid, Peptide, or Protein]

Phrase: "(90"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439083:>90 [Quantitative Concept]
  1000   C0439087:<90 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.145: These findings are consistent with a synergistic role of zinc and apoE4 in AD pathogenesis. 

Phrase: "These findings"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2607943:findings [Functional Concept]
  1000   C2926606:Findings [Clinical Attribute]
  1000   C3539655:Findings [Intellectual Product]
   966 E C0037088:Finding [Sign or Symptom]
   966 E C0243095:Finding [Finding]
   966 E C2825141:Finding [Finding]

Phrase: "are"

Phrase: "consistent with a synergistic role of zinc"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   778   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "and"

Phrase: "apoE4 in AD pathogenesis."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0052201:ApoE4 [Amino Acid, Peptide, or Protein]
   770   C2984964:APOE4 [Laboratory Procedure]
Processing 00000000.tx.146: Zinc also stimulates A aggregation in vitro (91, 92) and accumulates in amyloid plaques in the brains of AD patients and amyloid protein precursor transgenic mice (89, 93, 94). 

Phrase: "Zinc also"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0043481:Zinc [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   861   C2348288:Zinc [Element, Ion, or Isotope]

Phrase: "stimulates"

Phrase: "A aggregation"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332621:Aggregation [Functional Concept]
  1000   C0439168:% aggregation [Quantitative Concept]
   928 E C0205418:Aggregate [Qualitative Concept]

Phrase: "in vitro"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]

Phrase: "(91,"

Phrase: "92"

Phrase: ")"

Phrase: "and"

Phrase: "accumulates in amyloid plaques"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   833   C0333463:amyloid plaques [Acquired Abnormality]
           plaques
   833   C2936349:Plaques, Amyloid [Acquired Abnormality]
   770   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0011560:Amyloid [Pathologic Function]
   770   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   737 E C0011389:Plaque [Disease or Syndrome]
   737 E C0332461:Plaque [Finding]

Phrase: "in the brains"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0006104:Brains [Body Part, Organ, or Organ Component]
   966 E C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "of AD patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030705:Patients [Patient or Disabled Group]

Phrase: "and"

Phrase: "amyloid protein precursor transgenic mice"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   840   C0025936:Mice, Transgenic [Mammal]
   804   C0003069:Transgenic [Animal]
   804   C0025914:Mice [Mammal]
   804   C0025929:mice [Mammal]
   804   C0026809:Mice [Mammal]
   717   C0085151:Amyloid Protein Precursor [Amino Acid, Peptide, or Protein]

Phrase: "(89,"

Phrase: "93,"

Phrase: "94"

Phrase: ")."
Processing 00000000.tx.147: Moreover, in amyloid protein precursor transgenic mice, reducing the zinc concentration in the brain by treatment with a zinc chelator or by disrupting the zinc transporter protein dramatically inhibits A accumulation and plaque formation (93, 94). 

Phrase: "Moreover,"

Phrase: "in amyloid protein precursor transgenic mice,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   840   C0025936:Mice, Transgenic [Mammal]
   804   C0003069:Transgenic [Animal]
   804   C0025914:Mice [Mammal]
   804   C0025929:mice [Mammal]
   804   C0026809:Mice [Mammal]
   717   C0085151:Amyloid Protein Precursor [Amino Acid, Peptide, or Protein]

Phrase: "reducing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392756:Reducing [Qualitative Concept]

Phrase: "the zinc concentration in the brain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0086045:Concentration [Mental Process]
   753   C1446561:Concentration [Quantitative Concept]

Phrase: "by treatment"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0039798:treatment [Functional Concept]
  1000   C0087111:Treatment [Therapeutic or Preventive Procedure]
  1000   C1522326:Treatment [Functional Concept]
  1000   C1533734:Treatment [Therapeutic or Preventive Procedure]
  1000   C1705169:Treatment [Conceptual Entity]
  1000   C3538994:TREATMENT [Research Activity]

Phrase: "with a zinc chelator"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0007974:chelator [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   861   C1664784:Chelator [Eukaryote]

Phrase: "or by disrupting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0332454:disrupting [Qualitative Concept]

Phrase: "the zinc transporter protein dramatically"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0007292:Transporter Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "inhibits"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "A accumulation"

Phrase: "and"

Phrase: "plaque formation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0220781:formation [Biologic Function]
   861   C0439634:formation [Spatial Concept]
   861   C1522492:Formation [Functional Concept]

Phrase: "(93,"

Phrase: "94"

Phrase: ")."
Processing 00000000.tx.148: Zinc is highly concentrated in synaptic vesicles at the mossy fiber zone of the hippocampus (54) and is released into the synaptic cleft during synaptic activity, reaching concentrations that routinely exceed 1020 M (81) and may approach 300 M under pathophysiological conditions (95, 96). 

Phrase: "Zinc"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0043481:Zinc [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C2348288:Zinc [Element, Ion, or Isotope]

Phrase: "is"

Phrase: "highly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205250:Highly [Qualitative Concept]

Phrase: "concentrated in synaptic vesicles"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   833   C0039065:Synaptic Vesicles [Cell Component]
   770   C0333262:VESICLES [Acquired Abnormality]
   770   C1880165:Concentrated [Biomedical or Dental Material]
   737 E C1622418:vesicle [Cell Component]
   737 E C1880310:Concentrate [Manufactured Object]
   737 E C2003864:Concentrate [Substance]

Phrase: "at the mossy fiber zone"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C1710706:Zone [Spatial Concept]
   755 E C1564799:Zonal [Organic Chemical,Pharmacologic Substance]
   734   C0596975:mossy fiber [Cell Component]

Phrase: "of the hippocampus"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0019564:Hippocampus [Body Part, Organ, or Organ Component]
  1000   C0949582:Hippocampus [Fish]
  1000   C1029104:Hippocampus [Fish]
  1000   C1284077:Hippocampus [Body Part, Organ, or Organ Component]

Phrase: "(54"

Phrase: ")"

Phrase: "and"

Phrase: "is"

Phrase: "released into the synaptic cleft"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   806   C0682685:Synaptic cleft [Cell Component]
   760   C0205242:Cleft [Spatial Concept]
   760   C0391871:Released [Functional Concept]
   760   C1283071:Released [Functional Concept]
   726 E C0030685:Release [Health Care Activity]
   726 E C0439180:% release [Quantitative Concept]
   726 E C0680255:release [Health Care Activity]
   726 E C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "during synaptic activity,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "reaching"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2584321:Reaching [Organism Function]

Phrase: "concentrations"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0086045:Concentrations [Mental Process]
   966 E C1446561:Concentration [Quantitative Concept]
   916 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "that routinely"

Phrase: "exceed"

Phrase: "1020"

Phrase: "M ("

Phrase: "81"

Phrase: ")"

Phrase: "and"

Phrase: "may"

Phrase: "approach"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449445:Approach [Spatial Concept]

Phrase: "300 M under pathophysiological conditions"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0441923:M+ [Intellectual Product]

Phrase: "(95,"

Phrase: "96"

Phrase: ")."
Processing 00000000.tx.149: Because the increases in p-Erk (the current study) and p-tau (Ref. 29 and the current study) were maximal in the CA3 region and the mossy fiber zone of the hippocampus in NSE-apoE4 mouse brains, we speculate that neuronal deficits induced by apoE4 or apoE4 fragments, as previously shown in transgenic mice (28, 63, 97, 98), cause zinc release from synaptic termini, leading to Erk activation and abnormal phosphorylation of tau. 

Phrase: "Because"

Phrase: "the increases in p-Erk ("
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0442805:increases [Functional Concept]

Phrase: "the current study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]

Phrase: ")"

Phrase: "and"

Phrase: "p-tau"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1720655:Tau [Intellectual Product]
   861   C1947974:Tau [Research Activity]

Phrase: "(Ref. 29"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1425988:REF [Gene or Genome]

Phrase: "and"

Phrase: "the current study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]

Phrase: ")"

Phrase: "were"

Phrase: "maximal in the CA3 region"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0205289:Maximal [Qualitative Concept]
   760   C0806909:Maximal [Quantitative Concept]

Phrase: "and"

Phrase: "the mossy fiber zone of the hippocampus"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1710706:Zone [Spatial Concept]

Phrase: "in NSE-apoE4 mouse brains,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   810   C1521713:Mouse Brain [Tissue]
   799   C0006104:Brains [Body Part, Organ, or Organ Component]
   766 E C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "we"

Phrase: "speculate"

Phrase: "that neuronal deficits"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C2987487:deficits [Qualitative Concept]
   827 E C0162429:Deficit, NOS [Disease or Syndrome]

Phrase: "induced by apoE4"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0052201:ApoE4 [Amino Acid, Peptide, or Protein]
   790   C0205263:Induced [Functional Concept]
   790   C2984964:APOE4 [Laboratory Procedure]

Phrase: "or"

Phrase: "apoE4 fragments,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0332255:fragments [Functional Concept]
   861   C0486805:Fragments [Body Substance]
   827 E C1708096:Fragment [Qualitative Concept]

Phrase: "as"

Phrase: "previously"

Phrase: "shown in transgenic mice"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C0025936:Mice, Transgenic [Mammal]
   770   C0003069:Transgenic [Animal]
   770   C0025914:Mice [Mammal]
   770   C0025929:mice [Mammal]
   770   C0026809:Mice [Mammal]
   737   C1547282:Show [Intellectual Product]

Phrase: "(28,"

Phrase: "63,"

Phrase: "97,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439073:97 [Intellectual Product]
  1000   C0439082:>97 [Quantitative Concept]

Phrase: "98"

Phrase: ")"

Phrase: ","

Phrase: "cause zinc release from synaptic termini,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0030685:Release [Health Care Activity]
   753   C0391871:Release [Functional Concept]
   753   C0439180:% release [Quantitative Concept]
   753   C0680255:release [Health Care Activity]
   753   C1283071:Release [Functional Concept]
   753   C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "leading to Erk activation"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   770   C0332152:Leading [Temporal Concept]
   770   C1522538:Leading [Functional Concept]
   770   C1879547:Activation [Activity]
   737 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   737 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   737 E C2348269:Lead [Element, Ion, or Isotope]
   737 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "abnormal phosphorylation of tau."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0031715:Phosphorylation [Molecular Function]
   770   C1158886:Phosphorylation [Molecular Function]
Processing 00000000.tx.150: Alternatively, apoE4 or its fragments could increase tau phosphorylation by potentiating zinc-induced Erk activation in neurons, as demonstrated in vitro in the current study. 

Phrase: "Alternatively,"

Phrase: "apoE4"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0052201:ApoE4 [Amino Acid, Peptide, or Protein]
  1000   C2984964:APOE4 [Laboratory Procedure]

Phrase: "or"

Phrase: "its fragments"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332255:fragments [Functional Concept]
  1000   C0486805:Fragments [Body Substance]
   966 E C1708096:Fragment [Qualitative Concept]

Phrase: "could"

Phrase: "increase"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "tau phosphorylation by potentiating zinc-induced Erk activation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0031715:Phosphorylation [Molecular Function]
   744   C1158886:Phosphorylation [Molecular Function]

Phrase: "in neurons,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0027882:Neurons [Cell]
   916 E C0521390:Neuronal [Immunologic Factor]

Phrase: "as"

Phrase: "demonstrated"

Phrase: "in vitro in the current study."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   820   C0681828:in vitro study [Research Activity]
           study vitro
   790   C0021135:In Vitro [Intellectual Product]
   790   C1533691:in vitro [Qualitative Concept]
           vitro
   790   C2827718:In Vitro [Functional Concept]
Processing 00000000.tx.151: These possibilities are not mutually exclusive. 

Phrase: "These possibilities"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   916   C0332149:Possible [Qualitative Concept]
   916   C1705910:Possible [Qualitative Concept]
   916   C2362652:Possible [Qualitative Concept]

Phrase: "are"

Phrase: "not mutually exclusive."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1548966:Exclusive [Idea or Concept]
Processing 00000000.tx.152: Consequently, decreasing the concentration of zinc in the brain might help prevent AD in carriers of the APOE 4 allele.  

Phrase: "Consequently,"

Phrase: "decreasing"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0442797:Decreasing [Qualitative Concept]
   966 E C0392756:Decrease [Qualitative Concept]
   966 E C0547047:Decrease [Quantitative Concept]

Phrase: "the concentration of zinc"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0086045:Concentration [Mental Process]
   770   C1446561:Concentration [Quantitative Concept]

Phrase: "in the brain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006104:Brain [Body Part, Organ, or Organ Component]
  1000   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "might"

Phrase: "help"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0018896:Help [Social Behavior]
  1000   C1552861:help [Idea or Concept]

Phrase: "prevent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0309872:PREVENT [Pharmacologic Substance]

Phrase: "AD in carriers of the APOE 4 allele."
Processing 00000000.tx.153: FOOTNOTES  * This work was supported in part by National Institutes of Heath Grants P01 AG022074, R01 HL37063, and R21 NS046465. 

Phrase: "FOOTNOTES"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2825232:Footnote [Intellectual Product]

Phrase: "*"

Phrase: "This work"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043227:Work [Occupational Activity]

Phrase: "was"

Phrase: "supported in part"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0449719:Part [Spatial Concept]
   790   C1521721:Supported [Conceptual Entity]
   790   C1709471:Part [Quantitative Concept]
   756 E C0183683:Support [Medical Device]

Phrase: "by National Institutes"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0021622:Institutes [Organization]
   827 E C1272753:Institute [Idea or Concept]

Phrase: "of Heath Grants P01 AG022074,"

Phrase: "R01 HL37063,"

Phrase: "and"

Phrase: "R21 NS046465."
Processing 00000000.tx.154: The costs of publication of this article were defrayed in part by the payment of page charges. 

Phrase: "The costs of publication of this article"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0010186:Costs [Quantitative Concept]
   748   C0220812:Costs [Quantitative Concept]

Phrase: "were"

Phrase: "defrayed in part"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0449719:Part [Spatial Concept]
   790   C1709471:Part [Quantitative Concept]

Phrase: "by the payment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0220808:payment [Quantitative Concept]
  1000   C0680264:payment [Quantitative Concept]

Phrase: "of page charges."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0007961:Charges [Quantitative Concept]
   827 E C1706211:Charge [Organism Attribute]
Processing 00000000.tx.155: This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. 

Phrase: "This article"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1706852:Article [Intellectual Product]

Phrase: "must"

Phrase: "therefore"

Phrase: "be"

Phrase: "hereby"

Phrase: "marked"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0522501:Marked [Qualitative Concept]
  1000   C1706089:Marked [Qualitative Concept]

Phrase: """advertisement"""
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0949214:advertisement [Intellectual Product]

Phrase: "in accordance with 18 U.S.C."
Processing 00000000.tx.156: Section 1734 solely to indicate this fact. 

Phrase: "Section 1734 solely to"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   812   C0205155:Section [Spatial Concept]
   812   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   812   C1522472:Section [Substance]
   812   C1552923:Section [Quantitative Concept]
   812   C1705191:Section [Physical Object]

Phrase: "indicate"

Phrase: "this fact."
Processing 00000000.tx.157: ** To whom correspondence should be addressed: Gladstone Institute of Neurological Disease, P. 

Phrase: "*"

Phrase: "*"

Phrase: "To whom correspondence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0282413:Correspondence [Intellectual Product]

Phrase: "should"

Phrase: "be"

Phrase: "addressed"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0376649:Address [Intellectual Product]
   966   C1442065:Address [Spatial Concept]

Phrase: ":"

Phrase: "Gladstone Institute of Neurological Disease,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0021622:institute [Organization]
   760   C1272753:Institute [Idea or Concept]

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.158: O. 

Phrase: "O."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]
Processing 00000000.tx.159: Box 419100, San Francisco, CA 941419100. 

Phrase: "Box 419100,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0179400:Box [Manufactured Object]
   861   C1533124:Box [Medical Device]

Phrase: "San Francisco,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0036152:San Francisco [Geographic Area]
   861   C1826357:San [Gene or Genome]

Phrase: "CA 941419100."
Processing 00000000.tx.160: Tel.: 

Phrase: "Tel."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0254343:TEL [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0796520:TEL [Gene or Genome]
  1000   C3272379:TEL [Intellectual Product]

Phrase: ":"
Processing 00000000.tx.161: 415-826-7500; 

Phrase: "415-826-7500"

Phrase: ";"
Processing 00000000.tx.162: Fax: 415-285-5632; 

Phrase: "Fax"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0085205:Fax [Manufactured Object]
  1000   C1549619:FAX [Conceptual Entity]
  1000   C1880669:Fax [Manufactured Object]

Phrase: ":"

Phrase: "415-285-5632"

Phrase: ";"
Processing 00000000.tx.163: E-mail: yhuang{at}gladstone.ucsf.edu . 1 The abbreviations used are: apo, apolipoprotein; 

Phrase: "E-mail"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0013849:E-Mail [Intellectual Product]
  1000   C1705961:E-mail [Intellectual Product]
   861   C0024492:Mail [Manufactured Object]
   861   C1538057:MAIL [Gene or Genome]
   861   C1547565:Mail [Idea or Concept]

Phrase: ":"

Phrase: "yhuang{at}gladstone.ucsf.edu . 1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0059804:EDU [Organic Chemical,Pharmacologic Substance]

Phrase: "The abbreviations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0000723:Abbreviations [Intellectual Product]

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "are"

Phrase: ":"

Phrase: "apo,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003591:Apolipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "apolipoprotein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003591:Apolipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ";"
Processing 00000000.tx.164: AD, Alzheimer's disease; 

Phrase: "AD,"

Phrase: "Alzheimer's disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: ";"
Processing 00000000.tx.165: Cdk-5, cyclin-dependent kinase-5; 

Phrase: "Cdk-5,"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
  1000   C0249586:Cyclin-Dependent Kinase 5 [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1332735:CYCLIN-DEPENDENT KINASE 5 [Gene or Genome]
   923   C0243045:Cyclin-Dependent Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0072108:Cyclin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0079183:Cyclin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0851827:Dependent [Qualitative Concept]
   812   C1150565:cyclin [Molecular Function]
   812   C1701901:Dependent [Qualitative Concept]
   812   C3244310:dependent [Functional Concept]

Phrase: "cyclin-dependent kinase-5"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
  1000   C0249586:Cyclin-Dependent Kinase 5 [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1332735:CYCLIN-DEPENDENT KINASE 5 [Gene or Genome]
   923   C0243045:Cyclin-Dependent Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0072108:Cyclin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0079183:Cyclin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0851827:Dependent [Qualitative Concept]
   812   C1150565:cyclin [Molecular Function]
   812   C1701901:Dependent [Qualitative Concept]
   812   C3244310:dependent [Functional Concept]

Phrase: ";"
Processing 00000000.tx.166: Erk, extracellular signal-regulated kinase; 

Phrase: "Erk,"

Phrase: "extracellular signal-regulated kinase"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   979   C0600388:Extracellular Signal Regulated Kinases [Amino Acid, Peptide, or Protein,Enzyme]
   979   C0752312:Extracellular Signal-Regulated Kinases [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0521119:Extracellular [Cell Component]
   812   C0851285:Regulated [Governmental or Regulatory Activity]
   812   C1710082:Signal [Phenomenon or Process]

Phrase: ";"
Processing 00000000.tx.167: GSK-3, glycogen synthase kinase-3; 

Phrase: "GSK-3,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   923   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   812   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "glycogen synthase kinase-3"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   923   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   812   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: ";"
Processing 00000000.tx.168: NFT, neurofibrillary tangle; 

Phrase: "NFT,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0085400:NFT [Acquired Abnormality]

Phrase: "neurofibrillary tangle"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0085400:Neurofibrillary tangle [Acquired Abnormality]
  1000   C3543859:neurofibrillary tangle [Cell Component]

Phrase: ";"
Processing 00000000.tx.169: NSE, neuron-specific enolase; 

Phrase: "NSE,"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C1414404:ENOLASE, NEURON-SPECIFIC [Gene or Genome]
  1000   C1880904:Neuron-Specific Enolase [Amino Acid, Peptide, or Protein,Enzyme,Neuroreactive Substance or Biogenic Amine]
   827   C0027882:Neuron [Cell]
   827   C0031691:ENOLASE [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0205369:Specific [Qualitative Concept]
   827   C1552740:specific [Intellectual Product]
   755 E C0521390:Neuronal [Immunologic Factor]

Phrase: "neuron-specific enolase"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C1414404:ENOLASE, NEURON-SPECIFIC [Gene or Genome]
  1000   C1880904:Neuron-Specific Enolase [Amino Acid, Peptide, or Protein,Enzyme,Neuroreactive Substance or Biogenic Amine]
   827   C0027882:Neuron [Cell]
   827   C0031691:ENOLASE [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0205369:Specific [Qualitative Concept]
   827   C1552740:specific [Intellectual Product]
   755 E C0521390:Neuronal [Immunologic Factor]

Phrase: ";"
Processing 00000000.tx.170: PBS, phosphate-buffered saline; 

Phrase: "PBS,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1720830:PBS [Disease or Syndrome]
  1000   C1823521:PBS [Gene or Genome]

Phrase: "phosphate-buffered saline"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   884   C0991865:Phosphate Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   827   C0006353:Buffered [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   827   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   827   C0031701:phosphate [Organophosphorus Compound]
   827   C0036082:Saline [Substance]
   827   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]

Phrase: ";"
Processing 00000000.tx.171: p-tau, phosphorylated tau; 

Phrase: "p-tau,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1720655:Tau [Intellectual Product]
   861   C1947974:Tau [Research Activity]

Phrase: "phosphorylated tau"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1720655:Tau [Intellectual Product]
   861   C1947974:Tau [Research Activity]

Phrase: ";"
Processing 00000000.tx.172: A, amyloid-beta.  

Phrase: "A,"

Phrase: "amyloid-beta."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C3484390:Amyloid beta [Amino Acid, Peptide, or Protein]
   861   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0011560:Amyloid [Pathologic Function]
   861   C0330390:Beta [Plant]
   861   C0439096:Beta [Intellectual Product]
   861   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C2004068:Beta [Qualitative Concept]
Processing 00000000.tx.173: ACKNOWLEDGMENTS  We thank Drs. 

Phrase: "ACKNOWLEDGMENTS"

Phrase: "We"

Phrase: "thank"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986676:THANK [Gene or Genome]

Phrase: "Drs."
Processing 00000000.tx.174: Lennart Mucke and Karl Weisgraber for critical reading of the manuscript, Jennifer Polizzotto and Sylvia Richmond for manuscript preparation, Stephen Ordway and Gary Howard for editorial assistance, John C. 

Phrase: "Lennart Mucke"

Phrase: "and"

Phrase: "Karl Weisgraber for critical reading of the manuscript,"

Phrase: "Jennifer Polizzotto"

Phrase: "and"

Phrase: "Sylvia Richmond for manuscript preparation,"

Phrase: "Stephen Ordway"

Phrase: "and"

Phrase: "Gary Howard for editorial assistance,"

Phrase: "John C."
Processing 00000000.tx.175: W. 

Phrase: "W."
Processing 00000000.tx.176: Carroll and John Hull for graphics, and Stephen Gonzales and Chris Goodfellow for photography.  

Phrase: "Carroll"

Phrase: "and"

Phrase: "John Hull for graphics,"

Phrase: "and"

Phrase: "Stephen Gonzales"

Phrase: "and"

Phrase: "Chris Goodfellow for photography."
Processing 00000000.tx.177: REFERENCES TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES  Corder, E. 

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   795   C0557061:Discussion [Therapeutic or Preventive Procedure]
   795   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Corder,"

Phrase: "E."
Processing 00000000.tx.178: H., Saunders, A. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Saunders,"

Phrase: "A."
Processing 00000000.tx.179: M., Strittmatter, W. 

Phrase: "M."

Phrase: ","

Phrase: "Strittmatter,"

Phrase: "W."
Processing 00000000.tx.180: J., Schmechel, D. 

Phrase: "J.,"

Phrase: "Schmechel,"

Phrase: "D."
Processing 00000000.tx.181: E., Gaskell, P. 

Phrase: "E.,"

Phrase: "Gaskell,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.182: C., Small, G. 

Phrase: "C., Small, G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.183: W., Roses, A. 

Phrase: "W., Roses,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0035853:Roses [Plant]
   827 E C0995005:ROSE [Pharmacologic Substance]

Phrase: "A."
Processing 00000000.tx.184: D., Haines, J. 

Phrase: "D."

Phrase: ","

Phrase: "Haines,"

Phrase: "J."
Processing 00000000.tx.185: L., and Pericak-Vance, M. 

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "and"

Phrase: "Pericak-Vance,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.186: A. 

Phrase: "A."
Processing 00000000.tx.187: (1993) Science 261, 921-923[Medline] [OrderarticleviaInfotrieve] Farrer, L. 

Phrase: "(1993"

Phrase: ")"

Phrase: "Science 261,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036397:Science [Occupation or Discipline]

Phrase: "921-923"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Farrer,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.188: A., Cupples, L. 

Phrase: "A.,"

Phrase: "Cupples,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.189: A., Haines, J. 

Phrase: "A.,"

Phrase: "Haines,"

Phrase: "J."
Processing 00000000.tx.190: L., Hyman, B., Kukull, W. 

Phrase: "L., Hyman,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Kukull,"

Phrase: "W."
Processing 00000000.tx.191: A., Mayeux, R., Myers, R. 

Phrase: "A.,"

Phrase: "Mayeux,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Myers,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.192: H., Pericak-Vance, M. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Pericak-Vance,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.193: A., Risch, N., and Van Duijn, C. 

Phrase: "A.,"

Phrase: "Risch,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "and"

Phrase: "Van Duijn,"

Phrase: "C."
Processing 00000000.tx.194: M. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.195: (1997) J. 

Phrase: "(1997"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.196: Am. 

Phrase: "Am."
Processing 00000000.tx.197: Med. 

Phrase: "Med."
Processing 00000000.tx.198: Assoc. 

Phrase: "Assoc."
Processing 00000000.tx.199: 278, 1349-1356[Abstract] Selkoe, D. 

Phrase: "278,"

Phrase: "1349-1356"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Selkoe,"

Phrase: "D."
Processing 00000000.tx.200: J. 

Phrase: "J."
Processing 00000000.tx.201: (1991) Neuron 6, 487-498[Medline] [OrderarticleviaInfotrieve] Crowther, R. 

Phrase: "(1991"

Phrase: ")"

Phrase: "Neuron 6,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0027882:Neuron [Cell]
   789 E C0521390:Neuronal [Immunologic Factor]

Phrase: "487-498"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Crowther,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.202: A. 

Phrase: "A."
Processing 00000000.tx.203: (1993) Curr. 

Phrase: "(1993"

Phrase: ")"

Phrase: "Curr."
Processing 00000000.tx.204: Opin. 

Phrase: "Opin."
Processing 00000000.tx.205: Struct. 

Phrase: "Struct."
Processing 00000000.tx.206: Biol. 

Phrase: "Biol."
Processing 00000000.tx.207: 3, 202-206 Roses, A. 

Phrase: "3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "202-206 Roses,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0035853:Roses [Plant]
   793 E C0995005:ROSE [Pharmacologic Substance]

Phrase: "A."
Processing 00000000.tx.208: D. 

Phrase: "D."
Processing 00000000.tx.209: (1994) Curr. 

Phrase: "(1994"

Phrase: ")"

Phrase: "Curr."
Processing 00000000.tx.210: Neurol. 

Phrase: "Neurol."
Processing 00000000.tx.211: 14, 111-141 Smith, M. 

Phrase: "14,"

Phrase: "111-141 Smith,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0554249:Smith [Professional or Occupational Group]

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.212: A., Rudnicka-Nawrot, M., Richey, P. 

Phrase: "A.,"

Phrase: "Rudnicka-Nawrot,"

Phrase: "M."

Phrase: ","

Phrase: "Richey,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.213: L., Praprotnik, D., Mulvihill, P., Miller, C. 

Phrase: "L., Praprotnik,"

Phrase: "D."

Phrase: ","

Phrase: "Mulvihill,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Miller,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0402830:Miller [Professional or Occupational Group]

Phrase: "C."
Processing 00000000.tx.214: A., Sayre, L. 

Phrase: "A.,"

Phrase: "Sayre,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.215: M., and Perry, G. 

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Perry,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.216: (1995) J. 

Phrase: "(1995"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.217: Neurochem. 

Phrase: "Neurochem."
Processing 00000000.tx.218: 64, 2660-2666[Medline] [OrderarticleviaInfotrieve] Vickers, J. 

Phrase: "64,"

Phrase: "2660-2666"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Vickers,"

Phrase: "J."
Processing 00000000.tx.219: C., Riederer, B. 

Phrase: "C., Riederer,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.220: M., Marugg, R. 

Phrase: "M."

Phrase: ","

Phrase: "Marugg,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.221: A., Bue-Scherrer, V., Bue, L., Delacourte, A., and Morrison, J. 

Phrase: "A.,"

Phrase: "Bue-Scherrer,"

Phrase: "V.,"

Phrase: "Bue,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Delacourte,"

Phrase: "A.,"

Phrase: "and"

Phrase: "Morrison,"

Phrase: "J."
Processing 00000000.tx.222: H. 

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.223: (1994) Neuroscience 62, 1-13[CrossRef][Medline] [OrderarticleviaInfotrieve] Namba, Y., Tomonaga, M., Kawasaki, H., Otomo, E., and Ikeda, K. 

Phrase: "(1994"

Phrase: ")"

Phrase: "Neuroscience 62,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0027910:Neuroscience [Biomedical Occupation or Discipline]
   861   C1552241:Neuroscience [Professional or Occupational Group]
   861   C1555991:Neuroscience [Professional or Occupational Group]

Phrase: "1-13"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Namba,"

Phrase: "Y.,"

Phrase: "Tomonaga,"

Phrase: "M."

Phrase: ","

Phrase: "Kawasaki,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Otomo,"

Phrase: "E.,"

Phrase: "and"

Phrase: "Ikeda,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3613423:Ikeda [Eukaryote]

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.224: (1991) Brain Res. 

Phrase: "(1991"

Phrase: ")"

Phrase: "Brain Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347379:RES [Finding]
Processing 00000000.tx.225: 541, 163-166[CrossRef][Medline] [OrderarticleviaInfotrieve] Wisniewski, T., and Frangione, B. 

Phrase: "541,"

Phrase: "163-166"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Wisniewski,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "and"

Phrase: "Frangione,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.226: (1992) Neurosci. 

Phrase: "(1992"

Phrase: ")"

Phrase: "Neurosci."
Processing 00000000.tx.227: Lett. 

Phrase: "Lett."
Processing 00000000.tx.228: 135, 235-238[CrossRef][Medline] [OrderarticleviaInfotrieve] Strittmatter, W. 

Phrase: "135,"

Phrase: "235-238"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Strittmatter,"

Phrase: "W."
Processing 00000000.tx.229: J., Saunders, A. 

Phrase: "J.,"

Phrase: "Saunders,"

Phrase: "A."
Processing 00000000.tx.230: M., Schmechel, D., Pericak-Vance, M., Enghild, J., Salvesen, G. 

Phrase: "M."

Phrase: ","

Phrase: "Schmechel,"

Phrase: "D."

Phrase: ","

Phrase: "Pericak-Vance,"

Phrase: "M."

Phrase: ","

Phrase: "Enghild,"

Phrase: "J.,"

Phrase: "Salvesen,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.231: S., and Roses, A. 

Phrase: "S."

Phrase: ","

Phrase: "and"

Phrase: "Roses,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0035853:Roses [Plant]
   966 E C0995005:ROSE [Pharmacologic Substance]

Phrase: "A."
Processing 00000000.tx.232: D. 

Phrase: "D."
Processing 00000000.tx.233: (1993) Proc. 

Phrase: "(1993"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.234: Natl. 

Phrase: "Natl."
Processing 00000000.tx.235: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.236: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.237: U. 

Phrase: "U."
Processing 00000000.tx.238: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.239: A. 

Phrase: "A."
Processing 00000000.tx.240: 90, 1977-1981[Abstract] Roses, A. 

Phrase: "90,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439083:>90 [Quantitative Concept]
  1000   C0439087:<90 [Quantitative Concept]

Phrase: "1977-1981"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Roses,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0035853:Roses [Plant]
   966 E C0995005:ROSE [Pharmacologic Substance]

Phrase: "A."
Processing 00000000.tx.241: D. 

Phrase: "D."
Processing 00000000.tx.242: (1994) J. 

Phrase: "(1994"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.243: Neuropathol. 

Phrase: "Neuropathol."
Processing 00000000.tx.244: Exp. 

Phrase: "Exp."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1417055:EXP [Gene or Genome]
Processing 00000000.tx.245: Neurol. 

Phrase: "Neurol."
Processing 00000000.tx.246: 53, 429-437[Medline] [OrderarticleviaInfotrieve] Mahley, R. 

Phrase: "53,"

Phrase: "429-437"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Mahley,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.247: W., and Rall, S. 

Phrase: "W.,"

Phrase: "and"

Phrase: "Rall,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.248: C., Jr. 

Phrase: "C., Jr."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1708595:Jr [Idea or Concept]
   861   C3280986:JR [Disease or Syndrome]
Processing 00000000.tx.249: (2000) Annu. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Annu."
Processing 00000000.tx.250: Rev. 

Phrase: "Rev."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347961:Rev. [Professional or Occupational Group]
Processing 00000000.tx.251: Genomics Hum. 

Phrase: "Genomics Hum."
Processing 00000000.tx.252: Genet. 

Phrase: "Genet."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]
Processing 00000000.tx.253: 1, 507-537[CrossRef][Medline] [OrderarticleviaInfotrieve] Huang, Y., Weisgraber, K. 

Phrase: "1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "507-537"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450381:507 [Intellectual Product]

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Huang,"

Phrase: "Y.,"

Phrase: "Weisgraber,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.254: H., Mucke, L., and Mahley, R. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Mucke,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "and"

Phrase: "Mahley,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.255: W. 

Phrase: "W."
Processing 00000000.tx.256: (2004) J. 

Phrase: "(2004"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.257: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.258: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.259: 23, 189-204[CrossRef][Medline] [OrderarticleviaInfotrieve] Mahley, R. 

Phrase: "23,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: "189-204"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Mahley,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.260: W., and Huang, Y. 

Phrase: "W.,"

Phrase: "and"

Phrase: "Huang,"

Phrase: "Y."
Processing 00000000.tx.261: (1999) Curr. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Curr."
Processing 00000000.tx.262: Opin. 

Phrase: "Opin."
Processing 00000000.tx.263: Lipidol. 

Phrase: "Lipidol."
Processing 00000000.tx.264: 10, 207-217[CrossRef][Medline] [OrderarticleviaInfotrieve] Strittmatter, W. 

Phrase: "10,"

Phrase: "207-217"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Strittmatter,"

Phrase: "W."
Processing 00000000.tx.265: J., Weisgraber, K. 

Phrase: "J.,"

Phrase: "Weisgraber,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.266: H., Huang, D. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Huang,"

Phrase: "D."
Processing 00000000.tx.267: Y., Dong, L.-M., Salvesen, G. 

Phrase: "Y.,"

Phrase: "Dong,"

Phrase: "L.-M.,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0439394:l's [Quantitative Concept]
   861   C0441923:M+ [Intellectual Product]
   861   C1706495:L- [Intellectual Product]
   861   C3642217:/L [Quantitative Concept]

Phrase: "Salvesen,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.268: S., Pericak-Vance, M., Schmechel, D., Saunders, A. 

Phrase: "S."

Phrase: ","

Phrase: "Pericak-Vance,"

Phrase: "M."

Phrase: ","

Phrase: "Schmechel,"

Phrase: "D."

Phrase: ","

Phrase: "Saunders,"

Phrase: "A."
Processing 00000000.tx.269: M., Goldgaber, D., and Roses, A. 

Phrase: "M."

Phrase: ","

Phrase: "Goldgaber,"

Phrase: "D."

Phrase: ","

Phrase: "and"

Phrase: "Roses,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0035853:Roses [Plant]
   966 E C0995005:ROSE [Pharmacologic Substance]

Phrase: "A."
Processing 00000000.tx.270: D. 

Phrase: "D."
Processing 00000000.tx.271: (1993) Proc. 

Phrase: "(1993"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.272: Natl. 

Phrase: "Natl."
Processing 00000000.tx.273: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.274: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.275: U. 

Phrase: "U."
Processing 00000000.tx.276: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.277: A. 

Phrase: "A."
Processing 00000000.tx.278: 90, 8098-8102[Abstract/Free FullText] Ma, J., Yee, A., Brewer, H. 

Phrase: "90,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439083:>90 [Quantitative Concept]
  1000   C0439087:<90 [Quantitative Concept]

Phrase: "8098-8102"

Phrase: "[Abstract/Free FullText"

Phrase: "] Ma,"

Phrase: "J.,"

Phrase: "Yee,"

Phrase: "A.,"

Phrase: "Brewer,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0402217:Brewer [Professional or Occupational Group]

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.279: B., Jr., Das, S., and Potter, H. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Jr.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1708595:Jr [Idea or Concept]
  1000   C3280986:JR [Disease or Syndrome]

Phrase: "Das,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0051767:DAS [Organic Chemical,Pharmacologic Substance]
  1000   C0057671:DAS [Organic Chemical,Pharmacologic Substance]

Phrase: "S."

Phrase: ","

Phrase: "and"

Phrase: "Potter,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0336168:potter [Professional or Occupational Group]

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.280: (1994) Nature 372, 92-94[CrossRef][Medline] [OrderarticleviaInfotrieve] Wisniewski, T., Castao, E. 

Phrase: "(1994"

Phrase: ")"

Phrase: "Nature 372,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: "92-94"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Wisniewski,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Castao,"

Phrase: "E."
Processing 00000000.tx.281: M., Golabek, A., Vogel, T., and Frangione, B. 

Phrase: "M."

Phrase: ","

Phrase: "Golabek,"

Phrase: "A.,"

Phrase: "Vogel,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "and"

Phrase: "Frangione,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.282: (1994) Am. 

Phrase: "(1994"

Phrase: ")"

Phrase: "Am."
Processing 00000000.tx.283: J. 

Phrase: "J."
Processing 00000000.tx.284: Pathol. 

Phrase: "Pathol."
Processing 00000000.tx.285: 145, 1030-1035[Abstract] LaDu, M. 

Phrase: "145,"

Phrase: "1030-1035"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] LaDu,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.286: J., Falduto, M. 

Phrase: "J.,"

Phrase: "Falduto,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.287: T., Manelli, A. 

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Manelli,"

Phrase: "A."
Processing 00000000.tx.288: M., Reardon, C. 

Phrase: "M."

Phrase: ","

Phrase: "Reardon,"

Phrase: "C."
Processing 00000000.tx.289: A., Getz, G. 

Phrase: "A.,"

Phrase: "Getz,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.290: S., and Frail, D. 

Phrase: "S."

Phrase: ","

Phrase: "and"

Phrase: "Frail, D."
Processing 00000000.tx.291: E. 

Phrase: "E."
Processing 00000000.tx.292: (1994) J. 

Phrase: "(1994"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.293: Biol. 

Phrase: "Biol."
Processing 00000000.tx.294: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.295: 269, 23403-23406[Abstract/Free FullText] Holtzman, D. 

Phrase: "269,"

Phrase: "23403-23406"

Phrase: "[Abstract/Free FullText"

Phrase: "] Holtzman,"

Phrase: "D."
Processing 00000000.tx.296: M., Bales, K. 

Phrase: "M."

Phrase: ","

Phrase: "Bales,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2826220:BALE [Quantitative Concept]

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.297: R., Tenkova, T., Fagan, A. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Tenkova,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Fagan,"

Phrase: "A."
Processing 00000000.tx.298: M., Parsadanian, M., Sartorius, L. 

Phrase: "M."

Phrase: ","

Phrase: "Parsadanian,"

Phrase: "M."

Phrase: ","

Phrase: "Sartorius,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0224434:Sartorius [Body Part, Organ, or Organ Component]
  1000   C1305055:Sartorius [Body Part, Organ, or Organ Component]

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.299: J., Mackey, B., Olney, J., McKeel, D., Wozniak, D., and Paul, S. 

Phrase: "J.,"

Phrase: "Mackey,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Olney,"

Phrase: "J.,"

Phrase: "McKeel,"

Phrase: "D."

Phrase: ","

Phrase: "Wozniak,"

Phrase: "D."

Phrase: ","

Phrase: "and"

Phrase: "Paul,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.300: M. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.301: (2000) Proc. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.302: Natl. 

Phrase: "Natl."
Processing 00000000.tx.303: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.304: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.305: U. 

Phrase: "U."
Processing 00000000.tx.306: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.307: A. 

Phrase: "A."
Processing 00000000.tx.308: 97, 2892-2897[Abstract/Free FullText] Bales, K. 

Phrase: "97,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439073:97 [Intellectual Product]
  1000   C0439082:>97 [Quantitative Concept]

Phrase: "2892-2897"

Phrase: "[Abstract/Free FullText"

Phrase: "] Bales,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2826220:BALE [Quantitative Concept]

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.309: R., Verina, T., Cummins, D. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Verina,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Cummins,"

Phrase: "D."
Processing 00000000.tx.310: J., Du, Y., Dodel, R. 

Phrase: "J.,"

Phrase: "Du,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3540681:DU [Idea or Concept]

Phrase: "Y.,"

Phrase: "Dodel,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.311: C., Saura, J., Fishman, C. 

Phrase: "C., Saura,"

Phrase: "J.,"

Phrase: "Fishman,"

Phrase: "C."
Processing 00000000.tx.312: E., DeLong, C. 

Phrase: "E.,"

Phrase: "DeLong,"

Phrase: "C."
Processing 00000000.tx.313: A., Piccardo, P., Petegnief, V., Ghetti, B., and Paul, S. 

Phrase: "A.,"

Phrase: "Piccardo,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Petegnief,"

Phrase: "V.,"

Phrase: "Ghetti,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "Paul,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.314: M. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.315: (1999) Proc. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.316: Natl. 

Phrase: "Natl."
Processing 00000000.tx.317: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.318: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.319: U. 

Phrase: "U."
Processing 00000000.tx.320: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.321: A. 

Phrase: "A."
Processing 00000000.tx.322: 96, 15233-15238[Abstract/Free FullText] Irizarry, M. 

Phrase: "96,"

Phrase: "15233-15238"

Phrase: "[Abstract/Free FullText"

Phrase: "] Irizarry,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.323: C., Cheung, B. 

Phrase: "C., Cheung,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.324: S., Rebeck, G. 

Phrase: "S."

Phrase: ","

Phrase: "Rebeck,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.325: W., Paul, S. 

Phrase: "W., Paul,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.326: M., Bales, K. 

Phrase: "M."

Phrase: ","

Phrase: "Bales,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2826220:BALE [Quantitative Concept]

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.327: R., and Hyman, B. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Hyman,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.328: T. 

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.329: (2000) Acta Neuropathol. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Acta Neuropathol."
Processing 00000000.tx.330: 100, 451-458[CrossRef][Medline] [OrderarticleviaInfotrieve] Miyata, M., and Smith, J. 

Phrase: "100,"

Phrase: "451-458"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Miyata,"

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Smith,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0554249:Smith [Professional or Occupational Group]

Phrase: "J."
Processing 00000000.tx.331: D. 

Phrase: "D."
Processing 00000000.tx.332: (1996) Nat. 

Phrase: "(1996"

Phrase: ")"

Phrase: "Nat."
Processing 00000000.tx.333: Genet. 

Phrase: "Genet."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]
Processing 00000000.tx.334: 14, 55-61[Medline] [OrderarticleviaInfotrieve] Herz, J., and Beffert, U. 

Phrase: "14,"

Phrase: "55-61"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450382:55 [Intellectual Product]

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Herz,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439482:Herz [Quantitative Concept]

Phrase: "J.,"

Phrase: "and"

Phrase: "Beffert,"

Phrase: "U."
Processing 00000000.tx.335: (2000) Nat. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Nat."
Processing 00000000.tx.336: Rev. 

Phrase: "Rev."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347961:Rev. [Professional or Occupational Group]
Processing 00000000.tx.337: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.338: 1, 51-58[CrossRef][Medline] [OrderarticleviaInfotrieve] Strittmatter, W. 

Phrase: "1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "51-58"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Strittmatter,"

Phrase: "W."
Processing 00000000.tx.339: J., Saunders, A. 

Phrase: "J.,"

Phrase: "Saunders,"

Phrase: "A."
Processing 00000000.tx.340: M., Goedert, M., Weisgraber, K. 

Phrase: "M."

Phrase: ","

Phrase: "Goedert,"

Phrase: "M."

Phrase: ","

Phrase: "Weisgraber,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.341: H., Dong, L.-M., Jakes, R., Huang, D. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Dong,"

Phrase: "L.-M.,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0439394:l's [Quantitative Concept]
   861   C0441923:M+ [Intellectual Product]
   861   C1706495:L- [Intellectual Product]
   861   C3642217:/L [Quantitative Concept]

Phrase: "Jakes,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Huang,"

Phrase: "D."
Processing 00000000.tx.342: Y., Pericak-Vance, M., Schmechel, D., and Roses, A. 

Phrase: "Y.,"

Phrase: "Pericak-Vance,"

Phrase: "M."

Phrase: ","

Phrase: "Schmechel,"

Phrase: "D."

Phrase: ","

Phrase: "and"

Phrase: "Roses,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0035853:Roses [Plant]
   966 E C0995005:ROSE [Pharmacologic Substance]

Phrase: "A."
Processing 00000000.tx.343: D. 

Phrase: "D."
Processing 00000000.tx.344: (1994) Proc. 

Phrase: "(1994"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.345: Natl. 

Phrase: "Natl."
Processing 00000000.tx.346: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.347: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.348: U. 

Phrase: "U."
Processing 00000000.tx.349: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.350: A. 

Phrase: "A."
Processing 00000000.tx.351: 91, 11183-11186[Abstract/Free FullText] Tesseur, I., Van Dorpe, J., Spittaels, K., Van den Haute, C., Moechars, D., and Van Leuven, F. 

Phrase: "91,"

Phrase: "11183-11186"

Phrase: "[Abstract/Free FullText"

Phrase: "] Tesseur,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Van Dorpe,"

Phrase: "J.,"

Phrase: "Spittaels,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Van den Haute,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0178587:DEN [Quantitative Concept]
   827   C0557775:Van [Manufactured Object]

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Moechars,"

Phrase: "D."

Phrase: ","

Phrase: "and"

Phrase: "Van Leuven,"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.352: (2000) Am. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Am."
Processing 00000000.tx.353: J. 

Phrase: "J."
Processing 00000000.tx.354: Pathol. 

Phrase: "Pathol."
Processing 00000000.tx.355: 156, 951-964[Abstract/Free FullText] Huang, Y., Liu, X. 

Phrase: "156,"

Phrase: "951-964"

Phrase: "[Abstract/Free FullText"

Phrase: "] Huang,"

Phrase: "Y.,"

Phrase: "Liu,"

Phrase: "X."
Processing 00000000.tx.356: Q., Wyss-Coray, T., Brecht, W. 

Phrase: "Q., Wyss-Coray,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Brecht,"

Phrase: "W."
Processing 00000000.tx.357: J., Sanan, D. 

Phrase: "J.,"

Phrase: "Sanan,"

Phrase: "D."
Processing 00000000.tx.358: A., and Mahley, R. 

Phrase: "A.,"

Phrase: "and"

Phrase: "Mahley,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.359: W. 

Phrase: "W."
Processing 00000000.tx.360: (2001) Proc. 

Phrase: "(2001"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.361: Natl. 

Phrase: "Natl."
Processing 00000000.tx.362: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.363: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.364: U. 

Phrase: "U."
Processing 00000000.tx.365: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.366: A. 

Phrase: "A."
Processing 00000000.tx.367: 98, 8838-8843[Abstract/Free FullText] Ljungberg, M. 

Phrase: "98,"

Phrase: "8838-8843"

Phrase: "[Abstract/Free FullText"

Phrase: "] Ljungberg,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.368: C., Dayanandan, R., Asuni, A., Rupniak, T. 

Phrase: "C., Dayanandan,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Asuni,"

Phrase: "A.,"

Phrase: "Rupniak,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.369: H., Anderton, B. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Anderton,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.370: H., and Lovestone, S. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Lovestone,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.371: (2002) Neuroreport 13, 867-870[Medline] [OrderarticleviaInfotrieve] Harris, F. 

Phrase: "(2002"

Phrase: ")"

Phrase: "Neuroreport 13,"

Phrase: "867-870"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Harris,"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.372: M., Brecht, W. 

Phrase: "M."

Phrase: ","

Phrase: "Brecht,"

Phrase: "W."
Processing 00000000.tx.373: J., Xu, Q., Tesseur, I., Kekonius, L., Wyss-Coray, T., Fish, J. 

Phrase: "J.,"

Phrase: "Xu,"

Phrase: "Q.,"

Phrase: "Tesseur,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Kekonius,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Wyss-Coray,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Fish,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016163:Fish [Fish]
  1000   C2349190:Fish [Food]
  1000   C2700184:FISH [Qualitative Concept]

Phrase: "J."
Processing 00000000.tx.374: D., Masliah, E., Hopkins, P. 

Phrase: "D."

Phrase: ","

Phrase: "Masliah,"

Phrase: "E.,"

Phrase: "Hopkins,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.375: C., Scearce-Levie, K., Weisgraber, K. 

Phrase: "C., Scearce-Levie,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Weisgraber,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.376: H., Mucke, L., Mahley, R. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Mucke,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Mahley,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.377: W., and Huang, Y. 

Phrase: "W.,"

Phrase: "and"

Phrase: "Huang,"

Phrase: "Y."
Processing 00000000.tx.378: (2003) Proc. 

Phrase: "(2003"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.379: Natl. 

Phrase: "Natl."
Processing 00000000.tx.380: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.381: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.382: U. 

Phrase: "U."
Processing 00000000.tx.383: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.384: A. 

Phrase: "A."
Processing 00000000.tx.385: 100, 10966-10971[Abstract/Free FullText] Brecht, W. 

Phrase: "100,"

Phrase: "10966-10971"

Phrase: "[Abstract/Free FullText"

Phrase: "] Brecht,"

Phrase: "W."
Processing 00000000.tx.386: J., Harris, F. 

Phrase: "J.,"

Phrase: "Harris,"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.387: M., Chang, S., Tesseur, I., Yu, G.-Q., Xu, Q., Fish, J. 

Phrase: "M."

Phrase: ","

Phrase: "Chang,"

Phrase: "S."

Phrase: ","

Phrase: "Tesseur,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Yu,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1006780:yu [Plant]

Phrase: "G.-Q., Xu,"

Phrase: "Q.,"

Phrase: "Fish,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016163:Fish [Fish]
  1000   C2349190:Fish [Food]
  1000   C2700184:FISH [Qualitative Concept]

Phrase: "J."
Processing 00000000.tx.388: D., Wyss-Coray, T., Buttini, M., Mucke, L., Mahley, R. 

Phrase: "D."

Phrase: ","

Phrase: "Wyss-Coray,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Buttini,"

Phrase: "M."

Phrase: ","

Phrase: "Mucke,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Mahley,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.389: W., and Huang, Y. 

Phrase: "W.,"

Phrase: "and"

Phrase: "Huang,"

Phrase: "Y."
Processing 00000000.tx.390: (2004) J. 

Phrase: "(2004"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.391: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.392: 24, 2527-2534[Abstract/Free FullText] Raber, J., Wong, D., Buttini, M., Orth, M., Bellosta, S., Pitas, R. 

Phrase: "24,"

Phrase: "2527-2534"

Phrase: "[Abstract/Free FullText"

Phrase: "] Raber,"

Phrase: "J.,"

Phrase: "Wong,"

Phrase: "D."

Phrase: ","

Phrase: "Buttini,"

Phrase: "M."

Phrase: ","

Phrase: "Orth,"

Phrase: "M."

Phrase: ","

Phrase: "Bellosta,"

Phrase: "S."

Phrase: ","

Phrase: "Pitas,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.393: E., Mahley, R. 

Phrase: "E.,"

Phrase: "Mahley,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.394: W., and Mucke, L. 

Phrase: "W.,"

Phrase: "and"

Phrase: "Mucke,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.395: (1998) Proc. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.396: Natl. 

Phrase: "Natl."
Processing 00000000.tx.397: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.398: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.399: U. 

Phrase: "U."
Processing 00000000.tx.400: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.401: A. 

Phrase: "A."
Processing 00000000.tx.402: 95, 10914-10919[Abstract/Free FullText] Raber, J., Bongers, G., LeFevour, A., Buttini, M., and Mucke, L. 

Phrase: "95,"

Phrase: "10914-10919"

Phrase: "[Abstract/Free FullText"

Phrase: "] Raber,"

Phrase: "J.,"

Phrase: "Bongers,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "LeFevour,"

Phrase: "A.,"

Phrase: "Buttini,"

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Mucke,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.403: (2002) J. 

Phrase: "(2002"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.404: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.405: 22, 5204-5209[Abstract/Free FullText] Ji, Z.-S., Miranda, R. 

Phrase: "22,"

Phrase: "5204-5209"

Phrase: "[Abstract/Free FullText"

Phrase: "] Ji,"

Phrase: "Z.-S.,"

Phrase: "Miranda,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.406: D., Newhouse, Y. 

Phrase: "D."

Phrase: ","

Phrase: "Newhouse,"

Phrase: "Y."
Processing 00000000.tx.407: M., Weisgraber, K. 

Phrase: "M."

Phrase: ","

Phrase: "Weisgraber,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.408: H., Huang, Y., and Mahley, R. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Huang,"

Phrase: "Y.,"

Phrase: "and"

Phrase: "Mahley,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.409: W. 

Phrase: "W."
Processing 00000000.tx.410: (2002) J. 

Phrase: "(2002"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.411: Biol. 

Phrase: "Biol."
Processing 00000000.tx.412: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.413: 277, 21821-21828[Abstract/Free FullText] Cataldo, A. 

Phrase: "277,"

Phrase: "21821-21828"

Phrase: "[Abstract/Free FullText"

Phrase: "] Cataldo,"

Phrase: "A."
Processing 00000000.tx.414: M., Barnett, J. 

Phrase: "M."

Phrase: ","

Phrase: "Barnett,"

Phrase: "J."
Processing 00000000.tx.415: L., Pieroni, C., and Nixon, R. 

Phrase: "L., Pieroni,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "and"

Phrase: "Nixon,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.416: A. 

Phrase: "A."
Processing 00000000.tx.417: (1997) J. 

Phrase: "(1997"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.418: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.419: 17, 6142-6151[Abstract/Free FullText] Cataldo, A. 

Phrase: "17,"

Phrase: "6142-6151"

Phrase: "[Abstract/Free FullText"

Phrase: "] Cataldo,"

Phrase: "A."
Processing 00000000.tx.420: M., Peterhoff, C. 

Phrase: "M."

Phrase: ","

Phrase: "Peterhoff,"

Phrase: "C."
Processing 00000000.tx.421: M., Troncoso, J. 

Phrase: "M."

Phrase: ","

Phrase: "Troncoso,"

Phrase: "J."
Processing 00000000.tx.422: C., Gomez-Isla, T., Hyman, B. 

Phrase: "C., Gomez-Isla,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Hyman,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.423: T., and Nixon, R. 

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "and"

Phrase: "Nixon,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.424: A. 

Phrase: "A."
Processing 00000000.tx.425: (2000) Am. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Am."
Processing 00000000.tx.426: J. 

Phrase: "J."
Processing 00000000.tx.427: Pathol. 

Phrase: "Pathol."
Processing 00000000.tx.428: 157, 277-286[Abstract/Free FullText] Grbovic, O. 

Phrase: "157,"

Phrase: "277-286"

Phrase: "[Abstract/Free FullText"

Phrase: "] Grbovic,"

Phrase: "O."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]
Processing 00000000.tx.429: M., Mathews, P. 

Phrase: "M."

Phrase: ","

Phrase: "Mathews,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.430: M., Jiang, Y., Schmidt, S. 

Phrase: "M."

Phrase: ","

Phrase: "Jiang,"

Phrase: "Y.,"

Phrase: "Schmidt,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.431: D., Dinakar, R., Summers-Terio, N. 

Phrase: "D."

Phrase: ","

Phrase: "Dinakar,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Summers-Terio,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.432: B., Ceresa, B. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Ceresa,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.433: P., Nixon, R. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Nixon,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.434: A., and Cataldo, A. 

Phrase: "A.,"

Phrase: "and"

Phrase: "Cataldo,"

Phrase: "A."
Processing 00000000.tx.435: M. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.436: (2003) J. 

Phrase: "(2003"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.437: Biol. 

Phrase: "Biol."
Processing 00000000.tx.438: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.439: 278, 31261-31268[Abstract/Free FullText] Nathan, B. 

Phrase: "278,"

Phrase: "31261-31268"

Phrase: "[Abstract/Free FullText"

Phrase: "] Nathan,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.440: P., Bellosta, S., Sanan, D. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Bellosta,"

Phrase: "S."

Phrase: ","

Phrase: "Sanan,"

Phrase: "D."
Processing 00000000.tx.441: A., Weisgraber, K. 

Phrase: "A.,"

Phrase: "Weisgraber,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.442: H., Mahley, R. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Mahley,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.443: W., and Pitas, R. 

Phrase: "W.,"

Phrase: "and"

Phrase: "Pitas,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.444: E. 

Phrase: "E."
Processing 00000000.tx.445: (1994) Science 264, 850-852[Medline] [OrderarticleviaInfotrieve] Nathan, B. 

Phrase: "(1994"

Phrase: ")"

Phrase: "Science 264,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036397:Science [Occupation or Discipline]

Phrase: "850-852"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Nathan,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.446: P., Chang, K.-C., Bellosta, S., Brisch, E., Ge, N., Mahley, R. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Chang,"

Phrase: "K.-C., Bellosta,"

Phrase: "S."

Phrase: ","

Phrase: "Brisch,"

Phrase: "E.,"

Phrase: "Ge,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3538705:GE [Gene or Genome]

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Mahley,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.447: W., and Pitas, R. 

Phrase: "W.,"

Phrase: "and"

Phrase: "Pitas,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.448: E. 

Phrase: "E."
Processing 00000000.tx.449: (1995) J. 

Phrase: "(1995"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.450: Biol. 

Phrase: "Biol."
Processing 00000000.tx.451: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.452: 270, 19791-19799[Abstract/Free FullText] Bellosta, S., Nathan, B. 

Phrase: "270,"

Phrase: "19791-19799"

Phrase: "[Abstract/Free FullText"

Phrase: "] Bellosta,"

Phrase: "S."

Phrase: ","

Phrase: "Nathan,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.453: P., Orth, M., Dong, L.-M., Mahley, R. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Orth,"

Phrase: "M."

Phrase: ","

Phrase: "Dong,"

Phrase: "L.-M.,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0439394:l's [Quantitative Concept]
   861   C0441923:M+ [Intellectual Product]
   861   C1706495:L- [Intellectual Product]
   861   C3642217:/L [Quantitative Concept]

Phrase: "Mahley,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.454: W., and Pitas, R. 

Phrase: "W.,"

Phrase: "and"

Phrase: "Pitas,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.455: E. 

Phrase: "E."
Processing 00000000.tx.456: (1995) J. 

Phrase: "(1995"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.457: Biol. 

Phrase: "Biol."
Processing 00000000.tx.458: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.459: 270, 27063-27071[Abstract/Free FullText] Tesseur, I., Van Dorpe, J., Bruynseels, K., Bronfman, F., Sciot, R., Van Lommel, A., and Van Leuven, F. 

Phrase: "270,"

Phrase: "27063-27071"

Phrase: "[Abstract/Free FullText"

Phrase: "] Tesseur,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Van Dorpe,"

Phrase: "J.,"

Phrase: "Bruynseels,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Bronfman,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Sciot,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Van Lommel,"

Phrase: "A.,"

Phrase: "and"

Phrase: "Van Leuven,"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.460: (2000) Am. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Am."
Processing 00000000.tx.461: J. 

Phrase: "J."
Processing 00000000.tx.462: Pathol. 

Phrase: "Pathol."
Processing 00000000.tx.463: 157, 1495-1510[Abstract/Free FullText] Harris, F. 

Phrase: "157,"

Phrase: "1495-1510"

Phrase: "[Abstract/Free FullText"

Phrase: "] Harris,"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.464: M., Tesseur, I., Brecht, W. 

Phrase: "M."

Phrase: ","

Phrase: "Tesseur,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Brecht,"

Phrase: "W."
Processing 00000000.tx.465: J., Xu, Q., Mullendorff, K., Chang, S., Wyss-Coray, T., Mahley, R. 

Phrase: "J.,"

Phrase: "Xu,"

Phrase: "Q.,"

Phrase: "Mullendorff,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Chang,"

Phrase: "S."

Phrase: ","

Phrase: "Wyss-Coray,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Mahley,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.466: W., and Huang, Y. 

Phrase: "W.,"

Phrase: "and"

Phrase: "Huang,"

Phrase: "Y."
Processing 00000000.tx.467: (2004) J. 

Phrase: "(2004"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.468: Biol. 

Phrase: "Biol."
Processing 00000000.tx.469: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.470: 279, 3862-3868[Abstract/Free FullText] Goedert, M., Sisodia, S. 

Phrase: "279,"

Phrase: "3862-3868"

Phrase: "[Abstract/Free FullText"

Phrase: "] Goedert,"

Phrase: "M."

Phrase: ","

Phrase: "Sisodia,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.471: S., and Price, D. 

Phrase: "S."

Phrase: ","

Phrase: "and"

Phrase: "Price,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0080045:Price [Quantitative Concept]

Phrase: "D."
Processing 00000000.tx.472: L. 

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.473: (1991) Curr. 

Phrase: "(1991"

Phrase: ")"

Phrase: "Curr."
Processing 00000000.tx.474: Opin. 

Phrase: "Opin."
Processing 00000000.tx.475: Neurobiol. 

Phrase: "Neurobiol."
Processing 00000000.tx.476: 1, 441-447[CrossRef][Medline] [OrderarticleviaInfotrieve] Lee, V. 

Phrase: "1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "441-447"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Lee,"

Phrase: "V."
Processing 00000000.tx.477: M.-Y., Goedert, M., and Trojanowski, J. 

Phrase: "M.-"

Phrase: "Y.,"

Phrase: "Goedert,"

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Trojanowski,"

Phrase: "J."
Processing 00000000.tx.478: Q. 

Phrase: "Q."
Processing 00000000.tx.479: (2001) Annu. 

Phrase: "(2001"

Phrase: ")"

Phrase: "Annu."
Processing 00000000.tx.480: Rev. 

Phrase: "Rev."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347961:Rev. [Professional or Occupational Group]
Processing 00000000.tx.481: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.482: 24, 1121-1159[CrossRef][Medline] [OrderarticleviaInfotrieve] Grimes, C. 

Phrase: "24,"

Phrase: "1121-1159"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Grimes,"

Phrase: "C."
Processing 00000000.tx.483: A., and Jope, R. 

Phrase: "A.,"

Phrase: "and"

Phrase: "Jope,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.484: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.485: (2001) Prog. 

Phrase: "(2001"

Phrase: ")"

Phrase: "Prog."
Processing 00000000.tx.486: Neurobiol. 

Phrase: "Neurobiol."
Processing 00000000.tx.487: 65, 391-426[CrossRef][Medline] [OrderarticleviaInfotrieve] Billingsley, M. 

Phrase: "65,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450385:65 [Intellectual Product]

Phrase: "391-426"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Billingsley,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.488: L., and Kincaid, R. 

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "and"

Phrase: "Kincaid,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.489: L. 

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.490: (1997) Biochem. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Biochem."
Processing 00000000.tx.491: J. 

Phrase: "J."
Processing 00000000.tx.492: 323, 577-591[Medline] [OrderarticleviaInfotrieve] Dhavan, R., and Tsai, L.-H. 

Phrase: "323,"

Phrase: "577-591"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Dhavan,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Tsai,"

Phrase: "L.-H."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C2346686:L/h [Quantitative Concept]
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.493: (2001) Nat. 

Phrase: "(2001"

Phrase: ")"

Phrase: "Nat."
Processing 00000000.tx.494: Rev. 

Phrase: "Rev."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347961:Rev. [Professional or Occupational Group]
Processing 00000000.tx.495: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.496: Cell. 

Phrase: "Cell."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.497: Biol. 

Phrase: "Biol."
Processing 00000000.tx.498: 2, 749-759[CrossRef][Medline] [OrderarticleviaInfotrieve] Perry, G., Roder, H., Nunomura, A., Takeda, A., Friedlich, A. 

Phrase: "2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "749-759"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Perry,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Roder,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Nunomura,"

Phrase: "A.,"

Phrase: "Takeda,"

Phrase: "A.,"

Phrase: "Friedlich,"

Phrase: "A."
Processing 00000000.tx.499: L., Zhu, X., Raina, A. 

Phrase: "L., Zhu,"

Phrase: "X.,"

Phrase: "Raina,"

Phrase: "A."
Processing 00000000.tx.500: K., Holbrook, N., Siedlak, S. 

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Holbrook,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Siedlak,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.501: L., Harris, P. 

Phrase: "L., Harris,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.502: L. 

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.503: R., and Smith, M. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Smith,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0554249:Smith [Professional or Occupational Group]

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.504: A. 

Phrase: "A."
Processing 00000000.tx.505: (1999) Neuroreport 10, 2411-2415[Medline] [OrderarticleviaInfotrieve] Patrick, G. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Neuroreport 10,"

Phrase: "2411-2415"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Patrick,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.506: N., Zukerberg, L., Nikolic, M., de la Monte, S., Dikkes, P., and Tsai, L.-H. 

Phrase: "N., Zukerberg,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Nikolic,"

Phrase: "M."

Phrase: ","

Phrase: "de la Monte,"

Phrase: "S."

Phrase: ","

Phrase: "Dikkes,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "and"

Phrase: "Tsai,"

Phrase: "L.-H."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C2346686:L/h [Quantitative Concept]
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.507: (1999) Nature 402, 615-622[CrossRef][Medline] [OrderarticleviaInfotrieve] Lucas, J. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Nature 402,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: "615-622"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Lucas,"

Phrase: "J."
Processing 00000000.tx.508: J., Hernndez, F., Gmez-Ramos, P., Morn, M. 

Phrase: "J.,"

Phrase: "Hernndez,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Gmez-Ramos,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Morn,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.509: A., Hen, R., and Avila, J. 

Phrase: "A.,"

Phrase: "Hen,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Avila,"

Phrase: "J."
Processing 00000000.tx.510: (2001) EMBO J. 

Phrase: "(2001"

Phrase: ")"

Phrase: "EMBO J."
Processing 00000000.tx.511: 20, 27-39[Abstract/Free FullText] Brownlees, J., Irving, N. 

Phrase: "20,"

Phrase: "27-39"

Phrase: "[Abstract/Free FullText"

Phrase: "] Brownlees,"

Phrase: "J.,"

Phrase: "Irving,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.512: G., Brion, J.-P., Gibb, B. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Brion,"

Phrase: "J.-P.,"

Phrase: "Gibb,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.513: J. 

Phrase: "J."
Processing 00000000.tx.514: M., Wagner, U., Woodgett, J., and Miller, C. 

Phrase: "M."

Phrase: ","

Phrase: "Wagner,"

Phrase: "U.,"

Phrase: "Woodgett,"

Phrase: "J.,"

Phrase: "and"

Phrase: "Miller,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0402830:Miller [Professional or Occupational Group]

Phrase: "C."
Processing 00000000.tx.515: C. 

Phrase: "C."
Processing 00000000.tx.516: J. 

Phrase: "J."
Processing 00000000.tx.517: (1997) Neuroreport 8, 3251-3255[Medline] [OrderarticleviaInfotrieve] Ahlijanian, M. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Neuroreport 8,"

Phrase: "3251-3255"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Ahlijanian,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.518: K., Barrezueta, N. 

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Barrezueta,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.519: X., Williams, R. 

Phrase: "X.,"

Phrase: "Williams,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.520: D., Jakowski, A., Kowsz, K. 

Phrase: "D."

Phrase: ","

Phrase: "Jakowski,"

Phrase: "A.,"

Phrase: "Kowsz,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.521: P., McCarthy, S., Coskran, T., Carlo, A., Seymour, P. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "McCarthy,"

Phrase: "S."

Phrase: ","

Phrase: "Coskran,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Carlo,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0445462:carlo [Intellectual Product]

Phrase: "A.,"

Phrase: "Seymour,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.522: A., Burkhardt, J. 

Phrase: "A.,"

Phrase: "Burkhardt,"

Phrase: "J."
Processing 00000000.tx.523: E., Nelson, R. 

Phrase: "E.,"

Phrase: "Nelson,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.524: B., and McNeish, J. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "McNeish,"

Phrase: "J."
Processing 00000000.tx.525: D. 

Phrase: "D."
Processing 00000000.tx.526: (2000) Proc. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.527: Natl. 

Phrase: "Natl."
Processing 00000000.tx.528: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.529: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.530: U. 

Phrase: "U."
Processing 00000000.tx.531: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.532: A. 

Phrase: "A."
Processing 00000000.tx.533: 97, 2910-2915[Abstract/Free FullText] Drewes, G., Ebneth, A., Preuss, U., Mandelkow, E.-M., and Mandelkow, E. 

Phrase: "97,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439073:97 [Intellectual Product]
  1000   C0439082:>97 [Quantitative Concept]

Phrase: "2910-2915"

Phrase: "[Abstract/Free FullText"

Phrase: "] Drewes,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Ebneth,"

Phrase: "A.,"

Phrase: "Preuss,"

Phrase: "U.,"

Phrase: "Mandelkow,"

Phrase: "E.-M.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "and"

Phrase: "Mandelkow,"

Phrase: "E."
Processing 00000000.tx.534: (1997) Cell 89, 297-308[Medline] [OrderarticleviaInfotrieve] Nishimura, I., Yang, Y., and Lu, B. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Cell 89,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0007634:Cell [Cell]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "297-308"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Nishimura,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Yang,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2945617:yang [Idea or Concept]

Phrase: "Y.,"

Phrase: "and"

Phrase: "Lu,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0024171:LU [Body System]
  1000   C0024176:LU [Geographic Area]
  1000   C2697939:LU [Quantitative Concept]

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.535: (2004) Cell 116, 671-682 Lee, G., Thangavel, R., Sharma, V. 

Phrase: "(2004"

Phrase: ")"

Phrase: "Cell 116,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0007634:Cell [Cell]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "671-682 Lee,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Thangavel,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Sharma,"

Phrase: "V."
Processing 00000000.tx.536: M., Litersky, J. 

Phrase: "M."

Phrase: ","

Phrase: "Litersky,"

Phrase: "J."
Processing 00000000.tx.537: M., Bhaskar, K., Fang, S. 

Phrase: "M."

Phrase: ","

Phrase: "Bhaskar,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Fang,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0227136:Fang [Body Part, Organ, or Organ Component]

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.538: M., Do, L. 

Phrase: "M."

Phrase: ","

Phrase: "Do"

Phrase: ","

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.539: H., Andreadis, A., Van Hoesen, G., and Ksiezak-Reding, H. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Andreadis,"

Phrase: "A.,"

Phrase: "Van Hoesen,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "Ksiezak-Reding,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.540: (2004) J. 

Phrase: "(2004"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.541: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.542: 24, 2304-2312[Abstract/Free FullText] Wenzel, H. 

Phrase: "24,"

Phrase: "2304-2312"

Phrase: "[Abstract/Free FullText"

Phrase: "] Wenzel,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.543: J., Cole, T. 

Phrase: "J.,"

Phrase: "Cole,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.544: B., Born, D. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Born"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0004897:Bear [Mammal]

Phrase: ","

Phrase: "D."
Processing 00000000.tx.545: E., Schwartzkroin, P. 

Phrase: "E.,"

Phrase: "Schwartzkroin,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.546: A., and Palmiter, R. 

Phrase: "A.,"

Phrase: "and"

Phrase: "Palmiter,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.547: D. 

Phrase: "D."
Processing 00000000.tx.548: (1997) Proc. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.549: Natl. 

Phrase: "Natl."
Processing 00000000.tx.550: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.551: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.552: U. 

Phrase: "U."
Processing 00000000.tx.553: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.554: A. 

Phrase: "A."
Processing 00000000.tx.555: 94, 12676-12681[Abstract/Free FullText] Manzerra, P., Behrens, M. 

Phrase: "94,"

Phrase: "12676-12681"

Phrase: "[Abstract/Free FullText"

Phrase: "] Manzerra,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Behrens,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.556: M., Canzoniero, L. 

Phrase: "M."

Phrase: ","

Phrase: "Canzoniero,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.557: M. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.558: T., Wang, X. 

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Wang,"

Phrase: "X."
Processing 00000000.tx.559: Q., Heidinger, V., Ichinose, T., Yu, S. 

Phrase: "Q., Heidinger,"

Phrase: "V.,"

Phrase: "Ichinose,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Yu,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1006780:yu [Plant]

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.560: P., and Choi, D. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "and"

Phrase: "Choi,"

Phrase: "D."
Processing 00000000.tx.561: W. 

Phrase: "W."
Processing 00000000.tx.562: (2001) Proc. 

Phrase: "(2001"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.563: Natl. 

Phrase: "Natl."
Processing 00000000.tx.564: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.565: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.566: U. 

Phrase: "U."
Processing 00000000.tx.567: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.568: A. 

Phrase: "A."
Processing 00000000.tx.569: 98, 11055-11061[Abstract/Free FullText] Seo, S. 

Phrase: "98,"

Phrase: "11055-11061"

Phrase: "[Abstract/Free FullText"

Phrase: "] Seo,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.570: R., Chong, S. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Chong,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.571: A., Lee, S.-I., Sung, J. 

Phrase: "A.,"

Phrase: "Lee,"

Phrase: "S.-I.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C2603362:S' [Clinical Attribute]

Phrase: "Sung,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0037173:SING [Geographic Area]
   966   C0234857:sing [Individual Behavior]

Phrase: "J."
Processing 00000000.tx.572: Y., Ahn, Y. 

Phrase: "Y.,"

Phrase: "Ahn,"

Phrase: "Y."
Processing 00000000.tx.573: S., Chung, K. 

Phrase: "S."

Phrase: ","

Phrase: "Chung,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.574: C., and Seo, J. 

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "and"

Phrase: "Seo,"

Phrase: "J."
Processing 00000000.tx.575: T. 

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.576: (2001) J. 

Phrase: "(2001"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.577: Neurochem. 

Phrase: "Neurochem."
Processing 00000000.tx.578: 78, 600-610[CrossRef][Medline] [OrderarticleviaInfotrieve] An, W.-L., Cowburn, R. 

Phrase: "78,"

Phrase: "600-610"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "]"

Phrase: "An,"

Phrase: "W.-L., Cowburn,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.579: F., Li, L., Braak, H., Alafuzoff, I., Iqbal, K., Iqbal, I.-G., Winblad, B., and Pel, J.-J. 

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Li,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3495095:Li+ [Element, Ion, or Isotope]

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Braak,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Alafuzoff,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Iqbal,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Iqbal,"

Phrase: "I.-G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Winblad,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "Pel,"

Phrase: "J.-J."
Processing 00000000.tx.580: (2003) Am. 

Phrase: "(2003"

Phrase: ")"

Phrase: "Am."
Processing 00000000.tx.581: J. 

Phrase: "J."
Processing 00000000.tx.582: Pathol. 

Phrase: "Pathol."
Processing 00000000.tx.583: 163, 591-607[Abstract/Free FullText] Murakami, K., Whiteley, M. 

Phrase: "163,"

Phrase: "591-607"

Phrase: "[Abstract/Free FullText"

Phrase: "] Murakami,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Whiteley,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.584: K., and Routtenberg, A. 

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Routtenberg,"

Phrase: "A."
Processing 00000000.tx.585: (1987) J. 

Phrase: "(1987"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.586: Biol. 

Phrase: "Biol."
Processing 00000000.tx.587: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.588: 262, 13902-13906[Abstract/Free FullText] Lengyel, I., Fieuw-Makaroff, S., Hall, A. 

Phrase: "262,"

Phrase: "13902-13906"

Phrase: "[Abstract/Free FullText"

Phrase: "] Lengyel,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Fieuw-Makaroff,"

Phrase: "S."

Phrase: ","

Phrase: "Hall,"

Phrase: "A."
Processing 00000000.tx.589: L., Sim, A. 

Phrase: "L., Sim,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1420068:SIM [Gene or Genome]

Phrase: "A."
Processing 00000000.tx.590: T. 

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.591: R., Rostas, J. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Rostas,"

Phrase: "J."
Processing 00000000.tx.592: A. 

Phrase: "A."
Processing 00000000.tx.593: P., and Dunkley, P. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "and"

Phrase: "Dunkley,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.594: R. 

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.595: (2000) J. 

Phrase: "(2000"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.596: Neurochem. 

Phrase: "Neurochem."
Processing 00000000.tx.597: 75, 594-605[CrossRef][Medline] [OrderarticleviaInfotrieve] Weinberger, R. 

Phrase: "75,"

Phrase: "594-605"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Weinberger,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.598: P., and Rostas, J. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "and"

Phrase: "Rostas,"

Phrase: "J."
Processing 00000000.tx.599: A. 

Phrase: "A."
Processing 00000000.tx.600: P. 

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.601: (1991) J. 

Phrase: "(1991"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.602: Neurochem. 

Phrase: "Neurochem."
Processing 00000000.tx.603: 57, 605-614[Medline] [OrderarticleviaInfotrieve] Csermely, P., Szamel, M., Resch, K., and Somogyi, J. 

Phrase: "57,"

Phrase: "605-614"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Csermely,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Szamel,"

Phrase: "M."

Phrase: ","

Phrase: "Resch,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Somogyi,"

Phrase: "J."
Processing 00000000.tx.604: (1988) J. 

Phrase: "(1988"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.605: Biol. 

Phrase: "Biol."
Processing 00000000.tx.606: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.607: 263, 6487-6490[Abstract/Free FullText] Kim, S., Jung, Y., Kim, D., Koh, H., and Chung, J. 

Phrase: "263,"

Phrase: "6487-6490"

Phrase: "[Abstract/Free FullText"

Phrase: "] Kim,"

Phrase: "S."

Phrase: ","

Phrase: "Jung,"

Phrase: "Y.,"

Phrase: "Kim,"

Phrase: "D."

Phrase: ","

Phrase: "Koh,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0071767:KOH [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Chung,"

Phrase: "J."
Processing 00000000.tx.608: (2000) J. 

Phrase: "(2000"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.609: Biol. 

Phrase: "Biol."
Processing 00000000.tx.610: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.611: 275, 25979-25984[Abstract/Free FullText] Buttini, M., Orth, M., Bellosta, S., Akeefe, H., Pitas, R. 

Phrase: "275,"

Phrase: "25979-25984"

Phrase: "[Abstract/Free FullText"

Phrase: "] Buttini,"

Phrase: "M."

Phrase: ","

Phrase: "Orth,"

Phrase: "M."

Phrase: ","

Phrase: "Bellosta,"

Phrase: "S."

Phrase: ","

Phrase: "Akeefe,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Pitas,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.612: E., Wyss-Coray, T., Mucke, L., and Mahley, R. 

Phrase: "E.,"

Phrase: "Wyss-Coray,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Mucke,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "and"

Phrase: "Mahley,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.613: W. 

Phrase: "W."
Processing 00000000.tx.614: (1999) J. 

Phrase: "(1999"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.615: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.616: 19, 4867-4880[Abstract/Free FullText] Huang, Y., Liu, X. 

Phrase: "19,"

Phrase: "4867-4880"

Phrase: "[Abstract/Free FullText"

Phrase: "] Huang,"

Phrase: "Y.,"

Phrase: "Liu,"

Phrase: "X."
Processing 00000000.tx.617: Q., Rall, S. 

Phrase: "Q., Rall,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.618: C., Jr., Taylor, J. 

Phrase: "C., Jr.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1708595:Jr [Idea or Concept]
   861   C3280986:JR [Disease or Syndrome]

Phrase: "Taylor,"

Phrase: "J."
Processing 00000000.tx.619: M., von Eckardstein, A., Assmann, G., and Mahley, R. 

Phrase: "M."

Phrase: ","

Phrase: "von Eckardstein,"

Phrase: "A.,"

Phrase: "Assmann,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "Mahley,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.620: W. 

Phrase: "W."
Processing 00000000.tx.621: (1998) J. 

Phrase: "(1998"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.622: Biol. 

Phrase: "Biol."
Processing 00000000.tx.623: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.624: 273, 26388-26393[Abstract/Free FullText] Fiore, R. 

Phrase: "273,"

Phrase: "26388-26393"

Phrase: "[Abstract/Free FullText"

Phrase: "] Fiore,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.625: S., Bayer, V. 

Phrase: "S."

Phrase: ","

Phrase: "Bayer,"

Phrase: "V."
Processing 00000000.tx.626: E., Pelech, S. 

Phrase: "E.,"

Phrase: "Pelech,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.627: L., Posada, J., Cooper, J. 

Phrase: "L., Posada,"

Phrase: "J.,"

Phrase: "Cooper,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0335912:Cooper [Professional or Occupational Group]

Phrase: "J."
Processing 00000000.tx.628: A., and Baraban, J. 

Phrase: "A.,"

Phrase: "and"

Phrase: "Baraban,"

Phrase: "J."
Processing 00000000.tx.629: M. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.630: (1993) Neuroscience 55, 463-472[CrossRef][Medline] [OrderarticleviaInfotrieve] Mandelkow, E.-M., Drewes, G., Biernat, J., Gustke, N., Van Lint, J., Vandenheede, J. 

Phrase: "(1993"

Phrase: ")"

Phrase: "Neuroscience 55,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0027910:Neuroscience [Biomedical Occupation or Discipline]
   861   C0450382:55 [Intellectual Product]
   861   C1552241:Neuroscience [Professional or Occupational Group]
   861   C1555991:Neuroscience [Professional or Occupational Group]

Phrase: "463-472"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Mandelkow,"

Phrase: "E.-M.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Drewes,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Biernat,"

Phrase: "J.,"

Phrase: "Gustke,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Van Lint,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0460968:lint [Medical Device]

Phrase: "J.,"

Phrase: "Vandenheede,"

Phrase: "J."
Processing 00000000.tx.631: R., and Mandelkow, E. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Mandelkow,"

Phrase: "E."
Processing 00000000.tx.632: (1992) FEBS Lett. 

Phrase: "(1992"

Phrase: ")"

Phrase: "FEBS Lett."
Processing 00000000.tx.633: 314, 315-321[CrossRef][Medline] [OrderarticleviaInfotrieve] Mandelkow, E.-M., Schweers, O., Drewes, G., Biernat, J., Gustke, N., Trinczek, B., and Mandelkow, E. 

Phrase: "314,"

Phrase: "315-321"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Mandelkow,"

Phrase: "E.-M.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Schweers,"

Phrase: "O.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]

Phrase: "Drewes,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Biernat,"

Phrase: "J.,"

Phrase: "Gustke,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Trinczek,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "Mandelkow,"

Phrase: "E."
Processing 00000000.tx.634: (1996) Ann. 

Phrase: "(1996"

Phrase: ")"

Phrase: "Ann."
Processing 00000000.tx.635: N. 

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.636: Y. 

Phrase: "Y."
Processing 00000000.tx.637: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.638: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.639: 777, 96-106[Abstract] Hyman, B. 

Phrase: "777,"

Phrase: "96-106"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Hyman,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.640: T., Elvhage, T. 

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Elvhage,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.641: E., and Reiter, J. 

Phrase: "E.,"

Phrase: "and"

Phrase: "Reiter,"

Phrase: "J."
Processing 00000000.tx.642: (1994) Am. 

Phrase: "(1994"

Phrase: ")"

Phrase: "Am."
Processing 00000000.tx.643: J. 

Phrase: "J."
Processing 00000000.tx.644: Pathol. 

Phrase: "Pathol."
Processing 00000000.tx.645: 144, 565-572[Abstract] Ferrer, I., Blanco, R., Carmona, M., Ribera, R., Goutan, E., Puig, B., Rey, M. 

Phrase: "144,"

Phrase: "565-572"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Ferrer,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Blanco,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Carmona,"

Phrase: "M."

Phrase: ","

Phrase: "Ribera,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Goutan,"

Phrase: "E.,"

Phrase: "Puig,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Rey,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.646: J., Cardozo, A., Vials, F., and Ribalta, T. 

Phrase: "J.,"

Phrase: "Cardozo,"

Phrase: "A.,"

Phrase: "Vials,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0184301:vials [Medical Device]
  1000   C1533199:Vials [Quantitative Concept]
   966 E C1706497:VIAL [Medical Device]

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "and"

Phrase: "Ribalta,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.647: (2001) Brain Pathol. 

Phrase: "(2001"

Phrase: ")"

Phrase: "Brain Pathol."
Processing 00000000.tx.648: 11, 144-158[Medline] [OrderarticleviaInfotrieve] Pei, J.-J., Braak, H., An, W.-L., Winblad, B., Cowburn, R. 

Phrase: "11,"

Phrase: "144-158"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Pei,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0814202:PEI [Intellectual Product]
  1000   C1880568:PEI [Therapeutic or Preventive Procedure]

Phrase: "J.-J.,"

Phrase: "Braak,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "An,"

Phrase: "W.-L., Winblad,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Cowburn,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.649: F., Iqbal, K., and Grundke-Iqbal, I. 

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Iqbal,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Grundke-Iqbal,"

Phrase: "I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.650: (2002) Mol. 

Phrase: "(2002"

Phrase: ")"

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.651: Brain Res. 

Phrase: "Brain Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347379:RES [Finding]
Processing 00000000.tx.652: 109, 45-55[Medline] [OrderarticleviaInfotrieve] Trojanowski, J. 

Phrase: "109,"

Phrase: "45-55"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450382:55 [Intellectual Product]

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Trojanowski,"

Phrase: "J."
Processing 00000000.tx.653: Q., Mawal-Dewan, M., Schmidt, M. 

Phrase: "Q., Mawal-Dewan,"

Phrase: "M."

Phrase: ","

Phrase: "Schmidt,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.654: L., Martin, J., and Lee, V. 

Phrase: "L., Martin,"

Phrase: "J.,"

Phrase: "and"

Phrase: "Lee,"

Phrase: "V."
Processing 00000000.tx.655: M.-Y. 

Phrase: "M.-"

Phrase: "Y."
Processing 00000000.tx.656: (1993) Brain Res. 

Phrase: "(1993"

Phrase: ")"

Phrase: "Brain Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347379:RES [Finding]
Processing 00000000.tx.657: 618, 333-337[CrossRef][Medline] [OrderarticleviaInfotrieve] Korneyev, A. 

Phrase: "618,"

Phrase: "333-337"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Korneyev,"

Phrase: "A."
Processing 00000000.tx.658: Y. 

Phrase: "Y."
Processing 00000000.tx.659: (1998) Neurochem. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Neurochem."
Processing 00000000.tx.660: Res. 

Phrase: "Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347379:RES [Finding]
Processing 00000000.tx.661: 23, 1539-1543[CrossRef][Medline] [OrderarticleviaInfotrieve] Drewes, G., Lichtenberg-Kraag, B., Dring, F., Mandelkow, E.-M., Biernat, J., Goris, J., Dore, M., and Mandelkow, E. 

Phrase: "23,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: "1539-1543"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Drewes,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Lichtenberg-Kraag,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Dring,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Mandelkow,"

Phrase: "E.-M.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Biernat,"

Phrase: "J.,"

Phrase: "Goris,"

Phrase: "J.,"

Phrase: "Dore,"

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Mandelkow,"

Phrase: "E."
Processing 00000000.tx.662: (1992) EMBO J. 

Phrase: "(1992"

Phrase: ")"

Phrase: "EMBO J."
Processing 00000000.tx.663: 11, 2131-2138[Abstract] Goedert, M., Cohen, E. 

Phrase: "11,"

Phrase: "2131-2138"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Goedert,"

Phrase: "M."

Phrase: ","

Phrase: "Cohen,"

Phrase: "E."
Processing 00000000.tx.664: S., Jakes, R., and Cohen, P. 

Phrase: "S."

Phrase: ","

Phrase: "Jakes,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Cohen,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.665: (1992) FEBS Lett. 

Phrase: "(1992"

Phrase: ")"

Phrase: "FEBS Lett."
Processing 00000000.tx.666: 312, 95-99[CrossRef][Medline] [OrderarticleviaInfotrieve] Ledesma, M. 

Phrase: "312,"

Phrase: "95-99"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Ledesma,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.667: D., Correas, I., Avila, J., and Daz-Nido, J. 

Phrase: "D."

Phrase: ","

Phrase: "Correas,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Avila,"

Phrase: "J.,"

Phrase: "and"

Phrase: "Daz-Nido,"

Phrase: "J."
Processing 00000000.tx.668: (1992) FEBS Lett. 

Phrase: "(1992"

Phrase: ")"

Phrase: "FEBS Lett."
Processing 00000000.tx.669: 308, 218-224[CrossRef][Medline] [OrderarticleviaInfotrieve] Hyman, B. 

Phrase: "308,"

Phrase: "218-224"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Hyman,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.670: T., Reiter, J., Moss, M., Rosene, D., and Pandya, D. 

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Reiter,"

Phrase: "J.,"

Phrase: "Moss,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0282635:Moss [Plant]

Phrase: "M."

Phrase: ","

Phrase: "Rosene,"

Phrase: "D."

Phrase: ","

Phrase: "and"

Phrase: "Pandya,"

Phrase: "D."
Processing 00000000.tx.671: (1994) Neurosci. 

Phrase: "(1994"

Phrase: ")"

Phrase: "Neurosci."
Processing 00000000.tx.672: Lett. 

Phrase: "Lett."
Processing 00000000.tx.673: 166, 113-116[CrossRef][Medline] [OrderarticleviaInfotrieve] Westbrook, G. 

Phrase: "166,"

Phrase: "113-116"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Westbrook,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.674: L., and Mayer, M. 

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "and"

Phrase: "Mayer,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.675: L. 

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.676: (1987) Nature 328, 640-643[CrossRef][Medline] [OrderarticleviaInfotrieve] Peters, S., Koh, J., and Choi, D. 

Phrase: "(1987"

Phrase: ")"

Phrase: "Nature 328,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: "640-643"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Peters,"

Phrase: "S."

Phrase: ","

Phrase: "Koh,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0071767:KOH [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "J.,"

Phrase: "and"

Phrase: "Choi,"

Phrase: "D."
Processing 00000000.tx.677: W. 

Phrase: "W."
Processing 00000000.tx.678: (1987) Science 236, 589-593[Medline] [OrderarticleviaInfotrieve] Legendre, P., and Westbrook, G. 

Phrase: "(1987"

Phrase: ")"

Phrase: "Science 236,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036397:Science [Occupation or Discipline]

Phrase: "589-593"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Legendre,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "and"

Phrase: "Westbrook,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.679: L. 

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.680: (1990) J. 

Phrase: "(1990"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.681: Physiol. 

Phrase: "Physiol."
Processing 00000000.tx.682: 429, 429-449[Abstract] Forsythe, I. 

Phrase: "429,"

Phrase: "429-449"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Forsythe,"

Phrase: "I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.683: D., Westbrook, G. 

Phrase: "D."

Phrase: ","

Phrase: "Westbrook,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.684: L., and Mayer, M. 

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "and"

Phrase: "Mayer,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.685: L. 

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.686: (1988) J. 

Phrase: "(1988"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.687: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.688: 8, 3733-3741[Abstract] Vogt, K., Mellor, J., Tong, G., and Nicoll, R. 

Phrase: "8,"

Phrase: "3733-3741"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Vogt,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Mellor,"

Phrase: "J.,"

Phrase: "Tong,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0183964:Tong [Medical Device]

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "Nicoll,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.689: (2000) Neuron 26, 187-196[Medline] [OrderarticleviaInfotrieve] Weiss, J. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Neuron 26,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0027882:Neuron [Cell]
   789 E C0521390:Neuronal [Immunologic Factor]

Phrase: "187-196"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Weiss,"

Phrase: "J."
Processing 00000000.tx.690: H., Sensi, S. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Sensi,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.691: L., and Koh, J. 

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "and"

Phrase: "Koh,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0071767:KOH [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "J."
Processing 00000000.tx.692: Y. 

Phrase: "Y."
Processing 00000000.tx.693: (2000) Trends Pharmacol. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Trends"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0040833:trends [Temporal Concept]
  1000   C1521798:Trends [Temporal Concept]

Phrase: "Pharmacol."
Processing 00000000.tx.694: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.695: 21, 395-401[CrossRef][Medline] [OrderarticleviaInfotrieve] Choi, D. 

Phrase: "21,"

Phrase: "395-401"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Choi,"

Phrase: "D."
Processing 00000000.tx.696: W., Yokoyama, M., and Koh, J. 

Phrase: "W., Yokoyama,"

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Koh,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0071767:KOH [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "J."
Processing 00000000.tx.697: (1988) Neuroscience 24, 67-79[CrossRef][Medline] [OrderarticleviaInfotrieve] Tnder, N., Johansen, F. 

Phrase: "(1988"

Phrase: ")"

Phrase: "Neuroscience 24,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0027910:Neuroscience [Biomedical Occupation or Discipline]
   861   C1552241:Neuroscience [Professional or Occupational Group]
   861   C1555991:Neuroscience [Professional or Occupational Group]

Phrase: "67-79"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Tnder,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Johansen,"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.698: F., Frederickson, C. 

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Frederickson,"

Phrase: "C."
Processing 00000000.tx.699: J., Zimmer, J., and Diemer, N. 

Phrase: "J.,"

Phrase: "Zimmer,"

Phrase: "J.,"

Phrase: "and"

Phrase: "Diemer,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.700: H. 

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.701: (1990) Neurosci. 

Phrase: "(1990"

Phrase: ")"

Phrase: "Neurosci."
Processing 00000000.tx.702: Lett. 

Phrase: "Lett."
Processing 00000000.tx.703: 109, 247-252[CrossRef][Medline] [OrderarticleviaInfotrieve] Koh, J.-Y., Suh, S. 

Phrase: "109,"

Phrase: "247-252"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Koh,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0071767:KOH [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "J.-Y.,"

Phrase: "Suh,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1416171:SUH [Gene or Genome]
  1000   C1422188:SUH [Gene or Genome]

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.704: W., Gwag, B. 

Phrase: "W., Gwag,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.705: J., He, Y. 

Phrase: "J.,"

Phrase: "He,"

Phrase: "Y."
Processing 00000000.tx.706: Y., Hsu, C. 

Phrase: "Y.,"

Phrase: "Hsu,"

Phrase: "C."
Processing 00000000.tx.707: Y., and Choi, D. 

Phrase: "Y.,"

Phrase: "and"

Phrase: "Choi,"

Phrase: "D."
Processing 00000000.tx.708: W. 

Phrase: "W."
Processing 00000000.tx.709: (1996) Science 272, 1013-1016[Abstract] Suh, S. 

Phrase: "(1996"

Phrase: ")"

Phrase: "Science 272,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036397:Science [Occupation or Discipline]

Phrase: "1013-1016"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Suh,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1416171:SUH [Gene or Genome]
  1000   C1422188:SUH [Gene or Genome]

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.710: W., Chen, J. 

Phrase: "W., Chen,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0999213:Chen [Bird]

Phrase: "J."
Processing 00000000.tx.711: W., Motamedi, M., Bell, B., Listiak, K., Pons, N. 

Phrase: "W., Motamedi,"

Phrase: "M."

Phrase: ","

Phrase: "Bell,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1706917:Bell [Manufactured Object]

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Listiak,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Pons,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0032639:Pons [Body Part, Organ, or Organ Component]
  1000   C1280999:Pons [Body Part, Organ, or Organ Component]
   966 E C1418754:PON [Gene or Genome]
   966 E C1709588:PON [Mammal]

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.712: F., Danscher, G., and Frederickson, C. 

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Danscher,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "Frederickson,"

Phrase: "C."
Processing 00000000.tx.713: J. 

Phrase: "J."
Processing 00000000.tx.714: (2000) Brain Res. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Brain Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347379:RES [Finding]
Processing 00000000.tx.715: 852, 268-273[CrossRef][Medline] [OrderarticleviaInfotrieve] Deibel, M. 

Phrase: "852,"

Phrase: "268-273"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Deibel,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.716: A., Ehmann, W. 

Phrase: "A.,"

Phrase: "Ehmann,"

Phrase: "W."
Processing 00000000.tx.717: D., and Markesbery, W. 

Phrase: "D."

Phrase: ","

Phrase: "and"

Phrase: "Markesbery,"

Phrase: "W."
Processing 00000000.tx.718: R. 

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.719: (1996) J. 

Phrase: "(1996"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.720: Neurol. 

Phrase: "Neurol."
Processing 00000000.tx.721: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.722: 143, 137-142[CrossRef][Medline] [OrderarticleviaInfotrieve] Danscher, G., Jensen, K. 

Phrase: "143,"

Phrase: "137-142"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Danscher,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Jensen,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.723: B., Frederickson, C. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Frederickson,"

Phrase: "C."
Processing 00000000.tx.724: J., Kemp, K., Andreasen, A., Juhl, S., Stoltenberg, M., and Ravid, R. 

Phrase: "J.,"

Phrase: "Kemp,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Andreasen,"

Phrase: "A.,"

Phrase: "Juhl,"

Phrase: "S."

Phrase: ","

Phrase: "Stoltenberg,"

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Ravid,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.725: (1997) J. 

Phrase: "(1997"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.726: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.727: Methods 76, 53-59[CrossRef][Medline] [OrderarticleviaInfotrieve] Lovell, M. 

Phrase: "Methods 76,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0025663:Methods [Intellectual Product]
   861   C0025664:methods [Intellectual Product]
   861   C0449851:Methods [Functional Concept]
   827 E C0871511:METHOD [Intellectual Product]

Phrase: "53-59"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Lovell,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.728: A., Robertson, J. 

Phrase: "A.,"

Phrase: "Robertson,"

Phrase: "J."
Processing 00000000.tx.729: D., Teesdale, W. 

Phrase: "D."

Phrase: ","

Phrase: "Teesdale,"

Phrase: "W."
Processing 00000000.tx.730: J., Campbell, J. 

Phrase: "J.,"

Phrase: "Campbell,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0331936:Campbell [Health Care Related Organization]

Phrase: "J."
Processing 00000000.tx.731: L., and Markesbery, W. 

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "and"

Phrase: "Markesbery,"

Phrase: "W."
Processing 00000000.tx.732: R. 

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.733: (1998) J. 

Phrase: "(1998"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.734: Neurol. 

Phrase: "Neurol."
Processing 00000000.tx.735: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.736: 158, 47-52[CrossRef][Medline] [OrderarticleviaInfotrieve] Gonzlez, C., Martn, T., Cacho, J., Breas, M. 

Phrase: "158,"

Phrase: "47-52"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Gonzlez,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Martn,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Cacho,"

Phrase: "J.,"

Phrase: "Breas,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.737: T., Arroyo, T., Garca-Berrocal, B., Navajo, J. 

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Arroyo,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Garca-Berrocal,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Navajo,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0337879:Navaho [Population Group]
  1000   C0574545:Navajo [Language]

Phrase: "J."
Processing 00000000.tx.738: A., and Gonzlez-Buitrago, J. 

Phrase: "A.,"

Phrase: "and"

Phrase: "Gonzlez-Buitrago,"

Phrase: "J."
Processing 00000000.tx.739: M. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.740: (1999) Eur. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Eur."
Processing 00000000.tx.741: J. 

Phrase: "J."
Processing 00000000.tx.742: Clin. 

Phrase: "Clin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1315013:CLIN [Intellectual Product]
Processing 00000000.tx.743: Investig. 

Phrase: "Investig."
Processing 00000000.tx.744: 29, 637-642[CrossRef][Medline] [OrderarticleviaInfotrieve] Bush, A. 

Phrase: "29,"

Phrase: "637-642"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Bush,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0330099:Bush [Plant]

Phrase: "A."
Processing 00000000.tx.745: I., Pettingell, W. 

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Pettingell,"

Phrase: "W."
Processing 00000000.tx.746: H., Multhaup, G., Paradis, M. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Multhaup,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Paradis,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.747: D., Vonsattel, J. 

Phrase: "D."

Phrase: ","

Phrase: "Vonsattel,"

Phrase: "J."
Processing 00000000.tx.748: P., Gusella, J. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Gusella,"

Phrase: "J."
Processing 00000000.tx.749: F., Beyreuther, K., Masters, C. 

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Beyreuther,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Masters,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0444649:Master [Qualitative Concept]

Phrase: "C."
Processing 00000000.tx.750: L., and Tanzi, R. 

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "and"

Phrase: "Tanzi,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.751: E. 

Phrase: "E."
Processing 00000000.tx.752: (1994) Science 265, 1464-1467[Medline] [OrderarticleviaInfotrieve] Moir, R. 

Phrase: "(1994"

Phrase: ")"

Phrase: "Science 265,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036397:Science [Occupation or Discipline]

Phrase: "1464-1467"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Moir,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.753: D., Atwood, C. 

Phrase: "D."

Phrase: ","

Phrase: "Atwood,"

Phrase: "C."
Processing 00000000.tx.754: S., Romano, D. 

Phrase: "S."

Phrase: ","

Phrase: "Romano,"

Phrase: "D."
Processing 00000000.tx.755: M., Laurans, M. 

Phrase: "M."

Phrase: ","

Phrase: "Laurans,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.756: H., Huang, X., Bush, A. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Huang,"

Phrase: "X.,"

Phrase: "Bush,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0330099:Bush [Plant]

Phrase: "A."
Processing 00000000.tx.757: I., Smith, J. 

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Smith,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0554249:Smith [Professional or Occupational Group]

Phrase: "J."
Processing 00000000.tx.758: D., and Tanzi, R. 

Phrase: "D."

Phrase: ","

Phrase: "and"

Phrase: "Tanzi,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.759: E. 

Phrase: "E."
Processing 00000000.tx.760: (1999) Biochemistry 38, 4595-4603[CrossRef][Medline] [OrderarticleviaInfotrieve] Lee, J.-Y., Cole, T. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Biochemistry 38,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0005477:Biochemistry [Occupation or Discipline]

Phrase: "4595-4603"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Lee,"

Phrase: "J.-Y.,"

Phrase: "Cole,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.761: B., Palmiter, R. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Palmiter,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.762: D., Suh, S. 

Phrase: "D."

Phrase: ","

Phrase: "Suh,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1416171:SUH [Gene or Genome]
  1000   C1422188:SUH [Gene or Genome]

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.763: W., and Koh, J.-Y. 

Phrase: "W.,"

Phrase: "and"

Phrase: "Koh,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0071767:KOH [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "J.-Y."
Processing 00000000.tx.764: (2002) Proc. 

Phrase: "(2002"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.765: Natl. 

Phrase: "Natl."
Processing 00000000.tx.766: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.767: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.768: U. 

Phrase: "U."
Processing 00000000.tx.769: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.770: A. 

Phrase: "A."
Processing 00000000.tx.771: 99, 7705-7710[Abstract/Free FullText] Cherny, R. 

Phrase: "99,"

Phrase: "7705-7710"

Phrase: "[Abstract/Free FullText"

Phrase: "] Cherny,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.772: A., Atwood, C. 

Phrase: "A.,"

Phrase: "Atwood,"

Phrase: "C."
Processing 00000000.tx.773: S., Xilinas, M. 

Phrase: "S."

Phrase: ","

Phrase: "Xilinas,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.774: E., Gray, D. 

Phrase: "E.,"

Phrase: "Gray,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0556636:gray [Quantitative Concept]
  1000   C1269776:Gray [Qualitative Concept]

Phrase: "D."
Processing 00000000.tx.775: N., Jones, W. 

Phrase: "N., Jones,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0443013:Jones [Intellectual Product]

Phrase: "W."
Processing 00000000.tx.776: D., McLean, C. 

Phrase: "D."

Phrase: ","

Phrase: "McLean,"

Phrase: "C."
Processing 00000000.tx.777: A., Barnham, K. 

Phrase: "A.,"

Phrase: "Barnham,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.778: J., Volitakis, I., Fraser, F. 

Phrase: "J.,"

Phrase: "Volitakis,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Fraser,"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.779: W., Kim, Y.-S., Huang, X., Goldstein, L. 

Phrase: "W., Kim,"

Phrase: "Y.-S.,"

Phrase: "Huang,"

Phrase: "X.,"

Phrase: "Goldstein,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.780: E., Moir, R. 

Phrase: "E.,"

Phrase: "Moir,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.781: D., Lim, J. 

Phrase: "D."

Phrase: ","

Phrase: "Lim,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0449205:LIM [Body Location or Region]
  1000   C1538613:LIM [Gene or Genome]

Phrase: "J."
Processing 00000000.tx.782: T., Beyreuther, K., Zheng, H., Tanzi, R. 

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Beyreuther,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Zheng,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986502:Zheng [Therapeutic or Preventive Procedure]

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Tanzi,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.783: E., Masters, C. 

Phrase: "E.,"

Phrase: "Masters,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0444649:Master [Qualitative Concept]

Phrase: "C."
Processing 00000000.tx.784: L., and Bush, A. 

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "and"

Phrase: "Bush,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0330099:Bush [Plant]

Phrase: "A."
Processing 00000000.tx.785: I. 

Phrase: "I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.786: (2001) Neuron 30, 665-676[CrossRef][Medline] [OrderarticleviaInfotrieve] Assaf, S. 

Phrase: "(2001"

Phrase: ")"

Phrase: "Neuron 30,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0027882:Neuron [Cell]
   789 E C0521390:Neuronal [Immunologic Factor]

Phrase: "665-676"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Assaf,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.787: Y., and Chung, S.-H. 

Phrase: "Y.,"

Phrase: "and"

Phrase: "Chung,"

Phrase: "S.-"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.788: (1984) Nature 308, 734-736[Medline] [OrderarticleviaInfotrieve] Howell, G. 

Phrase: "(1984"

Phrase: ")"

Phrase: "Nature 308,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: "734-736"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Howell,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.789: A., Welch, M. 

Phrase: "A.,"

Phrase: "Welch"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043114:Welsh [Population Group]

Phrase: ","

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.790: G., and Frederickson, C. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "Frederickson,"

Phrase: "C."
Processing 00000000.tx.791: J. 

Phrase: "J."
Processing 00000000.tx.792: (1984) Nature 308, 736-738[Medline] [OrderarticleviaInfotrieve] Buttini, M., Akeefe, H., Lin, C., Mahley, R. 

Phrase: "(1984"

Phrase: ")"

Phrase: "Nature 308,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: "736-738"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Buttini,"

Phrase: "M."

Phrase: ","

Phrase: "Akeefe,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Lin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0861352:LIN [Neoplastic Process]

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Mahley,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.793: W., Pitas, R. 

Phrase: "W., Pitas,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.794: E., Wyss-Coray, T., and Mucke, L. 

Phrase: "E.,"

Phrase: "Wyss-Coray,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "and"

Phrase: "Mucke,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.795: (2000) Neuroscience 97, 207-210[CrossRef][Medline] [OrderarticleviaInfotrieve] Buttini, M., Yu, G.-Q., Shockley, K., Huang, Y., Jones, B., Masliah, E., Mallory, M., Yeo, T., Longo, F. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Neuroscience 97,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0027910:Neuroscience [Biomedical Occupation or Discipline]
   861   C0439073:97 [Intellectual Product]
   861   C0439082:>97 [Quantitative Concept]
   861   C1552241:Neuroscience [Professional or Occupational Group]
   861   C1555991:Neuroscience [Professional or Occupational Group]

Phrase: "207-210"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Buttini,"

Phrase: "M."

Phrase: ","

Phrase: "Yu,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1006780:yu [Plant]

Phrase: "G.-Q., Shockley,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Huang,"

Phrase: "Y.,"

Phrase: "Jones,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443013:Jones [Intellectual Product]

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Masliah,"

Phrase: "E.,"

Phrase: "Mallory,"

Phrase: "M."

Phrase: ","

Phrase: "Yeo,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Longo,"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.796: M., and Mucke, L. 

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Mucke,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.797: (2002) J. 

Phrase: "(2002"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.798: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.799: 22, 10539-10548[Abstract/Free FullText]

Phrase: "22,"

Phrase: "10539-10548"

Phrase: "[Abstract/Free FullText"

Phrase: "]"

